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A  conforming bandage must:
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■ have controlled stretch to 
create moderate compres­
sion without causing 
constriction
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softness for patients’ comfort 
be absorbent 
and, it should almost be...
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Unusual Gastric Foreign 
Bodies
To the editors. I read with great 
interest the article by Kuzon and 
colleagues on the management of 
intragastric foreign bodies, which 
appeared in the November 1988 
issue (pages 413-417). It called to 
mind a much earlier and similar 
report by W.S. Halsted,1 which was 
unusual in that his case was one of 
the first in which the x-ray was 
used to establish a preoperative 
diagnosis.
Halsted supplies the following in­
ventory of foreign objects removed 
at the time of gastrotomy: 28 pieces 
of chain that totalled 594 cm in 
length, 99 nails of assorted sizes, 
81 screws, tacks, pins, knife blades 
and knife handles of assorted sizes 
and 74 g of broken glass.
Like Kuzon’s patient, Halsted’s 
suffered from a psychopathologic 
condition. He is said to have made a
living by swallowing foreign objects 
for a price and, on the evening 
preceding his hospital admission 
and surgery, he apparently had 
acted as entertainer at a party of 
medical students. It seems that mat­
ters got somewhat out of hand!
Halsted’s patient convalesced sat­
isfactorily following operation al­
though, since no follow-up informa­
tion was provided, nothing is 
known of the patient’s further di­
etary practices.
W.B. Firor, MD, FRCPC
Department o f  Medicine.
University Hospital,
University o f  Saskatchewan.
Saskatoon, Sask.
S7N 0X0
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Doctor or Mister?
To the editors. I read with interest 
Eibel’s paper entitled “Doctor or 
Mister (the correct appellation of 
British surgeons)” (Can J Surg 
1988; 31: 452-453). The histori­
cal background of the British sur­
geon offers the clue to the custom 
of using “Mr.” to address a British 
surgeon. I always understood that 
“Dr.” in British medical practice 
was most frequently an honorary 
term and that the university degree, 
Bachelor of Medicine and Bachelor 
of Surgery, entitles the majority of 
British doctors to nothing other 
than “ Mr.”. The term “Dr.” is 
correct only for those who hold a 
doctorate in medicine which is a 
degree comparable to the D.Phil.
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CAIRNS
There is no doctorate in surgery. 
Dr. Eibel is correct in pointing out 
that the surgical degree is one of 
Master of Surgery. The correct ap­
pellation in this instance would be 
“ Master” or as it is used more 
commonly “ Mr.” .
It seems strange to me that any-
BOOK REVIEWS
BIOLOGY OF LUNG CANCER. Diag­
nosis and Treatment. Edited by Steven 
T. Rosen, James L. Mulshine, Frank 
Cuttitta and Paul G. Abrams. 362 pp. 
Illust. Marcel Dekker, Inc., New York, 
1988. $99.50 (US). ISBN 0-8247- 
7642-9.
The editors’ objective, stated in the 
preface to this slim, well-produced vol­
ume, is to produce a comprehensive 
review of important recent advances in 
our understanding of the basic cellular 
and molecular biology of lung cancer. 
This is a collection of papers on the 
results obtained by the application of 
new techniques in biochemical markers, 
growth factors, oncogenes and im­
munology to lung cancer. Although its 
subtitle suggests a clinical orientation, 
the text deals almost exclusively with 
results from laboratory based research 
on human tissue or cell lines. An up-to- 
date review of antigens associated with 
lung cancer and immunotherapy trials 
is the only paper with a clinical orienta­
tion. Thus, this book is directed to 
specialists in lung cancer, particularly 
those interested in current research, 
which, by turning up a host of observa­
tions, may give new insights appropri­
ate for clinical testing.
The book includes papers by experts 
in the field, with the largest representa­
tion from the National Cancer Institute 
in Washington. There is a concise open­
ing chapter on current views of the 
histologic patterns and the pathobiolog- 
ic information they convey. This is 
followed by descriptions of several bio­
chemical markers, autocrine growth 
factors and peptides, whose presence 
may yield more precise categorization 
of these heterogeneous tumours. An
one in North America would regard 
it as denigration to be addressed as 
“ Mr.” . I can assure you that a 
London surgeon would consider it a 
denigration to be referred to as 
“ Dr.” . These are curious customs 
but have age-old precedents to sup­
port them. They have a certain
excellent overview of oncogenetics in 
lung cancer is presented. Two chapters 
describe the characterization of tumour 
antigens in small-cell and non-small-cell 
cancer. The final chapters cover the use 
of monoclonal antitumour antibodies in 
diagnosis and therapy, with and without 
conjugation of the antibody with cyto­
toxic drugs.
This book is up to date, well refer­
enced and has clear diagrams and pho­
tographs. There is little doubt that our 
future understanding of lung cancer 
will be based on much of the science 
presented in this book. An overview of 
the biologic background and future 
directions as they relate to these papers 
would have helped in placing this book 
in perspective for non-experts and clini­
cians in the field. The book certainly 
deserves a place in libraries, institution­
al or private, and will be a useful 
reference work for all clinicians and 
scientists involved with lung cancer.
D. Payne, MD, FRCPC
Department o f Radiation Oncology,
Princess Margaret Hospital,
500 Sherbourne St.,
Toronto, Ont.
M4X 1K9
BREAST CANCER. Collaborative Man­
agement. Edited by Jay K. Harness, 
Harold A. Oberman, Allen S. Lichter, 
Dorit D. Adler and Robert L. Cody. 
390 pp. Illust. Lewis Publishers, Inc., 
Chelsea, Mich., 1988. $69.95 (US). 
ISBN 0-87371-106-8.
This is a collection of presentations 
from a conference sponsored by the 
University of Michigan Breast Cancer
charm even if they appear perverse 
to others, rather like driving on the 
left hand side of the road!
J.D. Cairns, MD, FACS, FRCSC 
Ste. 215,
1333 Sheppard Ave. E,
Willowdale, Ont.
M2J 1VI
Center after it had been in operation for 
2 years. Most of the 30 authors are 
from the centre. The book begins with 
a good, albeit brief, review of the cur­
rent biologic concept of the behaviour 
of breast cancer. To manage a disease, 
one should understand it. Unfortunate­
ly, most of the other authors do not 
appear to be familiar with the modern 
concept of breast cancer and revert to 
the Halstedian step-by-step view.
Although there is a neat, brief chap­
ter describing the technique of segmen­
tal mastectomy, axillary dissection is 
not described. Indeed, in subsequent 
chapters, a preference for total mastec­
tomy is evident and breast-conserving 
surgery without radiation is not even 
considered.
Three chapters deal in some detail 
with the dilemmas of the contralateral 
breast, occult carcinomas and Paget’s 
disease and management of breast can­
cer in pregnancy in young women. In 
this book, however, little or no personal 
experience is offered, and since some 
recent reports are not mentioned, the 
recommendations are traditional and 
unnecessarily aggressive.
One-third of the book is devoted to 
the vital, often overlooked, psychosocial 
aspects of breast cancer. Unfortunately, 
most of these chapters read like propa­
ganda, the authors trying to justify the 
involvement of their disciplines. Most 
Canadian surgeons recognize their re­
sponsibility to deal with psychosocial 
issues. Their ability to help their pa­
tients will not be advanced by the advice 
in this book that fatigue can be ma­
naged by taking naps or going to bed 
earlier, and the recommended aerobics
continued on page 108
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HOW I DO IT
Stapled Bypass Procedure for 
Unresectable Pancreatic Carcinoma
Fred L. Simon, MD, FRCSC, FACS; Paul H. Niloff, MD, FRCSC, FACS; Joan Darmstaedter, RN
B ecause the frequency of pancre­atic carcinoma in the United 
States is increasing and because, in 
most cases, the tumour is unresect­
able, there is an increasing demand 
for efficient palliative procedures. 
We describe one such procedure 
which includes a biliary tract by­
pass, a gastrojejunostomy and jeju- 
nojejunostomy. This procedure al­
leviates symptoms and eliminates 
the need for a subsequent operative 
procedure to bypass a gastric outlet 
obstruction.
The technique is rapid and effi­
cient. We used it in 10 patients with 
only one complication — a slight 
twist of the bowel causing partial 
obstruction in the distal jejunosto- 
my.
Technique
The Auto Suture GIA PREMIUM 
instrument (Auto Suture, Division 
of U.S. Surgical Corp., Norwalk, 
Conn.) is used to transect the jeju­
num approximately 60 cm from the 
ligament of Treitz (Fig. 1A). The 
proximal staple line is resected and 
the EEA stapler (Auto Suture) with­
out the anvil is introduced into the 
lumen of the jejunum, telescoping 
bowel onto the instrument up to the 
point of the gastric anastomosis 
(Fig. IB). The antimesenteric bor­
der of the jejunum is tented on the 
EEA stapler and a pursestring su-
From the Department o f Surgery, Doctors Hospital o f  Lake Worth, and Department o f  Surgery, 
John F. Kennedy Memorial Hospital, Atlantis, Fla.
Accepted for publication July 11, 1988
Reprint requests to: Dr. F.L. Simon, 2887 Lake Worth Rd., Lake Worth, FL 33461, USA
FIG. 1. Technique for stapled bypass of pancreatic tumour. It incorporates biliary tract bypass, gastrojejunostomy and 
jejunojejunostomy.
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An emerging
IN THE MANAGEMENT
mm
ture is placed around the centre rod 
which is in turn pushed through a 
small stab wound at the apex of the 
bowel. The pursestring suture is 
tied and the anvil then attached to 
the instrument.
The stomach is grasped at the
point of the intended anastomosis, 
using the Auto Suture pursestring 
instrument. A pursestring is insert­
ed and the protruding tissue resect­
ed (Fig. 1C). The EEA stapler anvil 
is eased through the stomach wall 
and the pursestring tied (Fig. ID).
The instrument is closed, fired and 
then removed.
The jejunojejunostomy is per­
formed in a similar fashion, approx­
imately 15 cm from the gastric 
anastomosis (Fig. IE). The chole- 
cystojejunostomy or choledo-
COMMUNITY-ACQUIRED INFECTIONS
STAPLED BYPASS FOR PANCREATIC CANCER
chojejunostomy was performed 
manually in our cases, although the 
EEA or TA stapler was used previ­
ously.1' 3 The final jejunojejunosto- 
my is completed (Fig. IF) and the 
jejunum closed with the Auto Su­
ture TA 55 stapler (Fig. 1G).
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STATE OF THE ART
\
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:
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Endometrial Cancer
Abdominal hysterectomy will cure cancer of the endometrium confined to the body of 
the uterus. If the tumour has spread beyond the uterus, adjuvant therapy will be 
needed. The likelihood of such spread can be predicted from postoperative histologic 
examination of the uterus or discovered by surgical staging. Surgical staging does 
not appear to be curative or to reduce the need for adjuvant therapy. Prognosis 
depends on the grade and location of the tumour in the uterus and the extent of 
invasion into the myometrium or beyond the uterus, and not on the removal of 
occult metastases.
L’hysterectomie par voie abdominale est curative dans les cas de cancer de l'endometre 
confine au corps de l’uterus. Quand la tumeur a envahi les autres tissus, une therapie 
adjuvante est necessaire. La probability d’une telle dissemination peut etre prevue a 
partir de l’examen histologique postoperatoire de l’uterus, ou decouverte lors d’une 
chirurgie destinee a etablir le stade evolutif de la maladie. Ce type d’intervention ne paralt 
pas avoir d’effet curatif et ne semble pas reduire la necessity d’une therapie adjuvante. Le 
pronostic depend du stade et de la localisation de la tumeur dans 1’uterus, ainsi que de 
l’importance de sa dissemination dans le myometre et hors de l’uterus, et non pas de 
l’elimination de metastases occultes.
Mark E. Boyd, MD, FRCSC, FRCOG
The current role of the general gynecologist or surgeon in 
managing the patient with gyneco­
logic malignant disease is usually 
limited to diagnosis and referral to a 
gynecologic oncologist. This is be­
cause invasive cancer of the cervix 
is treated by radiation or radical 
surgery and the general gynecolo­
gist or surgeon does not have the 
necessary expertise in selecting 
cases, performing surgery and prov­
iding the appropriate postoperative 
care. Likewise with cancer of the 
ovary, accurate staging and optimal 
surgery will generally be more ef­
fective when the patient is managed 
by the subspecialist. Moreover,
there is a need for experienced 
supervision of subsequent chemo­
therapy. Cancer of the vulva, a rare 
condition, should be handled by a 
gynecologist experienced in per­
forming radical vulvectomy and in 
deciding who needs other forms of 
therapy.
In this paper I shall attempt to 
determine if a similar attitude is 
needed when dealing with cancer of 
the endometrium, judged preopera- 
tively as being confined to the body 
of the uterus.
The rationale of treatment can 
best be understood by knowing the 
natural history of the disease, the 
methods by which we can discover
its spread or stage and the accuracy 
of these methods.
Natural History
Endometrial cancer, an adenocar­
cinoma, occurs in postmenopausal 
women who fall into one of two 
distinct categories: a relatively
young (fifth or sixth decade), nul- 
liparous, obese woman and an old­
er, multiparous thin woman. Those 
in the first group usually have a 
well-differentiated tumour and a 
good prognosis. The supposed eti­
ology in this group is excessive 
estrogen stimulation, either from 
endogenous production or exoge­
nous administration. In the second 
group, the tumour is poorly differ­
entiated and the prognosis poor. It 
is suggested1 that the volume of 
patients in this group is increasing 
disproportionately.
Two histologic variations of the 
adenocarcinoma pattern indicate a 
poor prognosis: if malignant squa­
mous elements are mixed with the 
glandular elements (adenosquamous 
carcinoma), the tumour is likely to 
invade the myometrium deeply2 and 
if the tumour is a papillary serous 
carcinoma, endometrial in origin 
but similar in behaviour to an ovari­
an carcinoma, upper abdominal me­
tastases will occur more frequently.3
The tumour is of three grades, 
classified according to the degree of 
differentiation. Just over 50% of 
cases are grade 1 (well differentiat­
ed).4 The grade of the tumour pre­
dicts its capacity to invade. Thus, 
there is deep invasion of the myo­
metrium in only 12% of grade 1 and
From the Department o f Obstetrics and Gynecology, Royal Victoria Hospital, Montreal, PQ 
Accepted for publication May 10, 1988
Reprint requests to: Dr. M.E. Boyd, Cynecologist-in-Chief, Royal Victoria Hospital, Women’s 
Pavilion, 687 Pine Ave. W, Montreal, PQ H3A 1A1
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15% of grade 2 tumours, but in 
46% of grade 3 tumours.5 The 
incidence of lymph-node metastasis 
parallels invasion; 3% of grade 1 
tumours, 10% of grade 2 and 36% 
of grade 3 have pelvic lymph-node 
involvement.6 There are exceptions; 
in one study,5 20% of well-differen­
tiated adenocarcinomas showed 
deep invasion of the myometrium, 
with a high risk for lymph-node 
involvement. If the myometrium is 
not invaded, less than 1% of pa­
tients have recurrent disease;3 if 
invasion is deep, 42% of the tu­
mours recur.7
The myometrial lymph channels 
lead first to the nodes along the 
iliac vessels and then to the aortic 
nodes. If the pelvic nodes are invad­
ed, 60% of the aortic nodes will be 
involved, whereas if the pelvic 
nodes are negative, only 1% of the 
aortic nodes will have tumour de­
posit.67 If the cervix or myometri­
um in the region of the cervix is 
involved, the possibility of paracer­
vical glandular metastases is in­
creased threefold.89 Lymph chan­
nels also favour metastases to the 
fallopian tubes and ovaries.
The peritoneal cavity is frequent­
ly seeded with tumours cells early 
in the course of the disease, pre­
sumably through the open tubal 
ostium; in stage I disease, cytologic 
examination of the peritoneum 
gives a positive result in 15% of 
cases.1011 Paradoxically, it is unusu­
al for peritoneal metastases to arise 
from tumour that erodes through 
the uterine serosa.
The frequent recurrences in the 
vaginal wall were thought to result 
from tumour implants at the time of 
surgery. We now believe they are 
manifestations of subclinical dis­
ease, reaching the vagina through 
paravaginal lymphatics and retro­
grade vessel flow; in the latter in­
stance, metastases are found char­
acteristically on the anterior vaginal 
wall just above the urethral orifice.
Death is most often due to dis­
tant hematogenous metastases, the 
lungs and liver being the most 
common sites.12
Staging
International Federation of Gyne­
cology and Obstetrics (FIGO) stag­
ing of corpus uteri (Table I) can be 
determined from physical examina­
tion, dilatation and curettage, and 
histologic and routine radiologic 
studies, but surgical staging is 
more accurate. In 77% of tumours 
diagnosed as stage I by the FIGO 
method,13 subsequent surgical stag­
ing will show one-third to be incor­
rectly staged,14 as a result of unsus­
pected cervical or adnexal invasion 
or metastases to lymph nodes or 
the peritoneal cavity. Especially 
worrying is that in 11% of tumours 
classified as stage I by the FIGO 
method, nodal involvement has 
been found,15 and these findings 
have been substantiated in a num­
ber of other studies.6-716
The diagnosis of FIGO stage II 
disease depends on gross disease 
being seen on the cervix preopera- 
tively. If microscopic spread to the 
cervix is found postoperatively the 
disease is often restaged to surgical 
stage II. Such patients have a nota­
bly better prognosis than those 
whose tumours are staged preoper- 
atively by FIGO criteria alone and 
this makes the credibility of pub­
lished results questionable.17 The 
improved results in stage II can also 
be demonstrated with surgical re­
staging in FIGO stage III disease. 
Patients who have microscopic me­
tastases to the ovary or fallopian 
tube have a much better prognosis 
than those who have gross disease 
in the pelvis. Despite the difference 
in prognosis, both groups are con­
sidered to have stage III disease.18
The FIGO staging classification 
has other serious deficiencies. Al­
though the size of the uterus is of 
little value in predicting out­
come,19-20 the length of the uterus is 
the criterion used in this classifica­
tion for dividing stage I patients 
into A and B groups. On the other 
hand, tumour size, not part of the 
FIGO classification has recently 
been shown to be prognostically 
important.21 When the tumour is 
larger than 2 cm in diameter, 22% 
of the patients were found to have 
lymph-node metastases, increasing 
to 40% when the entire endometrial 
surface was involved.21 Sivridis and 
colleagues22 reported that prognosis 
is much worse if the adenocarcino­
ma invades the lymphatic vascular 
spaces of the uterus. Furthermore, 
the FIGO classification does not 
include important prognostic infor­
mation such as tumour type and 
size and depth of myometrial inva­
sion. Finally, the grade and histo­
logic type of tumour are frequently 
found to be incorrect when the 
whole of the uterus is examined 
rather than isolated curettings.14
Diagnosis
An endometrial biopsy, usually
Table I. International Federation of Gynecology and Obstetrics Staging of Corpus Uteri
Stage/grade Description
Stage I Cancer confined to corpus
IA Uterine cavity is < 8 cm long
IB Uterine cavity is > 8 cm long
Grade 1 Highly differentiated adenomatous carcinoma
2 Differentiated adenomatous carcinoma with partly solid areas
3 Solid or entirely undifferentiated carcinoma
Stage II Carcinoma has involved corpus uteri and cervix but has not extended outside
uterus
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done for postmenopausal bleeding, 
identifies the disease. Endocervical 
curettage can be misleading be­
cause it may not identify extension 
of the disease to the cervix,23 and 
therefore therapy may not be ad­
justed.24
In addition to routine preopera­
tive investigation, computed axial 
tomography or magnetic resonance 
imaging have been suggested as a 
means of delineating invasion of the 
myometrium, cervix and lymph 
nodes.25
Treatment
The treatment of stage I cancer 
of the endometrium is total abdomi­
nal hysterectomy and bilateral sal- 
pingo-oophorectomy. Preoperative 
radiotherapy has fallen into dis­
favour; it is of no proven value, 
delays definitive therapy and ob­
scures the findings of postoperative 
histologic studies.
At laparotomy it is worthwhile to 
collect peritoneal washings:1011 nor­
mal saline (50 ml) is deposited in 
the cul de sac then aspirated into a 
container for examination by a cyto- 
pathologist.
When the disease is limited to the 
uterus, selected series have shown 
that hysterectomy provides a 98% 
rate of cure, although the overall 
survival is only 71.0%.26 27 The pro­
cedure is inadequate if the tumour 
has spread beyond the uterus at the 
time of surgery, thus putting con­
temporary therapeutic practice into 
question. Should the standard oper­
ation be extended? If not, will the 
patient’s future be compromised 
and options for additional postoper­
ative therapy limited? These ques­
tions are pertinent, since modifica­
tions such as radical hysterectomy, 
pelvic or aortic node biopsy are 
complex and best done by a gyneco­
logic oncologist.
He will decide on the indication
for lymph-node biopsy before hys­
terectomy (from histologic examina­
tion of the curettings) and at the 
time of surgery by determining the 
site of disease, tumour size and 
depth of myometrial invasion (by 
bisecting the operative specimen 
and examining a frozen section of 
the uterine wall). If the nodes are 
negative the patient can be spared 
postoperative radiotherapy; if they 
are positive, the radiotherapy can 
be directed to certain areas, and 
finally the need for chemotherapy 
may be more quickly realized.
Arguments against this proce­
dure are to me more persuasive. 
Node dissection is done for prog­
nostic purposes on patients who are 
generally in poor health. No pro­
spective trials have shown that sur­
gical restaging is beneficial; it does 
not alter the usual postoperative 
adjuvant treatment and there is no 
evidence that the removal of pelvic 
or aortic nodes is therapeutic in 
itself. The recommended procedure 
is extensive and difficult. Pelvic 
node biopsy involves the removal of 
tissue lateral to the external iliac 
arteries, medial to the common iliac 
arteries and within the obturator 
fossae. Aortic node biopsies consist 
of removing tissue from the bifurca­
tion of the aorta to the second part 
of the duodenum; some authors28 
recommend removal of additional 
tissue lateral to the aorta up to the 
level of the renal vessels.
Postoperative Management
Indications for postoperative pel­
vic radiotherapy in FIGO stage I 
cancer of the endometrium relate to 
surgical pathological findings. Inva­
sion of the myometrium, disease in 
the vicinity of the cervix and high- 
grade tumours suggest the need for 
radiation. Postoperative radiothera­
py decreases the frequency of vagi­
nal recurrence, but there is little
evidence that overall survival is in­
creased.29
Postoperative chemotherapy is 
another option. The type to be used 
is decided upon after evaluation of 
the results of receptor studies on 
the operative specimen. If the tu­
mour is estrogen and progesterone 
receptor-rich, it should respond to 
progestational agents; if not, other 
means of chemotherapy will be re­
quired. Receptor content can be 
predicted with reasonable accuracy 
from tumour differentiation;30 the 
more highly differentiated the tu­
mour is, the greater the likelihood 
of receptors being present.
Summary
If endometrial cancer is judged 
clinically to be confined within the 
body of the uterus, the indicated 
treatment is abdominal hysterecto­
my and bilateral salpingo-oophorec- 
tomy. The prognosis depends not 
so much on adjuncts to this therapy 
as on the surgical pathological find­
ings. The need for supplementary 
therapy postoperatively can be real­
ized from histologic examination of 
the uterus and cytologic examina­
tion of the peritoneal fluid; lymph- 
node biopsy does not add notably to 
this information. In contrast to 
other gynecologic malignant dis­
ease, there is no apparent indication 
for immediate referral of patients 
with stage I cancer of the endomet­
rium to the gynecologic oncologist.
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SESAP VI Question
Item 233
Thoracoabdominal aortic aneurysms are most often associated with
(A) medial degenerative disease
(B) aortic dissection
(C) median age < 50
(D) Ehlers-Danlos syndrome
(E) syphlitic aortitis
For the incomplete statement above, select the one completion that is 
best of the five given.
For the critique of Item 233 see page 138.
(Reproduced by permission from SESAP VI Syllabus; Surgical Educa­
tion and Self-Assessment Program No. 6. For enrolment in the Surgical 
Education and Self-Assessment No. 6, please apply to the American 
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Perforated Benign Gastric Ulcer: 
for Simple Closure
Olin G. Thurston, MD, FRCSC
During the 12 years from 1975 to 1986 at University of Alberta Hospital,
Edmonton, 36 patients were found to have a perforated gastric ulcer. A review of 
their operative treatment revealed that only one patient had a definitive gastric 
resection despite reports in the literature recommending the procedure. This study 
was undertaken to determine if simple closure was appropriate treatment for the 
majority of these patients.
Even the enthusiasts of gastric resection would agree that advanced patient age, 
serious underlying disease and delay in treatment are contraindications to the 
procedure for perforated gastric ulcer. We found that 28 (78%) of the 36 patients 
had one or more of these contraindications. Thus, the high-risk nature of the 
patients presenting to our institution with perforated gastric ulcer explains the 
frequent use of simple closure in these cases. The data from this study indicate that 
the profile of patients presenting with perforated benign gastric ulcer needs to be 
defined before generalizations regarding surgical treatment are made.
A l’Hopital universitaire d’Alberta d’Edmonton, sur une periode de 12 ans comprise 
entre 1975 et 1986, 36 cas d’ulceres perfores de l’estomac ont ete diagnostiques. 
L’etude des dossiers revele qu’un seul de ces patients a subi une resection gastrique 
definitive, malgre les publications recommandant ce type d’intervention. Cette etude 
fut entreprise dans le but de determiner si une fermeture simple constituait un 
traitement approprie, dans la majorite des cas.
Meme ceux qui pronent la resection gastrique pour l’ulcere perfore concederont 
que l’age avance d’un patient, la presence d’une maladie sous-jacente grave ou un 
delai de traitement sont des contre-indications a cette operation. II a ete observe que 
28 (78%) de nos 36 patients avaient au moins une de ces contre-indications. Le 
risque eleve que presentaient les patients re?us dans notre etablissement souffrant 
d’ulcere perfore, explique done l’utilisation frequente de la fermeture simple pour 
traiter ce genre de cas. Les donnees de cette etude indiquent qu’il est necessaire de 
bien definir le profil des patients admis dans un hopital pour ulcere gastrique benin 
perfore, avant d’etablir une ligne de conduite generate quant au mode operatoire.
From the Department o f  Surgery, University o f  Alberta, Edmonton, Alta.
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the Case
In 1937 Dr. Roscoe Graham of Toronto published the results of 
omental patch closure of perforated 
duodenal ulcer in a series of 51 
patients.1 His results — one early 
death and one late death — were at 
the time a quantum leap forward in 
the management of this condition 
and compare favourably to present- 
day results.2 Similar treatment was 
logically instituted for perforated 
gastric ulcers,3 the patients being 
older and having more serious un­
derlying diseases than those with 
perforated duodenal ulcers. In the 
1950s there was a trend toward 
definitive treatment of perforated 
duodenal ulcers in patients who 
presented early and had no serious 
underlying disease.4 Again a similar 
attitude was extended toward pa­
tients with perforated gastric ul­
cers,56 but in these circumstances 
the extension is illogical. In this 
study I propose to show that be­
cause of serious underlying disease 
and delay in making the diagnosis, 
the majority of these patients are 
poor candidates for definitive ulcer 
operations.
Patients and Methods
During the 12-year period 1975 
to 1986 inclusive, 36 patients seen 
at the University of Alberta Hospital 
had a recorded diagnosis of perfo­
rated benign gastric ulcer. Their
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medical records were reviewed, 
using the methods outlined by Fein- 
stein and colleagues.7 Particular at­
tention was paid to underlying med­
ical diseases and to the time interval 
from the onset of acute symptoms 
to diagnosis and definitive treat­
ment. The operative findings and 
degree of contamination of the peri­
toneal cavity were also noted since 
they tend to confirm the time-inter­
val data. For most patients in the 
study the end point is death or 
hospital discharge, although follow­
up data collected by clinic visit, 
telephone interview or report from 
another physician was available in 
14 of the patients. Where appropri­
ate, tests of statistical significance, 
Student’s unpaired f-test and the x2 
test, were done using a Hewlett- 
Packard HP97 programmable cal­
culator.
Findings
There were 21 women and 15 
men who ranged in age from 35 to 
94 years (mean 63 years). The mean 
age of the women was 59 years and 
the men 69 years, a significant (p < 
0.05) difference. Serious underlying 
medical problems, including ad­
vanced malignant disease, chronic 
obstructive pulmonary disease, car­
diac, vascular and renal diseases, 
were present in 23 patients (64%). 
During hospitalization for another 
illness, perforation occurred in six 
patients (17%). Factors predispos­
ing to gastric ulceration and perfo­
Tab le  1. Operative Procedures for 
Perforated Benign Gastric Ulcer
Procedure No. of p a tie n ts  (% )
Simple closure +  
omental patch 
Closure about
26 (72)
gastrostomy 6 (1 7 )
Draining of abscess 2 ( 6 )
Billroth II gastrectomy 1 (3)
None 1 (3)
Total 36
ration were noted as follows: 13 
patients (36%) were taking steroids, 
12 (33%) were taking nonsteroidal 
anti-inflammatory drugs and 5 
(14%) were alcohol abusers; 17 
(47%) had a history of acid-peptic 
disease. One or more of these fac­
tors was present in 31 patients 
(86% ).
Sudden onset of abdominal pain 
and rigidity occurred in about 67% 
of the patients in this study. Diag­
nosis was made and treatment car­
ried out within 24 hours of the 
onset of symptoms of perforation in 
23 (64%). However, in 13 patients 
(36%), the clinical picture was atypi­
cal or the condition not recognized 
immediately, so diagnosis and treat­
ment were delayed; in 1 of these, a 
perforated gastric ulcer was an un­
expected finding at autopsy.
Thirty-five patients underwent an 
operative procedure for the treat­
ment of a perforated benign gastric 
ulcer (Table I). Four patients, who 
underwent suture closure or closure 
about a gastrostomy, required reop­
eration for reperforation (three pa­
tients) or hemorrhage (one patient).
The hospital death rate for the 
36 patients was 25% (9 patients) 
and death was attributable to pul­
monary failure and sepsis in most 
cases. Although a number of varia­
bles including age, sex and antibiot­
ic use were studied in relation to 
death, the only two that correlated 
significantly were serious underly­
ing disease (p < 0.02) and delay in 
diagnosis and treatment beyond 24 
hours (p < 0.01). Taking these two 
factors together, we found that 27 
of the 36 patients (75%) had one or 
both factors operating against their 
chances for survival.
Postoperative septic complica­
tions occurred in 12 (34%) of the 
35 patients operated on and were 
related to a positive bacterial cul­
ture from the peritoneal cavity at 
the time of operation. They includ­
ed intra-abdominal sepsis (six) pa­
tients, wound infection (six) (includ­
ing one clostridial infection) and 
septicemia (two). Septic complica­
tions occurred in 7 of 18 patients 
who had a positive culture but in 
none of the 6 who had a negative 
culture (p < 0.05). Cultures were 
not taken in 11 patients. There 
were five deaths in the 18 patients 
(28%) who had positive cultures and 
one death in the 6 patients (17%) 
who had negative cultures (p < 
0.02) at the time of first operation.
Fourteen of the 27 who survived 
the initial surgical procedure and 
were discharged from hospital have 
been followed up for periods rang­
ing from 2 to 54 months (mean 14 
months). Within this period two 
patients died of causes unrelated to 
gastric ulcer, two subsequently un­
derwent gastrectomy (one died), two 
are alive with symptomatic ulcers 
and eight patients are alive and free 
of ulcer disease, including the one 
who underwent gastrectomy.
Discussion
Only one patient in our study had 
a gastric resection as the emergen­
cy treatment for perforated benign 
gastric ulcer while most had simple 
closure of the perforation. There 
has been no policy for or against 
either treatment at our institution; 
the choice was left to the attending 
surgeon. Records revealed that 75% 
of the patients had other serious 
underlying medical conditions or 
there was a delay in diagnosis be­
yond 24 hours after the estimated 
time of perforation. If patients over 
80 years of age are added to this 
list, then only 8 of 36 patients 
could be considered candidates for 
gastric resection, even by advocates 
of this treatment. The low numbers 
of patients suitable for gastric re­
section and the lack of evidence 
that acute perforations will require 
a definitive ulcer operation likely
CJS, VOL. 32, NO. 2, MARCH 1989 95
THURSTON
explains the low incidence of gastric 
resection in our series and others in 
the literature.89
A reason for proposing gastric 
resection as treatment is the diffi­
culty in differentiating benign from 
malignant gastric ulcers when they 
are perforated. This indication for 
resection is negated by follow-up 
endoscopy in all patients with perfo­
rated gastric ulcers. In addition, 
patients with perforated gastric car­
cinoma have a poor prognosis re­
gardless of treatment.8
The hospital death rate (25%) in 
this series is in the range reported 
by others.10 When compared with 
series reported in 19574 and 1973,3 
it has not changed appreciably. Pro­
ponents of gastric resection, McGee 
and Sawyers,6 reported a 29% death 
rate with simple closure and a 15% 
rate for gastric resection. However, 
this difference is not significant. It 
is suggested that for perforated 
duodenal ulcer, survival is deter­
mined by the state of the patient on 
admission rather than the choice of 
operation;211 this may apply equally 
to perforated gastric ulcer.
In this study, a positive culture 
from a sample taken from the peri­
toneal cavity at the time of initial 
surgery was a significant finding 
with regard to postoperative septic 
complications and death. The or­
ganisms most frequently cultured 
were non-hemolytic streptococci, 
Streptococcus viridans and yeast­
like organisms, mostly Candida.12 
Various anaerobic organisms were 
also isolated.13 Bacteria associated 
with gastroduodenal perforations 
are not as well defined as in lower 
intestinal perforations where Bac- 
teroides, coliform organisms and 
Clostridia form three well-defined 
groups against which antimicrobial 
therapy can be directed. Gas­
troduodenal perforations may be
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sterile early on or later present a 
bewildering array of weakly patho­
genic organisms. The situation is 
reminiscent of that existing with 
lower intestinal perforations before 
the importance of the gram-nega­
tive anaerobes, mainly Bacteroides 
sp., was appreciated. At present, it 
is difficult to predict which organ­
isms will emerge as pathogens in a 
patient with perforated gastric or 
duodenal ulcer,14 and thus it is 
difficult to select an antibiotic or 
suitable combination until septic 
complications occur. The value of 
cultures from the peritoneal cavity 
at the time of surgery for perforated 
gastric ulcer appears to be in identi­
fying the patients likely to suffer 
septic complications rather than 
identifying the likely pathogens.
Conclusions
In spite of recent reports recom­
mending gastric resection as the 
treatment of choice for patients 
with perforated gastric ulcers, there 
is a lack of good data supporting 
this recommendation. When the re­
sults of a simple procedure are 
roughly equivalent to those of a 
more complex one, surgeons work­
ing in an emergency situation with 
high-risk patients will choose the 
simple procedure.
Uncertainty about the bacteria 
associated with gastric perforations 
is a final reason for choosing simple 
closure over gastric resection. At 
operation, the peritonitis may be 
chemical or chemical and septic. 
Organisms of doubtful pathogenici­
ty may be cultured from the perito­
neal cavity. These organisms may 
or may not be responsible for future 
septic complications, making antibi­
otic use and choice somewhat of a 
lottery. In this setting, simple clo­
sure of a perforated gastric ulcer 
becomes an attractive procedure re­
gardless of the age or medical con­
dition of the patient.
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Biliary Tract Reconstruction in Liver 
Transplantation
William J. Wall, MD, FRCSC; David R. Grant, MD, FRCSC; Richard E. Mimeault, MD, FRCSC; 
David P. Girvan, MD, FACS, FRCSC; John H. Duff, MD, FRCSC
Refinements in biliary tract reconstruction and the frequent use of cholangiography 
have produced a marked decline in the number of deaths from biliary complications 
after liver transplantation. The authors’ method of reconstruction differs from those 
of others in that it employs no stents or T tubes and retains the donor gallbladder, 
allowing access to the biliary tract for radiologic purposes in the post-transplant 
period.
In a series of 161 consecutive liver transplants, the frequency of biliary 
complications was 13.6% (15 anastomotic and 7 gallbladder-related). Of three deaths 
that occurred in patients with biliary complications, one was due to the complication 
itself. A Roux-en-Y reconstruction with anastomosis to the donor duct was 
associated with the lowest anastomotic complication rate (2.2%). Upper abdominal 
surgery before transplantation, especially shunting, was a major risk factor for 
biliary complications.
Les ameliorations apportees a la reconstruction des voies biliaires et l’utilisation 
frequente de la cholangiographie ont entraine une baisse marquee du nombre de deces 
post-transplantation hepatiques, dus a des complications biliaires. La methode de 
reconstruction preconisee par les auteurs differe des autre en ce qu’elle n’utilise ni 
manchon d’anastomose, ni tube en T, et qu’elle conserve la vesicule biliaire du donneur, 
ce qui permet l’acces aux voies biliaires pour fins de radiographie durant la periode 
post-transplantation.
Lors d’une serie de 161 greffes hepatiques consecutives, la frequence des 
complications biliaires fut de 13.6% (15 au niveau des anastomoses et 7 au niveau de 
la vesicule). Sur trois deces survenus chez des patients souffrant de complications 
biliaires, une etait due a la complication meme. Une reconstruction de Roux-en-Y 
avec anastomose au choledoque du donneur fut associee au plus faible taux de 
complications anastomotiques (2.2%). Les operations abdominale hautes, surtout les 
interventions de derivation, ont represente un facteur de risque important de 
complication biliaire.
L iver transplantation prior to the late 1970s, at the time the liver 
transplant program was beginning 
in London, Ont., was associated 
with a distressingly high morbi-
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dity and mortality attributable to 
complications of the biliary recon­
struction.12 Almost one-third of 
liver transplant recipients had bili­
ary tract complications, which were
directly or indirectly the cause of 
nearly half of the deaths.12 Since 
then, deficient methods of recon­
struction have been recognized and 
abandoned, and refinements in op­
erative technique have reduced the 
frequency of biliary complications 
to 12% to 14%,34 although they 
remain the most common technical 
complication of liver transplanta­
tion. Our preferred method of bili­
ary drainage differs from those of 
other centres. It employs no T 
tubes or stents and uses the donor 
gallbladder as an external cholecys- 
tostomy for radiologic access to the 
biliary tree.5 We have reviewed our 
experience to determine the inci­
dence, type and outcome of biliary 
complications in liver transplanta­
tion.
Patients and Methods
We reviewed the first 161 or­
thotopic liver transplants performed 
in 145 recipients (92 females, 53 
males) at University Hospital and 
Children’s Hospital of Western On­
tario; 14 patients received two 
transplants and 1 received three. 
The ages of the patients ranged 
from 8 months to 68 years.
In 113 of the recipients, end- 
stage cirrhosis (e.g., primary biliary 
cirrhosis, cirrhosis from chronic ac­
tive hepatitis, biliary atresia) was 
the indication for transplantation. 
In the remainder, acute liver failure, 
sclerosing cholangitis, cholestatic 
syndromes, neonatal giant cell hep­
atitis, cancer and glycogen storage 
disease were the indications. Before 
transplantation, 61 (42%) of the
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recipients had undergone upper ab­
dominal surgery, including por­
tosystemic shunting (23 patients), 
biliary tract surgery (23), laparoto­
my and liver biopsy (9), splenecto­
my (5) and gastrectomy (1).
The general aspects of the recipi­
ent operation have been described 
elsewhere.6 Three types of biliary 
drainage were used: an end-to-end 
duct-to-duct anastomosis (D-D), a 
Roux-en-Y jejunal loop to the end 
of the donor duct (R-D), or a 
Roux-en-Y jejunal loop to the 
donor gallbladder (R-GB). The pre­
ferred method was a D-D anasto­
mosis if there was no disease of the 
recipient duct. When the recipient 
duct was abnormal or unsuitable, as 
in cases of sclerosing cholangitis, 
an R-D reconstruction was used. 
An R-GB anastomosis was per­
formed infrequently. The anastomo­
ses were single-layer, using inter­
rupted full-thickness bites with ap­
proximation of mucosal layers. 
Posterior-wall sutures were placed 
and tied first with knots on the 
inside. Anterior-wall sutures were
FIG. 1. Post-transplant cholangiogram 
of duct-to-duct anastomosis (white ar­
row) via gallbladder catheter. Shadow 
of catheter is visible in lumen of gall­
bladder (black arrow).
knotted on the outside. Sutures 
were 5-0 polydioxanone (PDS; Ethi- 
con Sutures, Peterborough, Ont.) in 
adults and 6-0 or 7-0 PDS in chil­
dren. Anastomotic stents and T 
tubes were not used.
In 139 transplants, the donor 
gallbladder was used as an external 
cholecystostomy with either a no. 
12 Malecot or no. 10 Foley catheter 
exiting from the fundus of the 
gallbladder (Fig. 1). In the remain­
ing 22 transplants, low entrance of 
the cystic duct resulted in its tran­
section at the site of division of the 
common duct in the donor, and 
therefore the gallbladder was re­
moved. The gallbladder catheter 
was left open to straight drainage 
for 1 week postoperatively, at the 
end of which the first of several 
cholangiograms over the ensuing 
weeks was obtained. If the anasto­
mosis was satisfactory, the gallblad­
der catheter was clamped. Repeat 
cholangiography was the first inves­
tigation performed if and when tests 
of liver function were abnormal. 
The gallbladder catheters were re­
moved between 6 and 12 weeks 
after transplantation.
There were 125 D-D reconstruc­
tions, 33 primary R-D reconstruc­
tions and 3 R-GB anastomoses. In 
12 patients, a failed reconstruction 
was revised to an R-D anastomosis, 
bringing the total R-D anastomoses 
to 45. In the group of 16 retrans­
plants, there were 12 D-D anasto­
moses and 4 R-D reconstructions. 
Statistical analysis was done using 
Fisher’s exact test. The average
follow-up period was 17.2 months 
(range from 3 months to 5.8 years).
Results
There were 22 biliary tract com­
plications in the 161 transplants, an 
overall incidence of 13.6%; 15 were 
anastomotic complications and 7 
were complications related to the 
gallbladder.
The anastomotic complications 
are summarized in Table I. The 11 
obstructions became evident at 3 
days, 2, 4, 5, 6 and 7 weeks and 3, 
5, 7, 17 and 18 months after trans­
plantation. Nine obstructions were 
revised to R-D anastomoses (in­
cluding 1 primary R-D anastomosis 
which was redone); two strictures 
were dilated percutaneously 3 and 4 
weeks after transplantation and 
both of these patients had normal 
liver function at 13 and 21 months’ 
follow-up. The four anastomotic 
leaks were all in D-D reconstruc­
tions; they occurred at 5, 20 and 26 
days and 3 months respectively. 
Three were revised to R-D anasto­
moses and one was managed by 
insertion of a T tube.
Of the seven gallbladder compli­
cations, four were leaks at the 
cholecystostomy tube exit site. One 
leak occurred 5 weeks after trans­
plantation when the gallbladder 
catheter was accidentally dislodged; 
the other three leaks occurred when 
the catheters were removed at 6, 9 
and 9 weeks after transplantation. 
Bile peritonitis developed within 
hours of catheter removal in each
Table 1. Biliary Anastomotic Complications in 161 Liver Transplants
Type of reconstruction
D-D R-D RGB
Complications (n =  125) (n =  45)* (n =  3)
Obstruction 9 1 1
Bile leak 4 0 0
Totals 13(10.4%) 1 (2.2%) 1 (33%)
‘ Includes 33 primary R-D anastomoses and 12 R-D revisions of failed primary reconstructions. 
D-D =  end-to-end, duct-to-duct anastomosis, R-D =  Roux-en-Y jejunal loop to end of donor duct, 
R-GB =  Roux-en-Y jejunal loop to donor gallbladder.
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case and the patients required lapa­
rotomy and reinsertion of the cathe­
ter. After the cluster of gallbladder 
leaks, we decided to delay catheter 
removal until 3 months after trans­
plantation. Since we adopted this 
policy there have been no leaks. 
One patient had sudden, unex­
plained bleeding from the gallblad­
der 5 weeks after transplantation 
and required emergency cholecys­
tectomy. Two patients who had 
cholelithiasis 17 and 23 months 
respectively after transplantation 
were managed by cholecystectomy.
A greater number of patients 
with anastomotic biliary complica­
tions had undergone upper abdomi­
nal surgery previously (Table II). 
Only 36.9% of patients without bili­
ary complications had previously 
undergone abdominal operations, 
but 86.7% of patients with failed 
biliary anastomoses had had a previ­
ous operation, most commonly a 
shunt (six) or biliary tract operation 
(three). This difference was highly 
significant (p < 0.003). The six 
shunts included two mesocaval 
shunts, two Warren shunts, one 
portacaval and one splenorenal 
shunt. Thus, of the 23 recipients 
who had a portosystemic shunt of 
some variety before transplantation, 
6 (26%) suffered a biliary complica­
tion after.
Of the 22 patients who had bili­
ary complications, 19 survived and 
are alive. Two of the three deaths 
occurred in patients who had anas­
tomotic complications. One patient, 
who had revision of a strictured D- 
D anastomosis, died of sepsis 2*/2
Table II P r e v io u s  S u r g e r y  in  L iv e r
T r a n s p la n t  R e c ip ie n t s  W ith  a n d  W ith o u t
B il ia r y  C o m p lic a t io n s
Without With
complications complications
Surgery (n =  130) (n =  15)
S h u n t in g 1 7 6
B il ia ry  t r a c t 2 0 3
O th e r 11 4
T o ta ls ,  n o . ( % )  4 8  ( 3 6 . 9 ) 1 3 ( 8 6 . 7 )
months after a subsequent retrans­
plant for chronic rejection. The sec­
ond death occurred in a child who 
required revision of an obstructed 
R-GB anastomosis. Hepatic artery 
thrombosis occurred, requiring re­
transplantation, but the second 
graft failed because of recurrent 
hepatic artery thrombosis. Neither 
of these deaths was related to the 
biliary complication. The third 
death occurred in the patient who 
had bile peritonitis after the gall­
bladder catheter became accidental­
ly dislodged. Candida septicemia re­
sulted in death 10 weeks after 
transplantation. The bile peritonitis 
was believed to be a major contrib­
uting factor in this patient’s death. 
Thus, the death rate in patients 
with biliary complications was 
13.6% (3 of 22), but in only 1 
patient was the biliary complication 
related to the death.
Of the 145 recipients, 112 
(77.2%) were alive from 3 months 
to 5.8 years after transplantation. 
One- and 5-year actuarial survival 
rates were 74.8% and 73.2% respec­
tively.
Discussion
The catastrophic complications of 
failed biliary reconstruction that 
plagued liver transplantation in the 
past resulted from their frequent 
occurrence plus failure to diagnose 
accurately and treat promptly the 
complications when they occurred. 
Better methods of reconstruction 
and the use of cholangiography to 
assess accurately the integrity of 
biliary drainage have reduced the 
morbidity and mortality.3’7-8 Death 
due primarily to biliary complica­
tions is now uncommon.4
The most popular current meth­
ods of reconstruction are the D-D 
or R-D anastomosis, performed 
over a T tube or stent, combined 
with removal of the donor gallblad­
der.34 The long tradition of using T
tubes and stents in bile-duct repairs 
in non-transplant surgery910 has 
undoubtedly had a positive influ­
ence on their use in liver transplan­
tation; however, convincing evi­
dence of a beneficial effect on heal­
ing of biliary anastomoses is lack­
ing. There are disadvantages to 
their use in liver transplantation. 
They may obstruct the lumen of 
smaller ducts, leakage from T-tube 
exit sites has been fairly common 
and retained stents have caused 
obstruction and sometimes needed 
reoperation for removal.3811 The 
choledochotomy and sutures re­
quired for inserting and securing T 
tubes or stents may damage the 
tenuous blood supply to the bile 
duct.12 For these reasons we have 
avoided their use; instead we retain 
the donor gallbladder whenever 
possible and employ a catheter 
cholecystostomy for radiologic ac­
cess to the biliary tree postopera- 
tively. Cholangiography plays an 
important role in detecting prob­
lems at the biliary anastomosis, 
thereby allowing corrective proce­
dures before either the graft or the 
patient’s life becomes jeopardized 
from biliary complications. In addi­
tion, cholangiography has helped to 
resolve the differential diagnosis of 
jaundice in the post-transplant peri­
od, in particular to separate biliary 
obstruction from rejection.
The 10% incidence of anastomot­
ic complications in D-D reconstruc­
tions and the superior results ob­
tained with R-D reconstructions in 
this series are similar to results 
reported by others.3413 The good 
blood supply to the Roux loop plus 
its bulk promote good healing. De­
sirable features of a D-D recon­
struction are that it is physiologic 
and is relatively quick and easy to 
perform. However, the lower mor­
bidity with R-D reconstruction is 
noteworthy and some surgeons ad­
vocate its routine use.13 Revision of 
a failed D-D anastomosis to an R-
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D reconstruction is effective, al­
though some early D-D strictures 
can be dilated with good long-term 
results, as seen in two patients in 
this series. We have no experience 
with the gallbladder conduit tech­
nique described by Caine;14 in situa­
tions in which this might be useful 
we have opted for an R-D recon­
struction.
The role of previous surgery, 
especially shunting, as a risk factor 
for the development of biliary anas­
tomotic complications was an im­
portant finding in our series and it 
has implications for selecting the 
type of drainage procedure to be 
used. Previous biliary surgery or 
procedures that dissect the struc­
tures of the portal triad (e.g., por­
tacaval shunts) logically increase 
the anastomotic complication rate 
because of subsequent scarring in 
the porta hepatis, ischemia of the 
duct and a technically more difficult 
anastomosis. The increased inci­
dence of biliary complications is not 
as easy to explain when the previ­
ous surgery has been a shunt re­
mote from the porta hepatis (e.g., 
Warren or mesocaval shunt). A 
practical consideration in this situa­
tion is that the effort required for 
the transplant surgery, augmented 
by the extra work and difficulty in 
dealing with the shunt, may result 
in operator fatigue, which may 
compromise the quality of the bili­
ary reconstruction at the end of a 6- 
or 7-hour operation. Because of the 
lower incidence of complications 
with R-D reconstruction it may be 
appropriate to use this type of 
drainage for these higher risk pa­
tients even though it makes the 
operation longer.
Leakage from the gallbladder 
catheter exit site should be avoid­
able. The paucity of adhesions 
around the cholecystostomy has 
been a notable feature in those 
patients who required laparotomy 
for bile peritonitis after catheter
removal. Steroids undoubtedly have 
had an effect and we no longer 
remove the catheter until 3 months 
or more after the transplant and 
when the daily steroid dose is less 
than 0.2 m g/kg body weight.
The long-term frequency of 
cholelithiasis in the donor gallblad­
der remains to be determined. Most 
recipients receive a relatively young 
donor organ, which in itself may 
delay the occurrence of cholelithia­
sis. Engel and associates15 studied a 
small number of our recipients and 
assessed gallbladder function as 
measured by fasting gallbladder vol­
umes, rate of gallbladder emptying 
and the release of cholecystokinin. 
Patients with transplanted gallblad­
ders had results similar to age- 
matched normal controls, so stasis 
does not appear to be characteristic 
of the transplanted gallbladder. 
Nevertheless, it is uncertain how 
problematic cholelithiasis might be­
come in these recipients over the 
long term, and ultrasonography of 
the biliary tract has become part of 
our annual follow-up. It is impor­
tant to irrigate the donor gallblad­
der and biliary tree gently but thor­
oughly at the time the liver is 
removed and again in the recipient 
before constructing the cholecys­
tostomy, to remove any blood clot 
or debris that could act as a nidus 
for stone formation.
The state of malnutrition of liver 
recipients at the time of transplan­
tation magnifies the potential for 
poor healing associated with im­
munosuppressive therapy. These 
factors underline the importance of 
the accepted principles of good 
blood supply, absence of local infec­
tion, lack of tension and sound 
technique that are prerequisites for 
satisfactory healing of any anasto­
mosis. The good results with R-D 
reconstruction without T tubes or 
stents in our patients who were at 
special risk for poor healing may 
merit a reappraisal of the use of
tubes and stents in non-transplant
biliary reconstructive surgery.
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Biologic and Structural Evaluation of 80 
Surgically Excised Human Umbilical Vein 
Grafts
Stephane Julien, MD; Francis Gill, BSc; Robert Guidoin, PhD; Randy Guzman, MD;
Jamal Charara, PhD; Paul-Emile Roy, MD; Michel Marois, MD; Gilles Laroche, MD, FACS, FRCSC;* 
Michel Batt, MD;t Paul Roy, MD;* Jean-Michel Serise;t Denis Marois, MD, FACS, FRCSC*
Human umbilical vein is a valuable alternative to autogenous saphenous vein in 
lower-limb revascularization. However, the long-term patency is not as good. To 
understand better the reasons for this, the authors studied the biologic and 
structural changes occurring in 80 segments of human umbilical vein (HUV) grafts 
excised from 70 patients. Morphologic, histologic and scanning electron microscopy 
examinations were performed on each specimen. It was noted that increasing 
duration of implantation was associated with greater encapsulation and less 
surrounding inflammatory reaction. Twenty-six percent of clinically noninfected 
grafts were found to harbour bacteria. Bacteremic colonization was often in the folds 
of the luminal surface. As a result of these findings, the authors emphasize the need 
for complete excision of clinically infected grafts. Anastomoses between HUV 
segments are discouraged because they are associated with a high frequency of 
infection and a corresponding decrease in duration of implantation. Delamination of 
the wall was common, and such sites may represent areas at risk for further 
degradation. Continued surveillance of the biologic and structural changes 
occurring in excised grafts remains an important method in increasing our 
understanding of the evolutive complications of HUV grafts.
La veine ombilicale humaine constitue une bonne alternative a la veine saphene autogene, 
pour la revascularisation des membres inferieurs. Toutefois, sa permeabilite a long terme 
n’est pas aussi bonne. Pour mieux comprendre les raisons de ceci, les auteurs ont etudie 
les changements biologiques et structuraux qui sont survenus dans 80 segments de 
greffons de veine ombilicale humaine (VOH) qui avaient ete excises chez 70 patients. Des 
examens morphologiques, histologiques et de microscopie electronique ont ete pratiques 
sur chaque echantillon. On a observe qu’avec [’augmentation de la duree de la greffe etait 
associee une plus grande encapsulation et une reaction inflammatoire moins importante. 
Vingt-six pourcent des greffons cliniquement non infectes abritaient des bacteries. La 
colonisation bacterienne apparaissaient souvent dans les replis de la surface luminale. 
Consequence de cette observation, les auteurs soulignent la necessite d’exciser 
completement les greffons cliniquement infectes. Les anastomoses entre des segments de 
VOH ne sont pas recommandees, car elles sont reliees a un fort taux d’infections et a une 
baisse correspondante de la duree des greffes. Une delamination de la paroi etait 
frequente, ce qui pourrait representer une region susceptible de developper une 
deterioration plus poussee. La poursuite d’une etroite surveillance des changements 
biologiques et structuraux qui surviennent dans les greffons excises, constitue un moyen 
important d’ameliorer nos connaissances des complications evolutives des greffons de 
VOH.
Autogenous saphenous vein is still the graft material of choice 
for lower limb revascularization.1 
However, this vein is not always
available: it may be inadequate, dis­
eased or absent because of previous 
vascular surgery.1 In the search for 
other blood conduits, human umbil­
ical vein (HUV) was found to be a 
valuable alternative for femoropo- 
pliteal and femorodistal bypasses23 
and for the creation of arteriove­
nous fistulas.45 The results of its 
use in these situations are compara­
ble to those obtained with expanded 
polytetrafluoroethylene in above­
knee bypasses and are better than 
those reported for below-knee by­
passes.6
Because the long-term patency of 
HUV grafts is inferior to that of 
autogenous saphenous vein, Dardik 
and colleagues7 have recommended 
limiting their use to patients with a 
deficient or absent autologous sa­
phenous vein and a limited life
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expectancy. Several groups89 have 
questioned the long-term fate of 
HUV grafts in vascular surgery be­
cause of dilatation observed in pa­
tent grafts. To understand better 
the in-vivo biostability of chemically 
processed HUV grafts, we have 
analysed, by morphologic, histolog­
ic and scanning electron microscopy 
examinations, 80 surgically excised 
grafts.
Materials and Methods
The 80 HUV grafts were surgi­
cally excised at eight different cen­
tres in Canada and five in France 
from 70 patients (49 men, 16 
women and 5 of unknown sex). The 
mean age of the patients at implan­
tation was 67 years (range from 29 
to 90 years). The mean duration of 
implantation was 9.7 months (range 
from 1 day to 78 months). Of the 
80 grafts, 78 were used for revascu­
larization of the lower limbs; 1 was 
implanted as an arteriovenous fistu­
la for plasmapheresis in a 
29-year-old woman with Behcet’s 
syndrome1011 and 1 was used to 
create an axilloaxillary bypass.
After excision, the grafts were 
opened longitudinally, carefully 
rinsed with heparinized saline, fixed 
in a buffered solution of 1.5% glu- 
taraldehyde and shipped immediate­
ly to the Laboratoire d’Analyses 
Fonctionnelles at the Hopital St- 
Franqois d’Assise in Quebec City. 
They were photographed and exam­
ined, using a Tessovar macro­
photography optical system (Carl 
Zeiss, Oberkochen, Germany). Rep­
resentative areas were selected for 
pathological studies. Each area was 
divided into three specimens. The 
first was post-fixed in a Perfix solu­
tion (Fisher Scientific, Montreal, 
PQ), dehydrated with ethanol and 
clarified with toluene before being 
mounted in paraffin. Sections 4 jum 
thick were stained in the following
order for viewing by light microsco­
py: Weigert’s, Masson’s trichrome, 
Brenn and Brown and Dahl stains. 
The second specimen was frozen in 
a bath of isopentane at — 150°C. 
The frozen tissue was sectioned in a 
cryostat and stained with oil red 0 
for neutral lipid (Sudan IV). The 
third specimen was post-fixed in 
thiocarbohydrazide and osmium te- 
troxide for scanning electron mi­
croscopy. In this case, dehydration 
was obtained by immersing the 
specimen in a series of ethanol 
solutions of increasing concentra­
tions, culminating in pure ethanol, 
followed by critical-point drying 
with liquid carbon dioxide as the 
transfer medium. The specimen was 
then coated with gold-palladium 
and examined in a JSM 35CF scan­
ning electron microscope (Soquelec, 
Montreal PQ) at 15 to 20 kV of 
accelerating voltage.
Results
Clinical Observations
The indications for implantation 
are set forth in Table I. Longer 
duration of implantation seemed to
be associated with less severe symp­
toms of arterial disease.
Thrombosis was the major indi­
cation for reoperation (Table II); 
74% of grafts were removed after a 
mean implantation period of 8 
months because of thrombosis. 
True aneurysm formation appeared 
to be a late (mean 3 years) and 
unusual (four cases) complication. 
One false aneurysm developed at 
the anastomotic site between two 
segments of HUV (Figs. 1 and 2).
The site of implantation also af­
fected the duration of patency of 
the graft (Table III). The duration 
of implantation was 50% longer for 
above-knee grafts than below-knee 
grafts.
Macroscopic Observations
About one-third of the grafts had 
irregular wall thickness. Most had 
folds on the luminal surface, about 
one-third being deep folds. The lu­
minal surface was often covered 
with thrombotic debris, particularly 
at anastomotic sites.
The external capsules of the ex­
cised grafts were classified using 
four degrees of encapsulation:
Table 1. Indications for Surgery
Mean age Mean duration
of patients, No. of of implantation,
Indication yr prostheses mo
Claudication 58 10 19
Rest pain 65 35 8
Limb salvage 76 23 8
Aneurysm 50 1 2
Arteriovenous fistula 29 1 4
Unknown 65 10 11
Table II. Indications for Reoperation*
Duration of implantation, mo
Indication <1 1-3 4 -12 >12 Unknown Total Mean
Thrombosis 21 7 16 9 6 59 8
Infection 4 6 9 1 1 21 5
Run-off degradation 4 1 4 2 1 12 8
Aneurysm 0 1 1 2 0 4 36
False aneurysm 0 0 0 2 0 2 17
Stenosis 0 0 0 1 1 2 19
'Some prostheses were excised for more than one reason.
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none, thin fibrous capsule, interme­
diate fibrous capsule and thick fi­
brous capsule. We found that high-
FIG. 1. Angiogram showing false an­
eurysm (arrow) at suture line of 
human umbilical vein (HUV) graft used 
for femorofemoral bypass in 72-year- 
old patient with limb-threatening isch­
emia. Prosthesis was in place for 12 
months.
er degrees of encapsulation were 
associated with increasing duration 
of implantation (Table IV).
The relation between duration of 
implantation, infection and the 
number of HUV segments is shown 
in Table V. The duration of implan­
tation decreased as the number of 
segments anastomosed and the per­
centage of grafts excised for infec­
tion increased.
Microscopic Analysis 
The evaluation of lipid uptake by
Table III. Sites of Implantation
Mean duration 
No. of of implantation, 
Site prostheses mo
Femoropopliteal 40 13
Above knee 10 21
Below knee 24 11
Unknown 6 7
Femorodistal 27 5
Other 4 6
Unknown 9 7
between prosthesis (P) and host artery (A).
Table IV. Effect of Duration of Implantation on Degree of Encapsulation
Degree of 
encapsulation
No. of 
prostheses 
(n =  65)
Mean
duration of 
implantation, mo
None 28 1
Thin capsule 16 3
Intermediate capsule 17 8
Thick capsule 4 24
the graft wall only by Sudan IV 
staining was not 100% reliable be­
cause of technical artifacts. Depos­
its of cholesterol were observed by 
scanning electron microscopy in 29 
prostheses. The accumulation was 
subjectively classified as follows: 
none, minimal, moderate and large. 
Table VI shows a relation between 
the extent of cholesterol accumula­
tion and presence or absence of 
dyslipidemia. Patients who had dys- 
lipidemia did not appear to accumu­
late cholesterol on the surfaces of 
their prosthesis compared with 
those without dyslipidemia. The 
patency of the graft did not seem to 
be influenced by cholesterol deposi­
tion.
Bacteria were observed histologi­
cally and by scanning electron mi­
croscopy in 38 grafts (Table VII). In 
two cases, the prosthesis was in­
fected clinically, but no bacteria 
were noted. In addition, 26% of 
prostheses were found to harbour 
bacteria while no infection was 
noted clinically. Sometimes the bac- 
teremic colonization was limited to 
the luminal surface of the prosthe­
sis (Figs. 3 and 4); in other cases 
the wall of the graft was invaded 
(Fig. 5). Folds on the luminal sur­
face of the graft may also offer a 
preferred site for bacteremic coloni­
zation (Figs. 6 and 7).
Inflammatory reactions were 
common, occurring in 26 cases. 
These reactions were subjectively 
classified as follows: no inflammato­
ry reaction, limited, intermediate 
and intense inflammatory reaction. 
Such reactions were often seen in 
clinically infected prostheses. When 
this reaction was intense, the dura­
tion of implantation was greatly 
reduced. An example of an inflam­
matory reaction is presented in Fig. 
8. This reaction was classified as 
moderate on our scale.
Delamination occurs frequently 
with HUV grafts (Fig. 9). We could 
not demonstrate any relation be-
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tween the extent of delamination 
and bacteremic colonization, al­
though delaminated sites would 
seem to be ideal for bacterial 
growth. They represent, at the very 
least, potential sites for further deg­
radation.
Discussion
Since most specimens were re­
trieved after thrombosis, we found 
it difficult to assess their biostabili­
ty. We also lacked a reliable control 
group (prostheses implanted for an 
equivalent length of time but with­
out failure). It would be possible to 
overcome this deficiency by examin­
ing patent grafts from autopsies. 
We believe that despite this lack of 
a control group we have made some 
observations that may have impor­
tant future implications. One of 
these is the high incidence of 
thrombosis with HUV grafts. Ef­
forts to develop an antithrombogen- 
ic flow surface seem reasonable. 
However, treatment of the surface 
by a mixture of heparin and alcohol 
or heparin alone12 is questionable 
since these techniques will deal only 
with resistance to thrombosis and 
will not necessarily resolve the com­
plications related to bacteremic col­
onization, aneurysmal formation, 
lipid uptake and bioresorption.
Despite these complications, the 
HUV graft is considered by 
some1314 to be the best material for 
below-knee revascularization when 
autogenous saphenous vein is not 
available. However, HUV is not the 
perfect material and, as we have 
demonstrated, grafts crossing the 
knee survive only half as long as 
those that do not. This may be 
related to kinking of the graft at 
the knee and the generally longer 
length of the graft.
Lipid uptake and cholesterol de­
position on the luminal surface of 
the graft may be related to the
individual patient’s metabolism.15 
We found that patients suffering 
from dyslipidemia are less likely to 
have cholesterol deposition on the 
luminal surface. Further investiga­
tions in this area need to be done in 
order to understand the effect of 
lipid metabolism on the patency of 
these grafts. Lipid uptake is diffi­
cult to assess because of the fre­
quent occurrence of artifacts on 
Sudan IV staining.
Bacteremic colonization of any 
foreign material exposed to blood 
flow is a widely recognized problem 
whose clinical importance has still 
to be established. It is unlikely that 
bacteria will be eliminated by any
Table V. Effect of the Number of Human Umbilical Vein Segments on the Incidence of Infection
No. of 
segments
No. of 
prostheses
Mean duration of 
implantation, mo
% of grafts 
excised for infection
1 61 12 20
2 13 3 46
3 6 3 50
Table VI. Effect of Dyslipidemia on the Luminal Deposition of Cholesterol Particles
Degree of
cholesterol
deposition
No. of 
prostheses 
(n =  64)
Mean duration 
of implantation, 
mo
% of patients 
suffering 
dyslipidemia
None 35 11 30
Minimal 21 10 9
Moderate 5 18 0
Large 3 8 0
Table VII. Relation Between the Clinical Declaration of infection and the Observation of Bacteria
Clinical No clinical
infection, no. (%) infection, no. (%)
Bacteria observed 17(24) 21 (30)
No bacteria observed 2 (3) 30 (43)
FIG. 3. Scanning electron micrograph of luminal surface of infected graft. Bacilli 
can be seen on curoric matrix composed of fibrous tissue embedding erythrocytes 
(original magnification X 1000).
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antibiotic therapy. Thus, the HUV 
graft must be totally excised in 
cases of an infected segment or 
amputation.16
Imperfections of the luminal sur­
face, such as folds, facilitate the 
bacteremic colonization of the graft 
wall. Moreover, these imperfections 
could be implicated in the throm­
botic process. The folds may result 
from the HUV processing, which is 
required to obtain a straight vessel. 
Therefore, quality control tests 
should be reinforced even if there is 
already a high standard of selection 
of the umbilical veins.
The high proportion of grafts
with bacteremic colonization but no 
clinically observed infection is of 
particular concern. It is difficult to 
say whether these grafts are resis­
tant to infection or whether the 
infections were merely dormant, 
awaiting the appropriate stimulus 
to be activated. Any bacteria, how­
ever transient, may have the poten­
tial to infect HUV grafts.
These infections are often associ­
ated with an inflammatory reaction 
in the graft wall, which may lead to 
thickening of the wall and therefore 
contribute to mechanical graft fail­
ure.
Bacteremic colonization is also
more likely when two or three um­
bilical veins are anastomosed to­
gether to construct a prosthesis of 
sufficient length. One study17 
showed that the addition of a su­
ture line at the middle of a polytet- 
rafluoroethylene prosthesis raised 
the bacterial adherence by 50%. 
Our clinical results with HUV agree 
with this study. Suture lines be­
tween anastomosed HUV grafts are 
sometimes the site of aneurysmal 
formation, thought to be related to 
compliance mismatch between anas­
tomosed HUV grafts.18 Measure­
ment of graft compliance before 
implantation, as a method of quality
FIG. 4. Gram-positive cocci in tissue covering luminal surface 
of clinically infected prosthesis implanted in 68-year-old 
patient (Brenn and Brown stain, original magnification X 
400).
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FIG. 5. Media of prosthesis is infected throughout with 
gram-positive bacilli. This prosthesis was implanted as femo- 
ropopliteal bypass for 2 months in 44-year-old man (Brenn 
and Brown stain, original magnification X 400).
FIG. 6. Scanning electron micrographs of bacteremic colonization into folds of luminal surface of graft. (A) Folds of luminal 
surface (original magnification X 20). (B) Cocci found in folds (original magnification X 2000).
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control, has been suggested for 
vascular grafts of biologic origin.18 
We consider that the anastomoses 
between grafts are an important 
factor in assessing the stability of 
the HUV graft.
Interestingly, we have never ob­
served such bacteremic colonization 
in animal experiments. Bacteria en­
countered in dogs do not show the 
same resistance as bacteria encoun­
tered in humans when antibiotics 
are administered prophylactically.19 
Therefore, new arterial prostheses 
should be implanted with caution in 
humans, no matter how successful 
they have been in animals.
Conclusions
Increasing duration of HUV graft 
implantation is associated with 
greater degrees of encapsulation. 
However, the surrounding inflam­
matory reaction is less in explants 
of longer duration. Clinical infec­
tion tends to increase this degree of 
inflammatory reaction. Bacterial 
colonization in a substantial num­
ber of clinically noninfected grafts 
and the discovery of bacteria in 
folds, often found in HUV grafts, 
support the need for increased vigi­
lance with respect to late complica­
tions. We recommend complete ex­
cision of clinically infected grafts. 
Furthermore, in considering the ap­
plication of HUV grafts, intergraft 
anastomoses should be avoided if 
possible because the frequency of 
infection is higher, there is a poten­
tial for aneurysm formation and the 
duration of implantation is de­
creased. The common finding of 
delamination further supports the 
continued surveillance of the bio­
logic and structural changes in ex­
cised HUV grafts.
We thank the operating room techni­
cians and hospital attendants for col-
FIG. 7. Infection in folds of luminal surface. (A) Subintimal hemorrhagic sites (Weigert’s stain, original magnification X 400). 
(B) Presence of gram-positive bacteria at these sites (Brenn and Brown stain, original magnification X 400).
FIG. 8. “Intermediate” inflammatory reaction between graft 
wall and surrounding polyester mesh. This graft was removed 
from 60-year-old woman because of infection (Weigert’s stain, 
original magnification X 100).
FIG. 9. Delamination of intima of graft implanted for 24 hours 
(original magnification X 100).
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lecting and preparing the specimens. 
The technical assistance of Marielle 
Corriveau, Nicole Massicotte, Suzanne 
Bourassa, Karen Horth and Richard 
Couture was greatly appreciated. Meet­
ings of the French and Quebec groups 
were supported in part by the Echanges 
France-Quebec.
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and diet program further burdens the 
patient.
Since the conference’s purpose was 
to involve all health-care disciplines, the 
book is not directed at any specific 
group, thus, there is inadequate detail 
to interest most physicians. The surgi­
cal concerns of epidemiology, diagnosis, 
screening, operative technique, patholo­
gy, adjuvant therapy and patient man­
agement are too meagre for the Canadi­
an surgeon’s needs.
J.E. Devitt, MD, CM, MSc, FRCS(Edin), 
FRCSC
Ste. 310,
1081 Carling Ave.,
Ottawa, Ont.
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HARDY’S TEXTBOOK OF SURGI­
CAL MANAGEMENT. 2nd edition. Ed­
ited by James D. Hardy. 1414 pp. 
Illust. J.B. Lippincott Company, Phila­
delphia, 1988. Price not stated. ISBN 
0-397-50817-4.
This textbook is stated to be a highly 
accessible book for “all standards of 
surgery” . This is its major problem. A 
book may be written for the undergrad­
uate, the surgical resident or surgeon, 
but not one book for all three. The 
contributors all work in the United 
States and have little interest in pre­
senting work or giving references to 
surgery elsewhere. The illustrations are 
mostly line drawings. The good artistic 
figures have generally been reproduced 
from other surgical texts. As is so 
common with multiauthored texts, 
there is considerable difference in the 
standard of the chapters.
The chapter on the breast might 
have been written 25 years ago; it 
contains many inaccuracies. In the sec­
tion on screening, the HIP study is 
described, but many important interna­
tional studies, especially those from 
Sweden, are not mentioned. The cur­
rent “gold standard” of treatment for 
breast cancer is no longer modified 
radical mastectomy, and surely there is 
no place for it today. It is stated that 
lymphatic drainage from cancers in the 
medial half of the breast and the areolar
region is mainly to the internal mamma­
ry nodes. It has been established from 
American and Italian studies that nodal 
involvement is not related to the posi­
tion of the tumour. Also, liver involve­
ment is not the result of lymphatic 
spread. Extensive axillary node dissec­
tion is advocated, yet it has been estab­
lished that control of disease in the 
axillary nodes is as well accomplished 
by radiotherapy as surgery. The term 
roentgen is used in this book, yet it has 
been supplanted first by the rad and 
then the gray. Only scant reference is 
made to receptor status, yet this has 
assumed major importance and prog­
nostic significance in patients with 
breast cancer. All fibroadenomas should 
not be enucleated; this leads to unnec­
essary surgery in teenagers. Little refer­
ence is made to the importance of 
family history.
Other chapters, especially the first 16 
on basic and support considerations, are 
mostly well written and concise. Of the 
remaining chapters, the ones on gyne­
cologic surgery and on morbid obesity 
are excellent.
In conclusion, I think better texts 
than this one are available, for the 
student, the resident or the surgeon.
John A. McCredie, MB, MCh, FRCS, 
FRCS(Edin), FRCSC, FACS
Department o f Surgery,
Victoria Hospital,
London, Ont.
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OBSTETRIC ANESTHESIA: THE
COMPLICATED PATIENT. Edited by 
Francis M. James, III, A. Scott Whee­
ler and David M. Dewan. 577 pp. 
Illust. F.A. Davis Company, Philadel­
phia, 1988. $79.00 (US). ISBN
0-8036-4914-2.
This text, as its title suggests, focuses 
on the administration of anesthesia dur­
ing labour to women with problem 
pregnancies. In the first section, aspects 
of maternal and fetal physiology are 
covered and a good discussion of fetal 
assessment and monitoring is provided. 
There is also an excellent chapter in 
which maternal and fetal morbidity and
mortality are reviewed. A section on 
anesthesia for the uncomplicated pa­
tient is included, but the emphasis is on 
complications of the anesthesia.
The section entitled “Maternal prob­
lems by system” covers all the major 
systems and is the core of the text. The 
chapter on neurologic disease is well 
done with a good discussion on epilepsy 
during pregnancy. One excellent chap­
ter is that on hematologic disease in 
which a discussion on coagulation dis­
orders is particularly complete. The 
section on fetal problems includes a 
unique chapter on fetal surgery along 
with the topics of preterm delivery and 
fetal distress. The last section of the 
text is reserved for what the editors 
consider special problems, including di­
abetes, pregnancy-induced hypertension 
and non-obstetric surgery, together 
with more unusual chapters such as 
one on the febrile parturient, the obese 
parturient, the traumatized obstetric pa­
tient and substance abuse.
The editors have done a commenda­
ble job in bringing together experts in 
the field, including Canadian research­
ers Biehl and Palahniuk in Winnipeg, 
McMorland in Vancouver and Writer in 
Halifax. The chapters are well refer­
enced and, for the most part, very up to 
date. Controversial areas are well ad­
dressed and the authors usually give 
practical direction to the reader. Most 
topics or treatment protocols are sum­
marized in tables or outlines, and many 
graphs have been reproduced from the 
literature to illustrate the results of 
investigation. The index is extensive 
and includes references to tables and 
figures.
In summary, the text is a welcome 
addition to my bookshelf. It serves as 
an excellent bridge between obstetrics 
and internal medicine and yet maintains 
the perspective of the anesthetist.
Robert D. Elliott, MD, FRCPC
Coordinator,
Obstetrical Anesthesia,
Ottawa General Hospital.
501 Smyth Rd.,
Ottawa, Ont.
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Identification of Clinically Significant 
Skeletal Muscle Necrosis by Single Photon 
Emission Computed Tomography
I. Forrest, MD, FRCSC;* G. Hayes, MD, FRCSC;* A. Smith;f T-C.K. Yip, MD, FRCPC;t 
Paul M. Walker, MD, PhD, FRCSC*
Ischemia-reperfusion damage to skeletal muscle may cause serious local as well as 
systemic complications, its impact predominantly related to the quantity of ischemic 
muscle in the lower extremity. To date, there has been no noninvasive method of 
estimating that quantity. The authors used single photon emission computed 
tomography (SPECT) to quantify the volume of muscle that takes up technetium-99 
pyrophosphate above a baseline threshold. Compared with the standard technique of 
staining slices of the muscle with nitroblue tetrazolium they found a close 
correlation using SPECT (r =  0.88, p < 0.01, n = 19) in the canine model. In 
humans, this clinically applicable noninvasive technique may allow the surgeon to 
document accurately the extent of muscle necrosis in the lower extremity, to 
anticipate the impact of an ischemia-reperfusion injury and evaluate methods of 
reducing the extent of post-ischemic skeletal muscle necrosis.
Les dommages ischemiques de reperfusion des muscles squelettiques peuvent causer 
des complications locales et generates graves; leur importance est d’abord reliee a la 
quantite de muscle ischemique dans les membres inferieurs. Jusqu’a ce jour on ne 
connaissait aucune methode non sanglante pour apprecier cette quantite. Les 
auteurs ont utilise la tomographie a emission photonique simple (TEPS) pour 
quantifier le volume musculaire qui fixe le pyrophosphate de technetium-99 au 
dessus d’un seuil de base. Comparativement a la technique courante qui consiste a 
colorer des coupes de muscle a l’aide de nitrobleu de tetrazolium, ils ont trouve, 
chez le chien, une etroite correlation avec la TEPS (r = 0.88, p < 0.01, n =  19). 
L’application clinique de cette technique non sanglante chez l’humain peut 
permettre au chirurgien d’etablir precisement l’etendue d’une necrose musculaire 
dans les membres inferieurs, d’anticiper l’effet des lesions ischemiques de reperfu­
sion et d’evaluer les methodes visant a reduire la necrose post-ischemique des 
muscles squelettiques.
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Supported by Medical Research Council o f  Canada grant MA 8076 
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Quantification of necrotic muscle in the lower extremity is a 
challenging clinical problem. Isch­
emia over a prolonged period, 
caused by acute arterial thrombosis 
or embolism, may be relieved surgi­
cally, but the combination of meta­
bolic events during ischemia and 
those resulting from reperfusion 
leads to cellular damage.1 We have 
demonstrated previously2 that there 
is a gradation in the extent of 
ischemic damage related to the time 
of absent circulation. In contrast to 
myocardial or cerebral ischemic 
damage, relatively large quantities 
of skeletal muscle necrosis can be 
tolerated without permanent disabil­
ity. Clinical techniques for estimat­
ing the extent of necrosis have been 
limited to visual examination during 
fasciotomy (to reduce compressive 
muscle death) or apparent alter­
ations in muscle contractions 
(which may be inaccurate due to 
concomitant nerve injury). We have 
described a method for accurately 
evaluating skeletal muscle necrosis 
in the canine gracilis muscle model 
using a combination of nitroblue 
tetrazolium staining and computed 
planimetry.3 The results compare 
favourably with the technetium-99 
pyrophosphate (PYP) uptake in this 
animal model using calibration of 
the density of the isotope uptake 
per gram of tissue, assessed after 
muscle removal.4 Both techniques
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are invasive and not applicable clini­
cally. A noninvasive technique for 
evaluating the quantity of tissue 
containing radioactivity above a 
threshold level has been developed, 
using single photon emission com­
puted tomography (SPECT). In this 
report we compare the ability of 
SPECT to quantify muscle necrosis 
in the canine model with standard 
invasive techniques.
Methods
Canine Model
In our study we used the bilateral 
canine gracilis muscle model de­
scribed previously.5 Both muscles 
were isolated on a single vascular 
pedicle by dividing all collateral ves­
sels, including the minor pedicle, 
the nerve and both tendinous at­
tachments, with resuturing to pre­
serve resting muscle tension. Re­
versible periods of ischemia were 
produced by applying microvascular 
clips to the vascular pedicle for 4 
hours. Normal reperfusion was in­
duced by removing the clips, and 
the patency of the pedicle was as­
sured by Doppler ultrasound. The 
muscles were harvested for evalua­
tion 48 hours later, 2 hours after 
injection of technetium-99 PYP 
(250 MBq). Both gracilis muscles 
were harvested and scanned using a 
large field of view gamma camera. 
Single photon emission computed 
tomography was performed with a 
64 X 64 matrix, low energy, all 
purpose collimator, using an ellipti­
cal orbit with a total acquisition 
time of approximately 30 minutes. 
When imaging was complete, each 
muscle was cut into six slices, 
weighed and incubated with nitrobl- 
ue tetrazolium. The volume of ne­
crosis in each slice was established 
using computed planimetry. The 
mean of the dead area divided by 
the mean of the total area on both
sides of the slice was multiplied by 
the weight to determine the volume 
(ml) of necrosis per slice.6
Transaxial slices were obtained 
by filtered back projection using a 
Hanning filter (a mathematical 
function used to reduce background 
variation) at 1 pixel thickness. A 
pixel is the smallest division of the
field of view of the gamma camera 
recognized by the computer (0.44 
cm2). The edge of each slice was 
determined using a threshold meth­
od.7 The pixel counts from all slices 
were then summed. The volume of 
necrosis with PYP activity (the vol­
ume of necrotic muscle) was com­
puted by multiplying the summed
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number of pixels by the voxel size. 
A voxel is a measure of the volume 
of the product of one pixel and slice 
thickness (0.29 cm3). (The thresh­
old and ability of this method to 
quantify the volume of necrosis in 
syringes containing a solution of 
technetium-99 PYP had already 
been established.8)
Statistical significance was deter­
mined by linear regression analysis.
Results
Nineteen muscles were studied. 
Sample scans in the coronal plane 
and in sagittal section are shown in 
Fig. 1, and transaxial projections 
are shown in Fig. 2. The volume of 
necrosis as measured by tetrazolium 
staining techniques and by SPECT 
for all points is shown in Fig. 3. 
Over a range of necrosis from less 
than 1 ml to more than 175 ml, the 
correlation was r = 0.88 (p < 
0.001). When only volumes of ne­
crosis greater than 20 ml were
MR* it £ 
•= 35.234
included, the correlation coefficient 
was r =  0.93 (p < 0.001).
Discussion
The prognosis following pro­
longed ischemia-reperfusion in the 
lower extremity depends mainly on 
the effects of muscle tissue and, to 
a lesser extent, the nerve.9 Inade­
quate revascularization is seldom 
the cause of major morbidity or 
mortality. Systemic consequences of 
muscle ischemia are the commonest 
cause of death. The washout of 
lactate, hydrogen and potassium 
ions, myoglobin and other toxic 
materials may lead to hypotension, 
cardiac or renal failure.10 Morbidity 
following a severe ischemia-reperfu­
sion injury to the lower extremity 
ranges from the need for urgent 
amputation (usually at a higher 
level than for chronic conditions) to 
motor dysfunction resulting in 
long-term disability and the pa­
tient’s inability to return to previ-
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FIG. 2. Transaxial projection of both gracilis muscles, with threshold used for 
calculation of volume of necrosis.
ous occupations.11 Limb dysfunc­
tion may be the result of muscle or 
nerve damage or both. Therefore, 
determining the extent of damage 
to skeletal muscle by a noninvasive 
method is pivotal in assessing the 
impact of ischemia-reperfusion. 
Quantification of post-ischemic 
skeletal muscle necrosis in the 
lower extremity has not been avail­
able to date. Our previous work12 in 
quantifying skeletal muscle necrosis 
in the canine gracilis muscle model 
demonstrated the usefulness of 
technetium-99 PYP. We used 
the suggested 48- to 72-hour win­
dow for our evaluation of necrosis. 
This is when intracellular accu­
mulation of technetium (a calcium 
ion follower) best reflects ongoing 
necrosis.12 The addition of SPECT 
for quantifying radioisotope accu­
mulation may permit reliable trans­
fer to the clinical situation of a 
technique developed in the laborato­
ry. Comparison of the gold standard 
of tetrazolium staining and SPECT 
demonstrated a close relationship 
between these two measurements of 
the volume of necrotic tissue within 
a gracilis muscle. We concluded 
that only when the amount of ne­
crosis is small is there a substantial 
discrepancy between the two mea­
surements.
The clinical usefulness of this 
noninvasive measurement remains
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FIG. 3. Graph showing relation be­
tween volume of necrosis as measured 
by tetrazolium staining and uptake of 
technetium-99 pyrophosphate (r =  
0.88, p < 0.01, n =  19).
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to be clearly defined. The quantifi­
cation of ischemic muscle in the 
lower extremity may allow us to 
predict the outcome of the injury 
and determine earlier the need for 
amputation or debridement. This 
technique may also be useful pro­
spectively for choosing therapeutic 
interventions aimed at reducing is­
chemia-reperfusion injury, as has 
been demonstrated in animal experi­
ments.13
We believe that technetium-99 
PYP accurately identifies necrotic 
skeletal muscle when measured 48 
to 72 hours after an ischemia-reper­
fusion injury. Single photon emis­
sion computed tomography is a 
clinically useful method for quanti­
fying the accumulation of radioiso­
tope, as a direct measurement of 
the volume of ischemic muscle pres­
ent in the lower extremity.
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For prescribing information see reverse
cost effective
prophylactic
alternative
cefotaxime
sodium
in contaminated 
or potentially 
contaminated 
gastro-intestinal 
surgery
Claforan .. was superior 
in preventing infectious 
morbidity and side effects 
and reduced hospital 
drug costs compared 
directly with multidose 
regimens of cefazolin 
or cefoxitin (p value not 
statistically significant)
Dr. R.N. Jones
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Action
In vitro studies indicate that the bacterial action of CLAFORAN (cefotaxime sodium) 
a semi-synthetic cephalosporin antibiotic, results from inhibition of cell wall 
synthesis.
Indications and Clinical Uses
Treatm ent: CLAFORAN (cefotaxime sodium) may be indicated for the treatment 
of infections caused by susceptible strains of the designated micro-organisms 
in the diseases listed below.
Lower respiratory trac t in fec tions : pneumonia and lung abscess caused by 
Streptococcus pneumoniae (formerly Diplococcus pneumoniae), other streptococci 
(excluding enterocci, eg. S. faecalis), Straphylococcus aureus (penicillinase and 
non-penicillinase producing), Escherichia coli, Hemophilus influenzae, (including 
ampicillin resistant strains) and unspecified Klebsiella species.
Urinary tract in fe c tio n s : caused by Escherichia coli, unspecified Klebsiella 
species (including K  pneumoniae), Proteus mirabilis, indole positive Proteus, Ser- 
ratia marcescens and Staphylococcus epidermidis. Also, uncomplicated gonor­
rhea caused by N. gonorrhoeae including penicillin resistant strains 
B a c te rem ia /S e p ticem ia : caused by Escherichia coli, unspecified Klebsiella 
strains and Serratia marcescens.
Skin in fec tions : caused by Staphylococcus aureus (penicillinase and non­
penicillinase producing, S. epidermidis, Group A streptococci, Escherichia coli, 
Proteus mirabilis and indole positive Proteus.
Intra-abdominal in fec tions: caused by Escherichia coli, and unspecified Kleb­
siella species.
Gynecological in fec tions : including pelvic inflammatory disease, endometritis 
and pelvic cellulitis caused by E. coli, Group A streptococci and Staphylococcus 
epidermidis-, anaerobic bacteria including unspecified Peptococcus and Peptostrep- 
tococcus strains and some strains of Bacteroides fragilis. In several cases, although 
clinical cures were achieved, bacteriological follow-up was not available. 
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN 
has been used with some success in wound and intra-abdominal infections against 
some strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas. 
In the treatment of infections encountered in immunosuppressed and granulo­
cytopenic patients, results of therapy with CLAFORAN have not been impressive. 
CLAFORAN should not be considered in the treatment of enterococcal infections, 
i.e. Streptococcus faecalis
Specimens for bacteriologic culture should be obtained prior to therapy in order 
to isolate and identify the causative organisms and to determine their suscep­
tibilities to CLAFORAN. Therapy may be instituted before results of susceptibility 
studies are known; antibiotic treatment should be re evaluated once these results 
become available.
Prophylactic U se ; The administration of CLAFORAN perioperatively (preoperative 
ly, intraoperatively and postoperatively) may reduce the incidence of certain infec­
tions in patients undergoing elective surgical procedures (e.g. abdominal or vaginal 
hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified 
as contaminated or potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased 
risk of infection, intraoperative (after clamping the umbilical cord) and postoperative 
use of CLAFORAN may also reduce the incidence of certain postoperative infections. 
Effective use for elective surgery depends on the time of administration (see Dosage 
and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation 
by mechanical cleansing as well as with a non absorbable antibiotic (e.g. neomycin) 
is recommended.
If there are signs of infection, specimens for culture should be obtained for iden­
tification of the causative organism so that appropriate therapy may be instituted. 
Contraindications
CLAFORAN is contraindicated in patients who have shown hypersensitivity to 
cefotaxime sodium, the cephalosporin or the penicillin groups of antibiotics. 
Warnings
Before therapy with CLAFORAN is instituted, it must be carefully determined whether 
the patient has had previous hypersensitivity reactions to cefotaxime, 
cephalosporins, penicillins or other drugs CLAFORAN should be given with caution 
to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including 
CLAFORAN should be administered with caution to any patient who has 
demonstrated some form of allergy, particularly to drugs. If an allergic reaction 
to CLAFORAN occurs, the drug should be discontinued and the patient treated 
with the usual agents (e.g. epinephrine, antihistamine, pressor-amines or 
corticosteroids).
Pseudomembranous colitis has been reported with the use of cephalosporins 
(and other broad spectrum antibiotics); therefore, it is important to consider its 
diagnosis in patients who develop diarrhea during the administration of CLAFORAN. 
This colitis can range from mild to life-threatening in severity.
Treatment with broad spectrum antibiotics, such as CLAFORAN, alters the nor­
mal flora of the colon and may permit overgrowth of Clostridium difficile or other 
Clostridia. It has been established that a toxin produced by Clostridium difficile 
is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to discontinuation of CLAFORAN and replace­
ment with a suitable specific antibiotic. Moderate to severe cases should be manag­
ed with fluid, electrolyte and protein supplementation as indicated. When the colitis 
is not relieved by discontinuance of CLAFORAN administration or when it is severe, 
an antibiotic specifically effective in antibiotic-associated pseudomembranous colitis 
(e.g. vancomycin) or other suitable therapy may be indicated. Other possible causes 
of colitis should also be considered (see Adverse Reactions).
Precautions
CLAFORAN (cefotaxime sodium) should be prescribed with caution in individuals 
with a history of lower gastrointestinal disease particularly colitis.
The safety of CLAFORAN in pregnancy has not been established. Consequently, 
use of the drug in pregnant women requires that the likely benefit from the drug 
be weighed against the possible risk to the mother and fetus.
Use of CLAFORAN in women of child-bearing potential requires that the anticipated 
benefits be weighed against the possible risks.
Cefotaxime is excreted in human milk in low concentrations. Caution should be 
exercised when the drug is administered to nursing mothers.
Prolonged use of CLAFORAN may result in the overgrowth of nonsusceptible 
organisms. Constant evaluation of the patient’s condition is essential. If super­
infection occurs, therapy should be discontinued and appropriate measures taken. 
Although CLAFORAN rarely produces alterations in kidney function, evaluation 
of renal status is recommended, especially in severely ill patients receiving high 
doses.
Patients with markedly impaired renal function should be placed on the special 
dosage schedule recommended under Dosage and Administration, because nor 
mal dosage in these individuals is likely to produce excessive and prolonged serum 
antibiotic concentrations.
Positive direct Coomb’s test is known to develop in individuals during treatment 
with the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing 
substances but not with the use of specific glucose oxidase methods. 
Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are 
Hypersensitivity (1.8%): Rash, pruritus, fever. Local (5%): Injection site inflam­
mation with intravenous administration. Pain, induration and tenderness after in­
tramuscular injection. Gastrointestinal (1.7%): Colitis, diarrhea, nausea and 
vomiting. Symptoms of pseudomembranous colitis can appear during or after 
CLAFORAN treatment. Hemic and Lymphatic System ( <  1%): Mild, reversi 
ble leukopenia, granulocytopenia and thrombocytopenia have been reported. Some 
patients developed positive direct Coomb’s test during treatment with CLAFORAN. 
Genitourinary System ( <  1%): Moniliasis, vaginitis. Liver ( <  1%): Transient 
elevations in SGOT, SGFT, serum LDH and serum alkaline phosphatase levels 
have been reported. Kidney ( <  1%): Increased serum creatinine and BUN have 
occasionally been observed. Central Nervous System (0.2%): Headache. 
Symptoms and Treatment of Overdosage 
Since no case of overdosage has been reported to date with CLAFORAN, no 
specific information on symptoms or treatment is available. Treatment of over­
dosage should be symptomatic.
Dosage and Administration
CLAFORAN (cefotaxime sodium) may be administered intramuscularly or in­
travenously after reconstitution (see Table with recommended mode of reconstitution 
according to route of administration).
Dosage
Adults
The dosage of CLAFORAN should be determined by susceptibility of the causative 
organisms, severity of the infection and condition of the patient.
Guidelines for Dosage of CLAFORAN (cefotaxime sodium)
Type of Infection
Daily Dose
(9) Frequency and Route
Uncomplicated
Gonorrhea
1 1 g IM (single dose)
Uncomplicated
infections
2 1 g every 12 hours 
IM or IV
Moderately 
severe to severe 
infections
3-6 1-2 g every 
8 hours IM or IV
Very severe 
infections (e.g. 
septicemia)
6-8 2g every 
6-8 hours IV
Life-threatening
infections
up to 12 2g every 
4 hours IV
To prevent postoperative infection in contaminated or potentially contaminated 
surgery, recommended doses are as follows.
(a) 1g IM or IV administered Vz to 1’/2 hours prior to the initial surgical incision 
to ensure that adequate antibiotic levels are present in the serum and tissues 
at the start of surgery
(b) 1 g IM or IV administered 1V2 to 2 hours following the first dose; for lengthy 
operative procedures, additional intraoperative doses may be administered, if 
necessary, at appropriate intervals (IV2 to 2 hours) during surgery
(c) 1 g IM or IV administered within 2 hours following completion of surgery 
The total cumulative prophylactic dose should not exceed 6 g in a 12 hour period. 
Caesarian Section Patients
The first dose of 1 g is administered IV as soon as the umbilical cord is clamped. 
The second and third doses should be given as 1 g IM or IV at 6 and 12 hours 
after the first dose.
Neonates, Infants, and Children
The following dosage schedule is recommended:
Neonates: 0-1 week of age 50 mg / kg IV q 12 h
1-4 weeks of age 50 mg / kg IV q 8 h
Infants and children (1 month to 12 years): For body weights less than 50 kg, 
the recommended daily dose is 50 to 100 mg / kg IM or IV of body weight divid­
ed into 4 to 6 equal doses, or up to 180 m g/kg /day for severe infections. 
For body weights 50 kg or more, the usual adult dosage should be used.
The maximum daily dosage should not exceed 12 grams.
Administration of CLAFORAN should be continued for a minimum of 48 to 72 
hours after the patient defervesces or after evidence of bacterial eradication has 
been obtained; a minimum of 10 days of treatment is recommended for infec­
tions caused by Group A beta-hemolytic streptococci in order to guard against 
the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical 
appraisal is necessary during therapy of chronic urinary tract infections and may 
be required for several months after therapy has been completed; persistent in­
fections may require prolonged treatment. Doses less than those recommended 
should not be employed.
Dosage for Patients with Impaired Renal Function
In patients with estimated creatinine clearance of less than 20 m L /m in / 1.73m2 
the dose of CLAFORAN should be halved (see Precautions).
If serum creatinine values alone are available, the following formula (based on 
sex, weight, and age of the patient) may be used to convert these values into 
creatinine clearance.
Males: Weight (kg) x  (140 -  age) Females: 0.85 x above value 
72 x  serum creatinine
Administration
Intramuscular: CLAFORAN should be injected well within the body of a relatively
large muscle such as the upper outer quadrant of the buttock (i.e. gluteus max- 
imus); aspiration is necessary to avoid inadvertent injection into a blood vessel. 
Intravenous: The intravenous route is preferable for patients with bacteremia, 
bacterial septicemia, or other severe or life-threatening infections, or for patients 
who may be poor risks because of lowered resistance resulting from such 
debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure, 
or malignancy, particularly if shock is present or impending.
For bolus administration a solution containing 1 or 2 g of CLAFORAN can be 
injected over a period of 3 to 5 minutes. Using an infusion system, it may also 
be given over a longer period of time through the tubing system by which the 
patient may be receiving other intravenous solutions Butterfly* or scalp vein type 
needles are preferred for this type of infusion. However, during infusion of the 
solution containing CLAFORAN, it is advisable to discontinue temporarily the ad­
ministration of other solutions at the same site.
Reg'd TM of Abbott Laboratories.
Reconstitution
For Intramuscular U se: CLAFORAN should be reconstituted with Sterile Water 
for Injection or Bacteriostatic Water for Injection in accordance with the volumes 
recommended in the following table.
Reconstitution Table
Intramuscular
Volume to be 
Added to 
Vial (mL)*
Approximate 
Available 
Vol. (mL)
Approx. Average 
Concentration 
(mg/mL)
500 mg vial 2 2.2 230
1 g vial 3 3.4 300
2 g vial 5 6.0 330
•shake to dissolve.
For direct intravenous injection (bolus) and /  or continuous intravenous 
in fu s io n : 500 mg, 1 and 2 g vials should be reconstituted with at least 10 mL 
of Sterile Water for Injection. Reconstituted solution may be further diluted with 
50 to 1000 mL of the fluids recommended for IV infusion.
Reconstitution Table
Intravenous
Volume to be 
Added to 
Vial (mL)*
Approximate 
Available 
Vol. (mL)
Approx. Average 
Concentration 
(mg/mL)
500 mg vial 10 10.2 50
1 g vial 10 10.4 95
2 g vial 10 11.0 180
•shake to dissolve.
Solutions for IV In fus ion : CLAFORAN is compatible with the following infu­
sion flu ids:
- Sterile Water for Injection
- 0.9% NaCI injection
- 5% dextrose injection
0.9% NaCI and 5% dextrose injection
-  0.45% NaCI and 5% dextrose injection
- 0.2% NaCI and 5% dextrose injection
-  Sodium Lactate injection
- 5% dextrose and 0.15% KCI injection
- Plasma-Lyte 56 Electrolyte Solution in 5% dextrose injection
- Ringer’s injection
- Lactated Ringer’s solution
- Lactated Ringer’s with 5% dextrose injection 
CLAFORAN is also compatible with lignocaine 1%.
A solution of 1 g of CLAFORAN in 14 mL of Sterile Water for Injection is isotonic. 
Stability o f Solution
S tora ge: Solutions of CLAFORAN range from light yellow to amber, depending 
on concentration and the diluent used. The solutions tend to darken depending 
on storage conditions and should be protected from elevated temperatures and 
excessive light.
**Reg’d TM of Baxter-Travenol Laboratories.
CLAFORAN reconstituted in the original vial as described under Reconstitution 
maintains satisfactory potency for 24 hours at room temperature (25°C) and for 
48 hours under refrigeration (0-5°C). Only freshly prepared reconstituted solu­
tions may be further diluted with 50 to 1000 mL of the recommended infusion 
fluids in Viaflex*’  intravenous bags. Such solutions maintain satisfactory poten­
cy for 24 hours at room temperature (25°C) and for 72 hours under refrigeration 
(0-5°C). Any unused solutions should be discarded.
CLAFORAN reconstituted with 1% lignocaine maintains satisfactory potency for 
up to 24 hours at room temperature and 48 hours under refrigeration (reference 
to lignocaine restrictions is advisable).
CLAFORAN solutions exhibit maximum stability in the pH 5-7 range.
Special Instru ctions: Parenteral drug products should be inspected visually 
for particulate matter and discoloration prior to administration. Solutions of 
CLAFORAN range from light yellow to amber, depending on concentration and 
diluent used. The dry powder as well as solutions tend to darken, depending 
on storage conditions.
Incom patib ilities: Solutions of CLAFORAN must not be admixed with 
aminoglycoside solutions. If CLAFORAN and aminoglycosides are to be ad­
ministered to the same patient, they must be administered separately and not 
as a mixed injection.
Solutions of CLAFORAN should not be prepared with diluents having a pH above 
75 such as Sodium Bicarbonate Injection.
Availability
Claforan (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder, 
in vials containing 500 mg, 1.0 and 2.0 g of cefotaxime sodium (expressed as 
acid on a dry basis).
S to ra ge : CLAFORAN in the dry state should be stored at room temperature, 
protected from light and heat.
Product monograph available on request 
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Extra-Anatomic Bypass Grafting: a Rational 
Approach
K.A Harris, MD, FRCSC; V. Niesobska; S.E. Carroll, MD, FRCSC; G. De Rose, MD, FRCSC; 
W.G. Jamieson, MD, FRCSC; G.E. Meads, MD, FRCSC; J.P. Sweeney, MD, FRCSC
To determine predictors of long-term patency in extra-anatomic bypass grafting, the 
authors studied retrospectively the charts of 134 patients who underwent bypass grafting 
(axillofemoral in 17, axillobifemoral in 32 and femorofemoral in 85). Of the study group, 
64% were men; the mean age was 65 ± 12 years (±SEM). The indications for grafting 
were limb salvage (102), claudication (27) and replacement of septic grafts (5), and for 
using the extra-anatomic route included high risk (83), sepsis (8) and unilateral disease 
(34). Operative mortality was 6% and the early graft occlusion rate 7.4%. The late death 
rate was 44%. At 3 years, the life-table patency rates for the various procedures were 
axillofemoral 52.5%, axillobifemoral 67.7% and crossfemoral 86.9%. Smoking 
significantly (p < 0.05) decreased the patency rate, but diabetes did not. However, 
amputation was more frequent in diabetics. Indications for operation did not alter patency 
rates, but did affect operative mortality. The authors conclude that extra-anatomic bypass 
grafting is highly successful, but not as successful as anatomic bypass. When 
appropriate, the axillobifemoral graft is preferred to the axillounifemoral graft because of 
its increased patency. Crossfemoral grafts must be carefully monitored to ensure that no 
donor limb stenosis occurs and this procedure should not be attempted unless the disease 
is truly unilateral.
Les auteurs ont etudie de fafon retrospective les dossiers de 134 patients qui avaient subi 
des interventions de derivation (17 axillofemorales, 32 axillobifemorales et 85 femoro- 
femorales) afin de determiner quels sont les facteurs previsionnnelles de permeabilite a 
long terme dans les cas de pontage extra-anatomique. Du groupe etudie, 64% etaient des 
hommes; l’age moyen etait de 65 ± 12 annees. La sauvegarde d’un membre (102), une 
claudication (27) ou le remplacement d’un greffon infectes (5) constituaient les causes de 
pontage. Les raisons invoquees pour utiliser une voie extra-anatomique comprenaient un 
risque eleve (83), une sepsie (8) et une atteinte unilaterale (34). La mortalite operatoire 
fut de 6% et le taux d’occlusion precoce du greffon, de 7.4%. La mortalite tardive a ete de 
44%. Apres 3 ans, le taux actuarielle de permeabilite etait de 52.5% pour les pontages 
axillofemorales, de 67.7% pour les axillobifemorales et de 86.9% pour les femorofemora- 
les. L’usage du tabac a reduit de fa?on significative (p < 0.05) le taux de permeabilite, mais 
pas le diabete. Neanmoins, l’amputation a ete plus frequente chez les diabetiques. Les 
indications operatoires n ’ont pas influence le taux de permeabilite mais elles ont affecte la 
mortalite operatoire. Les auteurs concluent que les pontages extra-anatomiques ont un 
haut taux de succes, mais pas autant que les derivations anatomiques. Quand c’est 
possible, le pontage axillobifemoral doit etre prefere a l’axillobifemoral, car il presente un 
meilleur taux de permeabilite. Les pontages femorofemoraux doivent etre surveilles 
etroitement afin de s’assurer qu’il n’y a pas de stenose de la partie donneuse; cette 
intervention ne devrait pas etre pratiquee a moins que l’atteinte soit vraiment unilaterale.
From the Division o f Vascular Surgery, Department o f  Surgery, St. Joseph’s Hospital and Division o f  
Vascular Surgery, Department o f Surgery, Victoria Hospital, University o f  Western Ontario, London, 
Ont.
Presented at the 10th annual meeting o f  the Canadian Society for Vascular Surgery, held in 
conjunction with the 57th annual meeting o f the Royal College o f  Physicians and Surgeons o f  Canada, 
Ottawa. Ont., Sept. 25,1988
Traditionally, vascular reconstruc­tion has followed the course of 
the native arterial tree. Sometimes, 
because of medical risk, old age or a 
locally hostile environment, it may be 
beneficial to avoid entering the major 
body cavities. The first axillofemoral 
extra-anatomic bypass was described 
in 1962 by Blaisell and Hall.1 Since 
then, the procedure has been modified 
to incorporate a crossover femoral 
limb to revascularize both ischemic 
lower extremities.2 The reported 
death and patency rates using these 
bypasses have varied,3'7 possibly 
owing to patient selection, indications 
for operation and operative technique.
Another procedure used to avoid 
direct aortic surgery is crossover fem­
oral grafting.8 This procedure may be 
used in young patients with truly 
unilateral disease, the elderly with 
critical ischemia secondary to iliac 
artery occlusion, and in patients with 
failure of one limb of an aortobifemor- 
al bypass graft.911 Acceptance of this 
procedure for these indications has 
been again sporadic. The axillofemor­
al, axillobifemoral and crossover fem­
oral bypasses are most commonly 
used; however, indications, complica­
tion rates and expected patency rates 
remain controversial. In an effort to 
define the role of these procedures 
and to assess our centre’s success 
rate, we reviewed retrospectively all 
axillofemoral, axillobifemoral and 
crossover femoral grafts that were 
carried out at the vascular units of 
St. Joseph’s Hospital and Victoria 
Hospital in London, Ont., over the 
past 10 years.
Accepted for publication Nov. is , 1988 Patients and Methods
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charts of all 134 patients who under­
went any of the designated opera­
tions. Follow-up information was ob­
tained from the surgeon’s office 
charts or by telephone from the pa­
tient or family doctor.
The findings were subjected to sta­
tistical analysis by the life-table meth­
od or x 2 test as required.
Findings
Of 134 patients, an axillofemoral 
graft was placed in 17, axillobifemoral 
in 32 and a crossover femoral graft in 
85. The mean (±SD) age of the 
patients was 65 ±  12.6 years (range 
from 39 to 93 years); 64% of the 
patients were men.
The indications for bypass grafting 
were critical limb ischemia in 102 
(76%), disabling claudication in 27 
(20%) and reconstruction following 
graft excision for infection in 5 (4%). 
Fifty-six (42%) patients had under­
gone bypass grafting previously. Indi­
cations for using the extra-anatomic 
route were intra-abdominal or graft 
sepsis in 8 (6%) and high medical risk 
in 83 (64%). Occasionally, factors 
associated with previous reconstruc­
tions (in 42% of patients) are indica­
tions for extra-anatomic bypass. In 
the crossover femoral graft group, 34 
patients had donor iliac arteries that 
were considered to be normal, though 
no grafts were taken from a donor 
limb with a flow-limiting stenosis.
In 95% of cases the graft material 
was polytetrafluoroethylene, and 98% 
of the grafting procedures were per­
formed under general anesthesia. No 
late graft degeneration or aneurysm 
formation was documented.
To permit adequate outflow for the 
graft and maintain patency, profunda- 
plasty was used liberally, particularly 
when there was stenosis of the origin 
of the deep femoral artery. There was 
no concomitant femoropopliteal by­
pass grafting which may indicate the 
presence of well-developed collateral 
circulation.
The operative death rate (within 30 
days of operation) was 6%; eight 
patients died of cardiac, pulmonary or 
central nervous system causes (Table 
I). The rate was increased when the 
indication for operation was limb sal­
vage. The operative occlusion rate 
was 9% (Table I) and was not affected 
by indications for bypass surgery, risk 
factors present before surgery or the 
occurrence of other complications.
At the time of writing, 59 (44%) of 
the patients had died. The patency 
rate was 66% (88 patients); this group 
comprised 59 patients who were alive 
with patent grafts and 29 patients in 
whom the graft was patent when they 
died. None of the patients in this 
group required thrombectomy. The 
secondary patency rate was 86% for 
all grafts. Twenty-four patients un­
derwent thrombectomy to maintain 
patency. When results were analysed 
by the life-table method, the standard
error was found to be too large after 3 
years for meaningful analysis, so fol­
low-up results were not included after 
that time. The 3-year primary patency 
rates were as follows: crossover femo­
ral 86.9% ±  4.1% (Fig. 1), axillobifem­
oral 67.7% ± 9.8% and axillofemoral 
52.5% ±  15.3% (Fig. 2). Long-term 
graft patency was not affected by the 
indications for operation, presence of 
diabetes, the size of the graft or the 
status of run-off vessels as determined 
angiographically. In smokers (96), the 
patency rate was significantly (p < 
0.05) reduced in comparison with 
nonsmokers (38). Of the 24 patients 
who required thrombectomy to main­
tain graft patency 20 were smokers.
The limb salvage rate (defined as 
patients not requiring a transmetatar­
sal or higher amputation) was 82%. 
Factors affecting salvage rate (p < 
0.05) are indications for operation and 
the presence of diabetes. Limb salvage 
was associated with, but not absolute­
ly dependent upon, graft patency. 
None of the grafts that were inserted 
to reconstruct septic grafts became 
occluded. In the crossfemoral group 
there was no improvement in patency 
for patients who had truly unilateral 
disease (occluded single limb of aor- 
tobifemoral graft or otherwise).
Discussion
Extra-anatomic bypass grafting is 
becoming more widely accepted. Our 
absolute indications include the need 
for reconstruction following excision 
of an infected graft and when peritoni­
tis precludes anatomic reconstruc­
tion. The more controversial indica­
tions include high medical risk, a 
desire to avoid an intracavitary proce­
dure and strictly unilateral disease. 
The operative death rate in our series 
of 6% compares favourably with more 
major reconstructions. This rate may 
reflect a selective bias to include the 
higher risk patients in the extra-ana­
tomic group. The operative complica-
Table 1. O pera tive  C o m p lic a tio n s
Xfem, Axfem, Axbifem, Totals,
no. (% ) no. (% ) no. (% ) no. (% )
Com plication (n =  85) (n =  17) (n =  32) (n =  134)
O cc lu s ive 4 ( 5 ) 3 ( 1 8 ) 3 ( 9 ) 1 0 ( 7 )
P u lm o n a ry 5 ( 6 ) 0 3 ( 9 ) 8 ( 6 )
C e n tra l n e rv o u s  s y s te m 1 (1) 0 1 (1 ) 2 ( 1 )
C a rd iac 2 ( 2 ) 0 6 ( 1 9 ) 8 ( 6 )
R ena l 1 (1 ) 0 0 1 (1 )
S e p tic 1 0 ) 1 (6 ) 0 2 ( 1 )
D ied 2 ( 2 ) 1 (6 ) 6 ( 1 6 ) 9 ( 7 )
T o ta ls 16 5 19 40
X fe m  =  c ro s s fe m o ra l g ra fts , A x fe m  =  a x illo fe m o ra l g ra fts , A xb ife m =  a x illo b ife m o ra l g ra fts .
114 CJS, VOL. 32, NO. 2, MARCH 1989
EXTRA-ANATOMIC BYPASS
►
i
tion rate remained below 10%, aided 
by careful postoperative observation 
and nursing in the surgical intensive 
care unit. The only factor that was 
found to affect primary graft patency 
was whether the patient continued to 
smoke; most of those who required 
thrombectomy to maintain graft pat­
ency were smokers. The presence of 
diabetes, the status of distal run-off 
and the indications for operation did 
not affect the patency rate.
Several factors may account for the 
increased patency of crossover femo­
ral grafts compared with other grafts.
This is the shortest bypass graft, so 
there is less thrombogenic surface 
exposed to blood elements. Bias was 
introduced in that this procedure was 
preferred for young people with uni­
lateral disease. In addition, the statis­
tical lack of improvement in patency 
in the unilateral group may indicate 
that the disease process is not truly 
unilateral. The diagnosis of unilateral 
disease was made on the basis of 
single-plane angiography; no pres­
sure measurements were made. The 
lack of improvement in patency may 
indicate the missed diagnosis of donor
limb stenosis. Crossover grafting may 
be recommended when unilateral iliac 
artery stenosis is confirmed angio- 
graphically by multiple views and 
pressure studies are normal after pa­
paverine infusion.12 In no instance in 
our series was the donor limb lost or 
threatened secondary to the arterial 
procedure.
As described by others,3 the paten­
cy of axillobifemoral bypass grafts is 
greater than unilateral axillofemoral 
grafts. The suggested reason for this 
is that the long arm of the axillofemor­
al component is exposed to higher 
flow rates,5 when outflow is doubled 
by run-off into both legs. Graft size did 
not correlate with patency in our 
study. Statistical significance was not 
attained when patency rates of axil­
lofemoral and axillobifemoral bypass 
grafts were compared, but a trend was 
noted. From these data we recom­
mend that symptoms on both sides be 
carefully assessed and that the selec­
tion of operation be governed by the 
symptoms. If there is bilateral isch­
emia or cause to believe that contra­
lateral ischemia may develop, then 
axillobifemoral grafting is indicated.
The limb salvage rate (82%) was 
higher than the primary graft patency 
rate (66%) and not all amputations 
occurred in patients with occluded 
grafts, indicating that long-term graft 
patency is not necessary to prevent 
amputation. The indications for oper­
ation were a determinant of the even­
tual amputation rate but did not affect 
graft patency. Patients suffering from 
claudication had fewer symptoms 
(5%) than those who underwent graft­
ing for other reasons (18%).
Our recommendations for extra- 
anatomic bypass grafting are as fol­
lows:
•  Patients should be encouraged 
to stop smoking because of its 
adverse effect on graft patency.
•  Extra-anatomic bypass graft­
ing, although historically less durable 
than anatomic reconstructions, is ac­
ceptable in high-risk patients or in
PATENCY (%)
FIG. 1. Life-table analysis of femorofemoral grafts up to 36 months after implantation. 
Numbers of patients followed up are indicated below line.
PATENCY (%)
MONTHS FOLLOW-UP
FIG. 2. Life-table analysis of axillounifemoral (crosses) and axillobifemoral (dots) grafts 
up to 36 months after implantation. Numbers of patients followed up are indicated above 
and below lines.
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patients with truly unilateral disease. 
It offers an acceptable mortality and 
morbidity for limb salvage to even 
high-risk patients.
•  For patients of all ages with 
unilateral disease, a crossover femoral 
graft may be a reasonable alternative 
to aortic procedures.
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OPERATIVE NEUROSURGICAL 
TECHNIQUES: INDICATIONS,
METHODS AND RESULTS. 2 volume 
set. Edited by Henry H. Schmidek and 
William H. Sweet. 1601 pp. Illust. 
Grune & Stratton, Inc., New York; 
W.B. Saunders Limited, Toronto, 
1982. $436.75. ISBN 0-8089-1439-1.
This comprehensive two-volume text is 
the result of the wide acceptance of 
Current Techniques in Operative Neuro­
surgery, by the same editors.
This text details the indications for, 
the surgical techniques and results of 
many operative procedures of the cen­
tral and peripheral nervous systems. As 
well as updated chapters from the origi­
nal volume, there are new chapters on 
anesthesia, pediatric neurosurgery, sur­
gery of the scalp and skull, head inju­
ries, brain tumours, cerebrovascular dis­
ease, functional neurosurgery, surgery 
of the spinal column and cord and 
operative treatment of lesions of the 
cranial and peripheral nerves. The text 
is noteworthy because not only are 
standard techniques presented, but al­
ternative methods and approaches are 
detailed.
Each chapter has been written by an 
expert in his field, the majority of the 
contributors being surgeons from the 
US or Canada and a few distinguished
European surgeons. Besides neurosur­
geons, the contributors include distin­
guished otolaryngologists, orthopedists, 
ophthalmologists, cardiothoracic sur­
geons, anesthesiologists and radiolo­
gists. As a result, an admirable balance 
and depth of coverage of each topic has 
been achieved.
The two volumes are beautifully pro­
duced, profusely illustrated and provide 
many key references. Every neurosur­
geon, and many surgeons in related 
fields, will find this book of value.
S.J. Peerless, MD, FRCSC
C.G. Drake Professor o f Neurosurgery, 
Chairman, Division o f Neurosurgery,
The University o f  Western Ontario,
London, Ont.
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Mills, Ont., 1986. $79.95. ISBN 
0-443-08351-7.
This is volume 7 in the series “Contem­
porary Issues in Surgical Pathology” . It 
is written by 19 authors, most of them 
well-known pathologists.
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It covers extremely well the various 
aspects of testicular tumours, including 
their epidemiology, histopathology, ul­
trastructure, pathogenesis, comparative 
pathology and clinical management. 
The five chapters on the pathology of 
tumours of the testicle and its adnexa 
are excellent and current. The different 
types of tumour are well described and 
illustrated by high-quality black and 
white photographs. The immunohisto- 
chemistry and the detection of interme­
diate filament proteins of germ cell 
tumour by the immunofluorescent 
method are also discussed. These rela­
tively new techniques of investigation, 
although in the initial stages of devel­
opment, have proven to have practical 
value in the correct typing of testicular 
germ cell tumours. The clinical man­
agement of testicular cancer and the 
value of serologic tumour markers such 
as human chorionic gonadotropin, a- 
fetoprotein and others in staging and 
monitoring the therapy of germ cell 
neoplasms are clearly presented. The 
information provided will be important 
and helpful to the practising patholo­
gist not specialized in neoplastic disease 
of the male genitourinary system when 
reporting on a testicular tumour. One 
excellent chapter discusses the patho-
continued on page 120
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Abdominal Aortic Aneurysm: 
Consequences of a Positive Family History
C. William Cole, MD, FRCSC; Graeme G. Barber, MD, FACS, FICS, FRCSC;
Adrien G. Bouchard, MD, FRCSC; Neil V. McPhail, MD, FRCSC; Celine Roberge;
Walter G. Waddell, MD, FACS, FRCSC; James L. Wellington, MD, FACS, FRCSC
To assess the prevalence of coexisting abdominal aortic aneurysm (AAA) within 
certain families, a retrospective review was carried out of patients who had 
undergone AAA repair over a 5-year period. Contact was made with 305 families 
(52%) and a positive history of an affected, first-degree relative was obtained in 34 
(11%). A known AAA was reported to affect approximately 20% of siblings at risk 
when the proband had an affected parent or sibling. Siblings of patients with an 
affected first-degree relative represent a high-risk group that may benefit from a 
screening program for earlier detection and elective management of AAA.
Dans le but d’evaluer la prevalence, au sein de certaines families, d’anevrismes de 
l’aorte abdominale (AAA), on a procede a une etude retrospective des patients qui 
avaient subi une reparation d’un AAA au cours d’une periode de 5 ans. Des contacts 
purent etre etablis avec 305 families (52%); dans 34 cas (11%), on obtint une histoire 
d’un diagnostic positif chez un parent du premier degre. Un AAA connu affectait 
environ 20% des freres et soeurs a risque quand un proposant avait un pere, une 
mere, un frere ou une soeur qui en etait atteint. Les freres et soeurs des patients qui 
ont un parent du premier degre affecte par cette maladie constituent un group a 
risque qui pourrait beneficier d’un programme de depistage visant a detecter de 
facon precoce les AAA et a les traiter de fajon non urgente.
The poor results of treatment for ruptured abdominal aortic an­
eurysm (AAA) make its early detec­
tion and elective surgical repair the 
ideal method of management. Be­
cause they are often asymptomatic 
and may be difficult to detect by 
physical examination alone, many 
AAAs go unnoticed until they rup­
ture. Abdominal aortic aneurysm 
has been likened to a “U boat in the 
belly” because it is a silent killer 
that can be detected by ultrasonog­
raphy.1 Recognition of a high-risk 
group for AAA could lead to earlier 
detection and treatment by screen­
ing with ultrasonography, and this 
may reduce the number of ruptures.
The tendency for AAA to occur in 
families23 may be one means of 
identifying high-risk individuals 
who might benefit from a screening 
program. To evaluate the potential 
for such a program we carried out a 
review of the families of patients 
known to have undergone repair of 
AAA.
Methods
Patients treated for AAA at the 
Ottawa Civic Hospital or Ottawa 
General Hospital between January 
1981 and December 1986 were 
identified by a computer search.4 
The patients (or their family) were 
contacted by telephone and, after 
they had given verbal consent to 
provide information, they completed 
a brief questionnaire which helped 
to establish whether or not any 
family member was known to have 
an AAA. Care was taken to conduct 
the telephone interview in lay 
terms, but no other term was sub­
stituted for “aneurysm”. When a 
family member other than the pro­
band was found to have an AAA, a 
detailed family tree was constructed 
to illustrate that person’s relation­
ship to the proband, and the even­
tual outcome of treatment. It was 
assumed that the probands would 
know of AAA among other family 
members if it had been detected, 
operated upon, or if death had been
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attributed to aneurysm rupture. No 
attempt was made to address the 
question of undetected AAA among 
family members.
Results
A total of 586 patients who had 
undergone repair of an AAA were 
identified, and it was possible to 
obtain information by telephone in­
terview from 305 (Fig. 1). Compli­
ance with our request was complete 
in all cases. Only one family report­
ed a relative with a cerebral aneu­
rysm. Only one affected offspring of 
a proband was reported (no. 1, Fig. 
2). Of 41 positive responses, AAA 
among the first-degree relatives of 
probands (parents, siblings or off­
spring) was found in 34 cases. The 
details of these relationships are 
illustrated as family trees in Fig. 2; 
family no. 29 had two probands. 
Seven AAAs reported during the 
interview were shown to have been 
in distant relatives or family mem­
bers without direct kinship to the 
proband and were excluded from 
the analysis (nos. 5, 9, 22, 26, 28, 
33, 38).
Of the 34 families that had a 
family history consisting of a pro­
band and at least one other affect­
ed, first-degree relative, 20% of the 
siblings had an AAA (Table I). In 16 
families in which the first-degree 
relative was a parent, AAA affected 
18% of siblings (Table II). Overall, 
AAA affected male siblings more 
often than females, but this rela­
tionship was most evident among 
the siblings of probands with a 
positive parental history.
Discussion
Our data were generated by 
“soft” techniques, which take ad­
vantage of information that is readi­
ly available at little or no cost, but
which lack scientific rigour. Never­
theless, data from studies such as 
this serve a useful purpose by act­
ing as signposts, if not benchmarks, 
for further study. In this series, we 
accepted the evidence given in a 
telephone interview regarding AAA 
in relatives, and made the assump­
tion that probands and their fami­
lies are well informed about AAA 
occurring in their relatives. Inher­
ent in this assumption was the fact 
that undetected AAA would not be 
reported, and uncertainty on the 
part of the family about “aneu­
rysm” could lead to a degree of 
over-reporting. Even with these 
weaknesses, our data are similar to 
those generated by others using 
patient interview techniques. In a 
similar study, carried out as a coop­
erative effort by the Puget Sound 
Vascular Society, in which patients 
with AAA were asked to complete a 
questionnaire and the results were 
compared with those of a control 
group, the estimated relative risk 
for AAA among persons with an 
affected first-degree relative was
11.6.2 In their study a history of 
AAA in a parent appeared to confer 
about the same excess risk as a 
history of AAA in a sibling.2
Age and sex are important fac­
tors in the development of AAA 
which is rare before the age of 50 
years and occurs predominantly in 
men.5 In our study the number of 
men affected by AAA was also 
greater than the number of women, 
but the number of women was not 
insignificant. Our data support the 
suggestion that all siblings of a 
patient with an AAA and a positive 
parental/sibling history are at in­
creased risk and should be advised 
to undergo a periodic screening 
regardless of sex.
The death rate for ruptured AAA 
compared with the excellent results 
with elective management presents 
a compelling argument for early 
detection and repair. In many cases, 
symptoms from an AAA may not 
develop before it ruptures and the 
death rate then exceeds 50% and 
associated morbidity, usually from 
multiorgan failure, may reach 80%.6
FIG. 1. Results of telephone interview to assess occurrence of abdominal aortic 
aneurysm (AAA) among relatives of patients with AAA.
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In contrast, elective repair of AAA 
carries a combined morbidity and 
mortality of less than 5%.7 Patients 
who survive the surgical procedure 
to repair an AAA have a life expec­
tancy similar to that of the general 
population.89 The frequency of 
AAA appears to be increasing,1011 
perhaps because the population as a 
whole is older or because detection 
of AAA is more common. Recogni­
tion of a previously undetected AAA
by ultrasonography or computed 
tomography of the abdomen is not 
uncommon and also may play a role 
in the apparent increasing frequen­
cy. The unreliability of physical 
examination alone in detecting 
asymptomatic AAA is well recog­
nized, and the potential for early 
detection by ultrasonography has 
led some1 to recommend that every­
one over 50 years of age should 
undergo periodic ultrasonography
of the abdomen. The investigation 
is inexpensive and noninvasive, it is 
widely used to  ch arac te rize  
AAA,1213 and in obese subjects has 
been recommended14 as part of the 
routine physical examination.
The wisdom of these recommen­
dations has not been tested by 
population studies, but these are 
clearly needed. Our data support 
the adoption of ultrasonography as 
a screening measure to detect AAA
surgery.
T a b le  1. A b d o m in a l A o r t ic  A ne u rysm  (A A A ) in  F irs t-D e g re e  R e la tive s  o f 3 4  P robands
R elation  to 
proband
No. at 
risk
W ith AAA, 
no. (% )
R upture ,
no. (% )
D eath
w ith  rupture , 
no. (% )
To ta l 
deaths , 
no. (% )
M o th e r 34 11 (32) 1 O ) 0 0
Father 34 7 ( 2 1 ) 5 ( 7 1 ) 5  (1 0 0 ) 7 ( 7 1 )
S is te r 83 1 4 (1 7 ) 4 ( 2 9 ) 4  (1 0 0 ) 5 (3 6 )
B ro the r 86 20 (23 ) 9  (4 5 ) 9  (1 0 0 ) 10 (5 0 )
T o ta ls 2 3 7 *5 3  (22 ) 19 (3 6 ) 18 (9 5 ) 22 (4 2 )
'O n e  fe m a le  p ro b a nd  had an a ffe c te d  son.
T a b le  II. P ro b a n d s  W h o se  P a re n ts  W ere
A ffe c te d
R e la tio n  to W ith  AAA,
proband No. no. (% )
M o th e r 16 11 (6 9 )
F a the r 16 7 ( 4 4 )
S is te r 27 4 ( 1 5 )
B ro th e r 27 6 ( 2 2 )
B o th  p a re n ts  o f  n o s . 10 and 19 w e re
a ffe c te d  w ith  AAA .
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in high-risk individuals, specifically, 
siblings of probands with a positive 
parental/sibling history of AAA. It 
seems reasonable to begin screen­
ing this group after the age of 50 
years.
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logic changes in testicular cancers after 
chemotherapy, an area rarely covered in 
standard textbooks of pathology. To 
complete the book, a chapter on mor­
phologic changes of the testicle and 
male infertility after systemic chemo­
therapy is included.
This small, easy-to-read book repre­
sents an up-to-date complete review of 
both pathological and clinical aspects of 
testicular tumours. It is a book that 
every practising pathologist and urolo­
gist should have in the office for con­
sultation.
Gia-Khanh Nguyen, MD, FRCPC
Department o f Pathology,
W.C. Mackenzie Health Sciences Centre, 
University o f  Alberta,
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we are also in the age of the imaging 
journal. Radiologists are inundated with 
peer-reviewed journals in radiology and 
its many subspecialties, with quarterly 
reviews, journals offering continuing 
medical education and “throw-away” 
publications sponsored by manufactur­
ers. Perspectives in Radiology is a hard­
cover hybrid of a journal and textbook. 
The text seeks a niche between the 
academic and clinical sectors by offer­
ing observational-type articles which 
were common 20 years ago but which 
the rigours of peer-review have pushed 
on to the endangered species list.
The distinguished radiologists from 
the University of California in San Fran­
cisco, who form the editorial board for 
the text, have invited comment from a 
general surgeon on the topic of sonog­
raphy in acute appendicitis and an or­
thopedic surgeon on the role of mag­
netic resonance imaging in internal de­
rangements of the knee. Other features 
are an exchange between a radiologist, 
lawyer and ethicist on contrast media 
and the presidential address, “On being 
a complete professional” , from the 
1987 annual meeting of the Congress 
of Neurological Surgeons.
Although I have no quarrel with the 
quality of the material in this work, it is 
not clear to whom the book is directed.
Those seeking editorial comment, in­
formed opinion or advice on “how to do 
it” can find these in the leading peer- 
reviewed publications. Readers seeking 
in-depth reviews are well served by 
quarterly journals and computer-assist­
ed literature searches.
The editor asks in the preface “Does 
a need exist for this publication?”. I 
think not, but I am willing to be proved 
wrong.
Ian Hammond, MD, FRCPC
Department o f Radiology,
Ottawa General Hospital,
501 Smyth Rd„
Ottawa, Ont.
K1H8L6
SURGICAL PATHOLOGY. 2 volumes. 
2nd edition. W.F. Coulson. 1824 pp. 
Illust. J.B. Lippincott Co., Philadel­
phia, 1988. $260.00. ISBN 0-397- 
50609-0 (set).
This revised reference book is truly 
comprehensive and current. No subject
continued on page 143
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Transiliac Bypass for Infected Femoral 
End of an Aortofemoral Graft
W. Brzezinski, MD; J.C. Callaghan, OC, MD, FRCSC
Infection of an aortofemoral fabric graft is among the most serious complications of 
vascular surgery and necessitates removal of the graft. The authors chose a 
transosseal (iliac bone) approach to permit a new graft to be carried down to the 
periphery without the risk of contamination or pressure on it from the patient’s 
position. They performed this procedure in a 71-year-old man. He underwent a 
transiliac bypass before the infected limb of an aortobifemoral graft was removed. He 
was well 11 months after the operation and the graft was functioning well with no 
evidence of infection.
L’infection d’un greffon prosthetique de l’aorte femorale constitue une des plus serieuses 
complications de la chirurgie vasculaire; elle necessite le retrait du greffon. Les auteurs 
ont choisi un abord transosseux (par l’os iliaque) pour permettre la realisation d’une 
nouvelle greffe pratiquee en Peripherie, tout en evitant le risque de contamination ou la 
pression exercee sur la greffe par la position du patient. Ils ont pratique cette intervention 
chez un homme de 71 ans qui fut soumis a une derivation transiliaque avant le retrait de la 
partie infectee de la greffe aortobifemorale. Onze mois apres l’operation, le patient se 
portait bien et la greffe fonctionnait, sans signe d’infection.
G raft infection is the most seri­ous complication of recon­
structive vascular surgery with 
respect to death and limb loss.14 
It presents the vascular surgeon 
with the greatest challenge to 
judgement and technique. Since 
1952, when Freeman and Leeds5 
reported the use of endarterecto- 
mized superficial femoral artery for 
a femorofemoral bypass, many 
other extra-anatomic bypasses have 
been described.6-9 In this paper we 
describe the use of a transosseal 
(iliac bone) approach in a 
71-year-old man to permit revascu-
Accepted for publication Nov. 18, 1988
larization of the lower limb and to 
bypass the infected groin.
Case Report
This 71-year-old man was healthy 
except for severe aortoiliac disease 
with disabling intermittent claudica­
tion. He had undergone an aor­
tobifemoral bypass with insertion of 
a Dacron graft in 1973. Five years 
later he required thrombectomy and 
revision of the right limb of the 
graft, which was followed by exci­
sion of the seroma (cultures were
negative). Since then he had experi­
enced periodic serous discharge 
from the right groin and had had 
serous collections aspirated on sev­
eral occasions. In October 1987, 
while he was in Japan, he noticed 
that purulent material was draining 
from the right groin. He was admit­
ted to the Cardiovascular and Tho­
racic Surgery Service of the Univer­
sity of Alberta Hospitals in Edmon­
ton. Cultures of purulent material 
grew /3-hemolytic Streptococcus. 
Computed tomography and angi­
ography (Fig. 1) showed that the 
infection did not extend above the 
inguinal ligament. The left limb of 
the aortobifemoral graft was oc-
FIG. 1. Angiogram of infected graft. 
There was no evidence of infection 
above level of inguinal ligament. Left 
limb of graft is occluded. Peripheral 
run-off from right limb is good.
From the Department o f Surgery, University o f Alberta, Edmonton, Alta.
Presented at the 10th annual meeting of the Canadian Society for Vascular Surgery, held in 
conjunction with the 57th annual meeting o f the Royal College o f Physicians and Surgeons o f 
Canada, Ottawa, Ont.. Sept. 25, 1988
Reprint requests to: Dr. J.C. Callaghan, Department o f Surgery, University o f Alberta Hospital 
Edmonton, Alta. T6C 2B7
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eluded. The graft-dependent right 
lower extremity demonstrated good 
peripheral run-off.
At operation through an ex- 
traperitoneal approach, the right 
limb of the aortobifemoral graft was 
transected just distal to the bifurca­
tion and the distal end ligated. The 
proximal end was anastomosed end- 
to-end to a new 8-mm Hemashield 
graft (Meadox Medical Inc., Oak­
land, NJ). The new graft was 
brought through a drilled “win­
dow” in the right iliac bone (Figs. 2 
and 3), passed laterally to the in­
fected groin and anastomosed end- 
to-side to the middle portion of the 
right superficial femoral artery (Fig. 
4). One week later the infected right 
limb of the aortobifemoral graft was 
removed. Cultures of the graft ma­
terial grew the two strains of coag- 
ulase negative Staphylococcus. The 
patient was treated with appropriate 
antibiotics and local wound care. 
The groin wound healed complete-
FIG. 2. Diagram showing position of window drilled in iliac bone through which 
new graft is passed.
FIG. 3. Roentgenograms showing hole drilled in right iliac bone to accomodate 
bypass graft.
ly, and follow-up angiography dem­
onstrated that the graft was func­
tioning well (Fig. 5).
FIG. 4. Right limb has been transected 
distal to bifurcation and new graft 
anastomosed end to end. New graft is 
carried through window in iliac bone 
and anastomosed end to side to super­
ficial femoral artery.
FIG. 5. Follow-up angiogram shows 
new graft functioning well.
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Six months later, the patient un­
derwent femorofemoral crossover 
grafting because of intermittent
FIG. 6. Diagram showing femorofem­
oral crossover graft inserted to allevi­
ate intermittent claudication of left 
lower extremity caused by occlusion of 
left limb of graft.
FIG. 7. Follow-up angiogram demon­
strates good function of all graft limbs.
claudication of the left lower ex­
tremity (Fig. 6). Follow-up angiog­
raphy again demonstrated well­
functioning grafts (Fig. 7). The pa­
tient was asymptomatic 5 months 
after the last procedure.
Discussion
Vascular graft infection in the 
groin necessitates removal of the 
infected portion.310 Simultaneous 
revascularization of the affected ex­
tremity can be accomplished in 
many ways. Axillofemoral bypass is 
the most common method, but the 
graft is prone to occlusion from 
prolonged compression when the 
patient is sleeping. Its extension to 
the popliteal or tibial arteries de­
creases long-term patency.11-12 Ob­
turator bypass is an effective meth­
od of lower extremity revasculariza­
tion.9-13-17 However, it makes subse­
quent revascularization of the oppo­
site extremity more complicated be­
cause of repeated intra-abdominal 
and retroperitoneal dissection.
We chose a new approach to the 
problem of extra-anatomic revascu­
larization of the graft-dependent 
limb, using transiliac bypass. To the 
best of our knowledge this has 
never before been reported. The 
procedure appears to be safe and 
effective and is technically simple to 
perform. Furthermore, it offers an 
excellent, easily accessible inflow 
source should future bypass to the 
opposite extremity be necessary.
Long-term follow-up of a greater 
number of patients is needed to 
determine the potential of this route 
compared with others.
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R enal Oncocytoma in Pregnancy: a Case 
Report
William D. Fraser, MD, FRCSC;* Manon Auger, MD;t Ronald M. Onerheim, MD, FRCPC$
Oncocytoma is an uncommon renal tumour and this is the first report of such a tumour 
occurring in a pregnant woman. Optimal treatment is nephrectomy and the prognosis is 
usually good, though metastasis has been reported. It is unknown whether pregnancy 
alters tumour behaviour or the prognosis.
L’oncocytome est une tumeur renale rare; il s’agit de la premiere description d’une telle 
tumeur a survenir chez une femme enceinte. La nephrectomie est le traitement optimal et 
le pronostic est habituellement favorable, bien que des metastases aient deja ete 
rapportees. On ignore si la grossesse peut modifier le comportement de la tumeur ou le 
pronostic.
Renal oncocytoma is a rare tumour which has been recognized as a 
distinct pathological entity only in the 
last decade. We describe the case of a 
pregnant woman who had a renal 
oncocytoma. We believe this is the 
first such case to be reported.
Case Report
A 3 1 -year-old black Canadian 
woman of Haitian origin presented at 
23 weeks’ gestation complaining of 
severe back pain on the right side, 
radiating to the ipsilateral thigh and 
shoulder. A transient episode of simi­
lar pain had occurred 2 weeks earlier. 
Her first pregnancy was a twin gesta­
tion which culminated in vaginal de­
livery at 37 weeks, after induction for 
severe pre-eclampsia. She had no re­
cent complaints of fever, chills, dys- 
uria or hematuria and no history of 
urinary tract infection or tuberculosis.
Abdominal examination revealed a 
nontender uterus which was appropri­
ate size for gestational age. Fetal 
heart tones were present. There was 
no costovertebral angle tenderness. 
Her blood pressure was 1 0 0 /6 5  mm 
Hg.
Urinalysis and microscopic exami­
nation of the urine gave normal re­
sults. Hematologic investigation 
yielded the following: hemoglobin 
level 98 g /L ; hematocrit 0.27; leuko­
cyte count 5.9 X 109/ L ;  platelets 289 
X  109/L ; mean corpuscular volume 
84 fl; mean corpuscular hemoglobin
*Department o f  Obstetrics and Gynecology, Foothills Hospital and University o f  Calgary, 
Calgary, Alta.
tMedical student, McGill University, Montreal, PQ
fAssistant Professor, McGill University, St. Mary’s Hospital, Montreal, PQ
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concentration 34 g /L ; sickle cell prep 
was negative. The serum sodium, 
potassium, chloride, uric acid, creati­
nine, urea nitrogen and iron levels 
were within normal limits as was the 
total iron binding capacity. The serum 
ferritin level was 15.8 jug/L. The 
purified protein derivative test (5TU) 
was negative. The creatinine clear­
ance, based on a 24-hour urine collec­
tion, was 93 ml/min. Cytologic exam­
ination of the urine showed no malig­
nant cells and urine culture was nega­
tive.
Abdominal ultrasonography re­
vealed an echogenic zone on the 
upper pole of the right kidney measur­
ing approximately 10 X 12 cm. A 
single-shot intravenous pyelogram 
(10-minute film) confirmed the pres­
ence of a mass filling the upper pole of 
the right kidney. The left kidney 
appeared normal. Renal arteriography 
was attempted but abandoned for 
technical reasons. The chest x-ray 
film was normal.
On day 6 after admission to hospi­
tal, the patient received 2 units of 
packed red blood cells and then under­
went a right radical nephrectomy 
through a subcostal incision. A large 
mass was present in the right kidney 
but there was no gross evidence of 
surrounding disease. She had a 
smooth recovery and was discharged 
from hospital on postoperative day 9.
Routine examination at 31 weeks' 
gestation revealed, for the first time 
during the pregnancy, an elevated 
blood pressure of 1 3 0 /9 0  mm Hg. 
The patient was readmitted at 34 
weeks’ gestation with severe head-
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ache; blood pressure was 180/112 
mm Hg. Findings of chest and heart 
examinations were within normal lim­
its. Deep tendon reflexes were slightly 
increased, but there was no clonus. 
Fetal heart sounds were present and 
the cervix was long and closed. The 
following laboratory results were ob­
tained: semiquantitative test for uri­
nary protein 4+; hemoglobin level 
114 g/L ; hematocrit 0.35; leukocyte 
count 8.5 X 109/L ; platelets 223 X 
109/L ; serum creatinine level 88.4 
/umol/L; serum sodium 138 mmol/L; 
serum potassium 5.2 mmol/L and 
serum carbon dioxide 24 mmol/L.
A diagnosis of severe pre-eclampsia 
was made. The patient was stabilized 
with an infusion of magnesium sulfate 
and, after a failed induction, under­
went a low transverse cesarean sec­
tion to deliver a live female infant 
weighing 2160 g.
Her convalesence was complicated 
by bouts of severe hypertension which 
were brought under control with a -  
methyldopa. The urinary creatinine 
clearance on postoperative day 8 was 
1.1 m l/s. The patient was discharged 
on postoperative day 10 and was well 
at her 1-year follow-up.
Pathological Features
The operative specimen consisted 
of a right kidney and ureter. The 
former, measuring 12.5 X 7 X 4.5 cm, 
was deformed by a mass occupying 
the anterior aspect of the upper pole; 
the renal capsule was intact.
The round solid tumour measured 
12.5 X 12 X 11.5 cm, appeared 
encapsulated and compressed the sur­
rounding renal parenchyma, imping­
ing on the renal pelvis but without 
invasion into the surrounding struc­
tures. It had a uniform appearance 
and was vascular with a tan coloura­
tion. There were no areas of hemorrh­
age or necrosis.
On microscopic examination the 
tumour was composed of uniform
polygonal cells with an abundant, 
strikingly eosinophilic granular cyto­
plasm and well-defined cytoplasmic 
borders. The cells were arranged in a 
predominantly alveolar pattern sup­
ported by a prominent delicate vascu­
lar framework. Nuclear pleomor- 
phism was absent, nucleoli were not 
prominent and mitotic figures were 
lacking. The margin of the tumour, a 
thin fibrous capsule, was not invaded.
The electron microscopic appear­
ance was typical of oncocytoma. The 
cytoplasm of the neoplastic cells was 
filled with mitochondria, to the virtual 
exclusion of other organelles, and 
there were no fat vacuoles found (Fig. 
1). Many mitochondria had tubulove- 
sicular christae; others showed the 
characteristic stacked mitochondrial 
christae (Fig. 2).
Discussion
Hamperl,1 in 1962, coined the term 
“oncocyte” to describe a special type 
of tumour cell arising from metaplas­
tic transformation, mainly in the sali­
vary, parathyroid and thyroid glands. 
“The cytoplasm is more or less dense­
ly filled with...acidophilic granules.... 
Electron microscopy studies showed 
that the cytoplasm is extremely rich in 
mitochondria.”1
In 1976, Klein and Valensi2 report­
ed on 13 proximal renal tumours 
which they called proximal tubular 
adenomas; these tumours had on­
cocytic features, but they also referred 
to them as oncocytomas. Their mor­
phology and behaviour were de­
scribed. The clinical presentation was, 
in most cases, silent. The tumours 
were discovered incidentally during 
the work-up for another condition.
Based on the excellent long-term 
survival of affected patients after ne­
phrectomy, Klein and Valensi1 sur­
mised that these tumours were be­
nign. However, it has become appar­
ent that this is not always so. Lieber 
and colleagues3 described 90 patients
who had oncocytoma; 4 died of meta­
static renal carcinoma, which demon­
strated anisocytosis and nuclear irreg­
ularity in the metastases. They pro­
posed a grading system for on­
cocytoma, based on cellular differenti­
ation, and suggested that grading 
may be useful in determining progno­
sis.
More recently, Lewi and associates4 
described two patients with well-dif­
ferentiated or grade 1 renal on­
cocytoma in whom metastatic disease 
developed, suggesting that the ability
FIG. 1. Electron photomicrograph of 
typical tumour cell of renal oncocytoma, 
with mitochondria filling cytoplasm 
(original magnification X 7000).
FIG. 2. Electron photomicrograph of 
mitochondria with stacked cristae (ar­
rows) (original magnification X 17 500).
►
►
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to metastasize may not be related to 
histologic appearance.
Renal tumours presenting in preg­
nancy are rare. Ney and colleagues,5 
in 1971, described a pregnant woman 
with a renal tumour containing gran­
ular areas which were probably on­
cocytic. However, that tumour also 
contained clear cell areas, as well as 
sites of hemorrhage and necrosis. By 
modern consensus it would be diag­
nosed as renal cell carcinoma on the 
basis o f the presence of clear cell areas 
and on size (9 cm).
The gross, light microscopic and 
electron microscopic features of the 
tumour in our patient were consistent 
with those described in the literature 
for renal oncocytoma.2-6
As with other neoplasms, the 
growth o f some renal tumours may be 
influenced by the concentrations of 
ambient sex steroids. In 1948, Kirk- 
man7 demonstrated that estrogens 
may induce renal carcinomas in ham­
sters. Occasional therapeutic re­
sponses to medroxyprogesterone ace­
tate therapy have been observed in 
patients with advanced renal cell car­
cinoma. In an attempt to assess the 
mechanism o f response in one such 
patient, Cummings and associates8 
obtained tissue cultures of renal carci­
noma cells and exposed them to vary­
ing concentrations of both medroxy­
progesterone acetate and estradiol 
cypionate. Neither hormone was 
found to influence tumour growth in 
tissue culture so they reasoned that 
the patient’s response was based on 
some other mechanisms.
The effect of hormonal factors on 
the growth of renal oncocytoma has 
not been studied. As noted, the acute 
clinical presentation seen in our pa­
tient is unusual and one may specu­
late as to whether this presentation 
was related to a sudden change in 
tumour size, perhaps hormonally me­
diated.
Current preoperative diagnostic 
techniques cannot accurately distin­
guish between renal oncocytoma and
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renal carcinoma. Although angio­
graphic features typical of on­
cocytoma have been described,9 renal 
cell carcinoma may display identical 
characteristics. Fine-needle aspiration 
cytology of renal oncocytomas has 
been reported;10 however, as renal cell 
carcinoma may also contain inter­
posed areas of oncocytes in a mosaic 
pattern, this technique is not reliable 
in differentiating the two. To achieve 
accurate diagnosis and minimize the 
risk of recurrence for pregnant pa­
tients with suspected renal on­
cocytoma, nephrectomy is the treat­
ment of choice.
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(sterile cefoxitin sodium, MSD Std.)
ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bactericidal 
action of cefoxitin, a cephamycin derived from 
cephamycinC, results from the inhibition of 
bacterial cell wall synthesis. Evidence suggests 
that the methoxy group in the 7a position is 
responsible for the resistance of cefoxitin to 
degradation by bacterial beta-lactamases.
INDICATIONS AND CLINICAL USES 
TREATMENT
The treatment of the following infections when 
due to susceptible organisms:
1 - Intra-abdominal infections such as peritonitis
and intra-abdominal abscess
2 - Gynecological infections such as endo­
metritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and 
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and jo in t infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies 
should be performed to determine the suscepti- 
b il ity  of the causative organism (s) to 
MEFOXIN®. Therapy may be started while 
awaiting the results ot these tests, however, 
modification of the treatment may be required 
once these results become available.
Organisms particularly appropriate for therapy 
with MEFOXIN® are:
Gram positive
Staphylococci, penicillinase producing and 
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing and 
non-producing strains)
E. coli
Klebsiella species (including K. pneumoniae) 
Proteus, indole positive and negative 
Haemophilus influenzae 
Providencia species 
Anaerobes 
Bacteroides fragilis
MEFOXIN® may also be appropriate for the 
treatment of infections involving susceptible 
strains of both aerobic and anaerobic bacteria.
MEFOXIN® is not active against Pseudomonas, 
most strains of enterococci, many strains of 
Enterobacter cloacae, and methicillin-resistant 
staphylococci and Listeria monocytogenes.
Clinical experience has demonstrated that 
MEFOXIN® can be administered to patients who 
are also receiving carbenicillin, gentamicin, 
tobramycin, or amikacin (see PRECAUTIONS 
and ADMINISTRATION).
Intravenous Administration 
The intravenous route is preferable for patients 
with bacteremia, bacterial septicemia, or other 
severe or life-threatening infections, or for 
patients who may be poor risks because of 
lowered resistance resulting from such debili­
tating conditions as malnutrition, trauma, 
surgery, diabetes, heart failure, or malignancy, 
particularly if shock is present or impending. 
PROPHYLACTIC USE
MEFOXIN® may be administered periopera- 
tively (preoperatively, intraoperativelyand post- 
operatively) to patients undergoing vaginal or 
abdom inal hysterectom y and abdominal 
surgery when there is a significant risk of 
postoperative infection or where the occurrence 
of postoperative infection is considered to be 
especially serious.
In patients undergoing cesarean section, intra­
operative (after clamping the umbilical cord) 
and postoperative use of MEFOXIN® may 
reduce the incidence of surgery related post­
operative infections.
Effective prophylactic use depends on the time 
of administration. MEFOXIN® usually should be 
given one-half to one hour before the operation. 
Prophylactic administration should usually be 
stopped within 12 hours. It has been generally
reported that continuing administration of any 
antibiotic beyond 24 hours following surgery 
increases the possibility of adverse reactions 
but, in the majority of surgical procedures, does 
not reduce the incidence of subsequent 
infection.
If signs of postsurgical infection should appear, 
specimens for culture should be obtained for 
identification of the causative organism(s) so 
that appropriate therapy may be instituted.
CONTRAINDICATIONS
MEFOXIN® is contraindicated in persons who 
have shown hypersensitivity to cefoxitin or to 
the cephalosporin group of antibiotics.
WARNINGS
Before therapy with MEFOXIN® is instituted, 
careful inquiry should be made to determine 
whether the patient has had previous hyper­
sensitivity reactions to MEFOXIN®, cephalo­
sporins, penicillins or other drugs. MEFOXIN® 
should be given with caution to penicillin- 
sensitive patients.
There is some clinical and laboratory evidence 
of p a rtia l c ro s s -a lle rg e n ic ity  between 
cephamycins and the other beta-lactam anti­
biotics, penicillins and cephalosporins. Severe 
reactions (including anaphylaxis) have been 
reported with most beta-lactam antibiotics.
Pseudomembranous colitis has been reported 
with virtually all antibiotics. This colitis can 
range from mild to life threatening in severity. 
Antibiotics should therefore be prescribed with 
caution in individuals with a history of gastro­
intestinal disease, particularly colitis. It is 
important to consider a diagnosis of pseudo­
membranous colitis in patients who develop 
diarrhea in association with antibiotic use. While 
studies indicate that a toxin produced by 
Clostridium difficile is one primary cause of 
antibiotic-associated colitis, other causes 
should also be considered.
Any patient who has demonstrated some form of 
allergy, particularly to drugs, should receive 
antibiotics including MEFOXIN® with caution.
If an allergic reaction to MEFOXIN® occurs, 
administration of the drug should be discon­
tinued. Serious hypersensitivity reactions may 
require treatment with epinephrine and other 
emergency measures.
PRECAUTIONS
The total daily dosage should be reduced when 
MEFOXIN® is administered to patients with 
transient or persistent reduction of urinary 
output due to renal insufficiency (see DOSAGE 
AND ADMINISTRATION) because high and 
prolonged serum antibiotic concentrations can 
occur from usual doses.
In patients treated with MEFOXIN® a false­
positive reaction to glucose in the urine may 
occur with Benedict's or Fehling's solutions but 
not with the use of specific glucose oxidase 
methods.
Using the Jaffe Method, falsely high creatinine 
values in serum may occur if serum concen­
trations of cefoxitin exceed 100/rg/mL. Serum 
samples from patients treated with MEFOXIN® 
should not be analyzed for creatinine if with­
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported 
fo llow ing concom itant adm inistration of 
cephalosporins and aminoglycoside antibiotics. 
The safety of MEFOXIN® in the treatment of 
infections during pregnancy has not been 
established. If the administration of MEFOXIN® 
to pregnant patients is considered necessary, its 
use requires that the anticipated benefits be 
weighed against possible hazards to the fetus. 
Reproductive and teratogenic studies have been 
performed in mice and rats and have revealed no 
evidence of impaired fertility or harm to the fetus 
due to MEFOXIN®.
Cefoxitin has been observed in the milk of 
nursing mothers receiving the drug.
Prolonged use of MEFOXIN® may result in the 
overgrowth of non-susceptible organisms. 
Repeated evaluation of the patient's condition is 
essential and if superinfection occurs during 
therapy, appropriate measures should be taken. 
Should an organism become resistant during 
antibiotic therapy, another antibiotic should be 
substituted.
In children 3 months of age or older, higher 
doses of MEFOXIN® (100mg/kg/day and
above) have been associated with an increased 
incidence of eosinophilia and elevated SGOT.
ADVERSE REACTIONS
MEFOXIN® is generally well tolerated. Adverse 
reactions rarely required cessation of treatment 
and usually have been mild and transient.
Local Reactions
Thrombophlebitis has occurred with intra­
venous administration. Some degree of pain and 
tenderness is usually experienced after intra­
muscular injections using water. Induration has 
occasionally been reported.
Allergic
Maculopapular rash, urticaria, pruritus, eosino­
philia, fever and other allergic reactions have 
been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can 
appear during or after antibiotic treatment. 
Nausea and vomiting have been reported rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia, 
hemolytic anemia, and thrombocytopenia have 
been reported. Some individuals, particularly 
those with azotemia, may develop positive direct 
Coombs tests during therapy with MEFOXIN®. 
Liver Function
Transient elevations in SGOT, SGPT, serum 
LDH, and serum alkaline phosphatase have 
been reported.
Kidney
Elevations in serum creatinine and/or blood 
urea nitrogen levels have been observed. As 
with the cephalosporins, acute renal failure has 
been reported rarely. The role of MEFOXIN® in 
changes in renal function tests is difficult to 
assess, since factors predisposing to prerenal 
azotemia or to impaired renal function have 
often been present.
TREATMENT OF OVERDOSE
Other than general supportive treatment, no 
specific antidote is known. MEFOXIN® can be 
eliminated by dialysis in patients with renal 
insufficiency.
DOSAGE AND ADMINISTRATION
MEFOXIN® may be administered intravenously 
or in tram uscu larly  when required. (See 
complete monograph on ADMINISTRATION 
and RECONSTITUTION.)
TREATMENT DOSAGE 
Adults
The usual adult dosage is 1 g or 2 g of 
MEFOXIN® every 6 to 8 hours. Dosage and route 
of administration should be determined by 
severity of infection, susceptibility of the 
causative organisms, and condition of the 
patient. The usual adult dosages are shown in 
the Table below.
Usual Adult Dosage
Type of 
infection
Daily
Dosage
Frequency 
and Route
Uncomplicated 
forms* of in­
fections such as 
pneumonia, 
urinary tract 
infection, soft 
tissue infection
3-4 g 1 g every 6-8 h 
I.V. or I.M.
Moderately 
severe or severe 
infections
6-8 g 1 g every 4 h
or
2 g every 6-8 h I.V.
Infections 
commonly 
needing anti­
biotics in higher 
dosage (e.g. gas 
gangrene)
12 g 2 g every 4 h
or
3 g every 6 h I.V.
■Including patients 
absent or unlikely
in whom bacteremia is
Therapy may be started while awaiting the 
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic 
streptococcal infections should be maintained 
for at least 10 days to guard against the risk of 
rheumatic fever or glomerulonephritis. In 
staphylococcal and other infections involving a 
collection of pus, surgical drainage should be 
carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN® may be used in patients with 
reduced renal function but a reduced dosage
should be employed and it is advisable to 
monitor serum levels in patients with severe 
impairment.
In adults with renal insufficiency, an initial 
loading dose of 1 g to 2 g should be given. After 
a loading dose, the following recommendations 
for maintenance dosage may be used as a guide:
RENAL CREATININE
FUNCTION CLEARANCE DOSE FREQUENCY
mL/mln
Mild
impairment
Moderate
50-30 1-2 g every 8-12 h
impairment
Severe
29-10 1-2 g every 12-24 h
impairment
Essentially
9-5 0.5-1 g every 12-24 h
no function <5 0.5-1 g every 24-48 h
In the patient undergoing hemodialysis, the 
loading dose of 1 - 2 g should be given after each 
hemodialysis, and the maintenance dose should 
be given as indicated in the Table above. 
Neonates (Including Premature Infants), Infants 
and Children (See WARNINGS for Neonates 
under ADMINISTRATION in the complete 
monograph.)
Premature Infants 
with Body Weights 
Above 1500 g 20-40 mg/kg every 12 h I.V.
Neonates
0- 1 week of age
1- 4 weeks of age
20-40 mg/kg every 12 h I.V. 
20-40 mg/kg every 8 h I.V.
Infants
1 month to 2 years 
of age
20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
Children 20-40 mg/kg every 6 h or 
every 8 h I.M. or I.V.
In severe infections, the total daily dosage in 
infants and children may be increased to 
200 mg/kg, but not to exceed 12 g per day. 
MEFOXIN® is not recommended for the therapy 
of meningitis. If meningitis is suspected, an 
appropriate antibiotic should be used.
At present there is in su ffic ie n t data to 
recommend a specific dosage for children with 
impaired renal function. However, if the 
administration of MEFOXIN® is deemed to be 
essential the dosage should be modified 
consistent with the recommendations for adults 
(see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of 
MEFOXIN® is recommended as follows: 
Vaginal or abdominal hysterectomy and 
abdominal surgery
2 g administered intram uscularly or intra­
venously just prior to surgery (approximately 
one-half to one hour before initial incision).
The second and third 2g doses should be 
administered at 2-6 hour intervals afterthe initial 
dose.
Cesarean Section
The first dose of 2g should be administered 
intravenously as soon as the umbilical cord has 
been clamped. The second and third 2g doses 
should be given in travenously or in tra ­
muscularly four hours and eight hours after the 
first dose.
AVAILABILITY
MEFOXIN® is supplied as sterile powder in 
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca -  2 g cefoxitin as sodium salt 
Storage
MEFOXIN® in the dry state should be stored 
below 30° C.
PRODUCT MONOGRAPH AVAILABLE 
ON REQUEST
(425-a,6,87x)
®Trademark Merck & Co., Inc./
Merck Frosst Canada Inc., R.U.
2177
PAAR I | (.M A C  1 P.O. BOX 1005. POINT E-CLAIRE
----- --------1 t___ I DORVAL H9R4P8
MSP
MERCK
SHARft
DOHME
ORIGINAL ARTICLES
Failure of Preoperative Cultures to 
Predict Development of Staphylococcus 
aureus Wound Infections After Cardiac 
Surgery
G. Taylor, MD, FRCPC; R. Wiens, BScN; L. Miedzinski, MD
To assess the predictive value of preoperative surveillance cultures for the 
postoperative development of Staphylococcus aureus wound infection, the findings 
in 563 patients who underwent elective cardiac surgery were evaluated. One 
hundred and forty-seven (26%) were found to be S. aureus carriers preoperatively. 
Postoperatively, 11 S. aureus wound infections developed, 4 in patients whose 
cultures were positive preoperatively and 7 in patients whose cultures were negative 
preoperatively. The patient’s endogenous flora appears to be the source of only a 
minority of such postoperative infections. The authors conclude that preoperative 
surveillance cultures are not of value in predicting patients at risk for wound 
infection after elective cardiac surgery.
On a etudie les donnees portant sur 563 patients de chirurgie cardiaque non urgente 
afin d’evaluer la valeur previsionnelle d’une surveillance preoperatoire par culture 
bacterienne sur le developpement postoperatoire des infections de plaie a Staphylo­
coccus aureus. Cent quarante-sept patients (26%) furent trouves porteurs de S. 
aureus avant T operation. En postoperatoire, 11 infections de plaie a S. aureus 
furent denombrees, 4 chez des patients dont les cultures etaient positives avant 
l’operation et 7 chez des patients dont les cultures etaient negatives. La flore 
endogene des malades semble etre a l’origine d’un petit nombre d'infections 
postoperatives seulement. Les auteurs concluent que la surveillance bacterienne 
preoperatoire ne permet pas de predire quels patients sont a risque de developper 
une infection de plaie apres la chirurgie cardiaque non urgente.
Despite the routine prophylactic use of antibiotics, as many as 
9% of patients who undergo cardiac 
surgery continue to have wound 
infection,1-4 the consequences of 
which can be severe and include 
such life-threatening problems as 
endocarditis, pericarditis, mediasti-
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nitis and bacteremia.5 Further, hos­
pital stay may be prolonged. In a 
study by Green and Wenzel,6 pa­
tients who had a wound infection 
after coronary artery bypass spent 
14 days longer in hospital than 
uninfected controls.
Staphylococcus aureus continues
to be one of the commonest causes 
of surgical infection in this popula­
tion.45 In the preantibiotic era it 
was shown that persons who car­
ried S. aureus preoperatively were 
more likely to have a S. aureus 
wound infection after, and that the 
infecting organism was usually of 
the same phage type as the preoper­
ative isolate.7 If it could be shown 
that in patients who underwent car­
diac surgery, preoperative carriage 
of S. aureus was predictive of post­
operative wound infection, then 
eradication of the carrier state 
might prevent many such infec­
tions. This technique has been ap­
plied with success in patients who 
undergo long-term hemodialysis.8
For 12 months, we routinely ob­
tained cultures preoperatively from 
our patients scheduled to undergo 
cardiac surgery to assess the predic­
tive value of the cultures for the 
postoperative development of S. au­
reus wound infection.
Patients and Methods
All patients who underwent elec­
tive cardiac surgery at the Universi­
ty of Alberta Hospital, Edmonton, 
between August 1986 and July 
1987 were assessed. The nursing 
staff obtained culture specimens 
from anterior nares, chest skin and 
groin skin of each patient within
From the Department o f Medicine. University o f Alberta Hospital, Edmonton, Alta.
Reprint requests to: Dr. G.D. Taylor, 2E3.11 Walter C. Mackenzie Health Sciences Centre, 
University o f Alberta Hospital. Edmonton. Alta. T6G 2B7
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48 hours of surgery by vigorously 
rubbing these areas with cotton- 
tipped swabs. The specimens were 
placed in transport media and sent 
to the microbiology laboratory. 
They were plated on mannitol salt 
agar plates to enhance the recovery 
of S. aureus and read at 48 hours. 
Staphylococcal colonies were identi­
fied using standard techniques.
Adult patients were given 1 g to 
2 g of cephalothin or cefamandole 
prophylactically 1 hour preopera- 
tively and at 6-hour intervals for the 
next 48 hours. (Some of the adult 
patients were involved in a random­
ized open study of cefamandole ver­
sus cepalothin.) Pediatric patients 
received cephalothin in a dose of 25
Table 1. Preoperative Cultures for
Staphylococcus aureus in Cardiac Surgery
Patients
Result No. (%)
Negative all sites 416(74)
Positive one or more sites 147 (26)
Nose negative 13
Nose positive 134
m g/kg prophylactically 1 hour pre- 
operatively and at 6-hour intervals 
postoperatively for two doses after 
the test tube was removed.
The patients were followed up by 
one of us (R.W.) from 48 hours 
postoperatively until discharge. 
Those who died within 48 hours 
were omitted from our analysis. 
Patients who underwent multiple 
procedures were entered only on 
the first occasion.
A surgical infection was diag­
nosed by the following:
•  Discharge of pus from the 
surgical incision.
•  Presence of erythema and se- 
rosanguineous discharge from the 
incision associated with a positive 
culture.
•  Diagnosis of deep-seated infec­
tion (endocarditis, purulent pericar­
ditis, mediastinitis or sternal osteo­
myelitis). Endocarditis was consid­
ered to be surgically related in every 
instance.
The results were analysed by 
Fisher’s exact test.
Table II. Breakdown of Cardiac Surgery Patients With Preoperative Cultures Positive for 
Staphylococcus aureus
No. (%)
Age/sex/operation Total no. positive cultures
Age, yr
< 1 23 4(17)
1 - 9 61 11(18)
1 0 - 1 9 20 7(35)
2 0 - 2 9 16 3(19)
3 0 - 3 9 25 6(24)
4 0 - 4 9 49 12(24)
5 0 - 5 9 126 29 (23)
> 60 243 75 (31)
Sex
Male 392 104(27)
Female 171 43 (25)
Operation
Coronary artery bypass grafting 269 79 (29)
Valve replacement 120 25(21)
Other cardiac 174 43 (25)
Table III. Preoperative Cultures and Postoperative Staphylococcus aureus Wound Infections
Postop wound
Preop cultures No. infection, no. (%)
Negative 416 7(1.7)
Positive 147 4(2.7*)
Totals 563 11 (2.0)
*p =  0.3 by Fisher’s exact test.
Findings
Of the 563 patients in the study, 
269 underwent coronary bypass, 
170 valve replacement with or with­
out coronary bypass and 163 other 
cardiac procedures. Results of pre­
operative cultures are shown in Ta­
bles I and II. Overall, 26% (147) 
were found to be carriers of S. 
aureus. There was a trend for older 
patients and for coronary bypass 
patients to be carriers, though in 
neither case was this trend signifi­
cant. Nose cultures were by far the 
most useful for identifying carriers, 
cultures being positive in 91% of 
patients ultimately found to be car­
riers. Swabs from other sites were 
only occasionally positive, and in 
only 13 instances were they positive 
when the nose culture was nega­
tive.
Postoperatively, 29 patients 
(5.2%) had a surgical infection. 
Thirteen infections occurred at the 
leg incision made for vein harvest­
ing and 16 (7 superficial, 4 medias­
tinitis, 2 purulent pericarditis and 3 
endocarditis) at tissue exposed by 
sternotomy or thoracotomy.
Organisms were cultured in 24 of 
these 29 patients; in 5, cultures 
were not submitted or were submit­
ted and showed no growth. There 
were 29 isolates in these 24 pa­
tients. Staphylococcus aureus was 
isolated 11 times (38%), Escherichia 
coli 7 times, Streptococcus faecalis 
6 times, Pseudomonas sp. twice, 
Enterobacter sp. twice and Sta­
phylococcus epidermidis once.
Table III shows the relationship 
between preoperative isolation of S. 
aureus and postoperative develop­
ment of S. aureus wound infection. 
Of the 11 postoperative isolates, 7 
were obtained from patients who 
were negative for S. aureus preop- 
eratively and 4 from patients who 
carried the organism preoperatively. 
Preoperative cultures were not rou­
tinely saved, therefore it was impos-
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sible to undertake phage typing or 
other tests of strain identity to 
determine whether, in these four, 
the pre- and postoperative strains 
were identical.
Ten of the postoperative S. au­
reus infections occurred in patients 
receiving cephalothin prophylaxis 
and 1 in a patient receiving cefa- 
mandole prophylaxis (who was also 
positive preoperatively for S. au­
reus).
Discussion
The follow-up for this study was 
limited to the inpatient stay and so 
precluded the detection of late in­
fection. The wound infection rate of 
5.2% was similar to or below that 
seen in other studies.1-4 We were 
able to confirm that, despite the use 
of effective antistaphylococcal pro­
phylaxis (cephalothin or cefaman- 
dole), S. aureus remains the single 
commonest causative organism, 
having been isolated from 38% of 
infected patients. And though 10 of 
11 S. aureus wound infections oc­
curred in patients receiving ceph­
alothin, this is likely a reflection of 
its selection for routine use at our 
institution, apart from patients in­
volved in a comparison study with 
cefamandole. Cephalothin and cefa- 
mandole are equivalent in their ac­
tivity against S. aureus.9 Failure to 
detect more instances of S. epider- 
midis infection is also likely a reflec­
tion of the short follow-up in this 
study compared with that of other 
series.4’5
The source of the infecting or­
ganisms in patients who undergo 
clean surgery (such as cardiac sur­
gery) has not been determined, but 
likely derives from the human pop­
ulation in the operating room dur­
ing the procedure — either the 
surgical team or the patient.10-12 
Some hospitals used to culture the 
anterior nares of the surgical team
members regularly to detect S. au­
reus carriers. Most hospitals have 
discontinued this practice because 
few carriers were shown to transmit 
their organisms to patients, and 
eradication of the carrier state was 
neither easy nor permanent in many 
cases.13 On the other hand, if the 
patient was shown to be an impor­
tant source of infecting organsims, 
then even transient eradication 
could be effective in reducing 
wound infection rates. With the 
advent of more effective agents to 
eradicate the carrier state,1415 this 
prospect is more attractive. Unfor­
tunately, our study has shown that 
the patient is the source of the 
infecting organisms in only a minor­
ity of instances. In only 4 of 11 
cases (36%) in which S. aureus was 
isolated from an infected wound, 
was the patient shown to be a 
carrier preoperatively, and even in 
these 4 cases, since phage typing or 
other tests to determine identity of 
strains were not done, it cannot be 
stated with certainty that the pa­
tient was the source.
The statistical analysis of this 
study could not exclude a mild 
positive effect of the S. aureus 
carrier state on postoperative infec­
tion rates. To do so would have 
required a much larger study popu­
lation. Even a modest reduction in 
wound infection would be of value 
to patients, however, so the possi­
bility of eradicating the carrier state 
preoperatively should be explored 
further. With the advent of topically 
effective agents,14 this approach 
could safely be applied to large 
numbers of patients without the 
need to target known carriers.
We thank members of the Division of 
Cardiovascular Surgery for allowing us 
to study their patients, the Division of 
Diagnostic Microbiology who performed 
the cultures and Mrs. L. Darragh who 
typed the manuscript.
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Incidence and Importance of Bacteriuria 
in Postoperative, Short-Term Urinary 
Catheterization
J. Curtis Nickel, MD, FRCSC; Peter Feero, MD; J. William Costerton, PhD; Elda Wilson, RN
The frequency and importance of bacteriuria in patients requiring short-term 
postoperative catheterization (24 to 48 hours) is unknown. From a prospective, 
controlled study of 100 patients requiring catheterization postoperatively, the 
authors determined that there was a definite risk (6%) of bacteriuria; however, a 
symptomatic urinary tract infection developed in only 1% of the patients. There was 
no advantage to using either a latex or silicone catheter. It appears that the risk of 
symptomatic bacteriuria in this group of patients is very low when a closed urinary 
drainage system is used under strict, sterile conditions of catheter insertion and with 
meticulous ongoing catheter care.
On ignore la frequence et l’importance des bacteriuries chez les patients qui 
necessitent un catheterisme postoperatoire de courte duree (de 24 a 48 heures). 
Dans une etude prospective controlee portant sur 100 patients qui ont eu besoin 
d’un catheterisme postoperatoire, les auteurs ont etabli qu’il existe un risque 
definitif (6%) de bacteriurie; toutefois une infection urinaire symptomatique ne se 
developpe que chez seulement 1% des patients. Les catheters de latex et de silicone 
ne presentent aucun avantage, l’un par rapport a l’autre. II semble que, chez ce 
groupe de patients, le risque de bacteriurie symptomatique soit tres faible quand un 
systeme de drainage urinaire ferme est utilise, que l’insertion de la sonde se fait 
dans des conditions de sterilite stride et que le catheter fait l’objet de soins 
meticuleux suivis.
Catheter-associated urinary tract infection is the most common 
nosocomial infection in North 
America.1 The reported risk of in­
fection is 5% to 10% for each day of 
catheterization.2 In critically ill 
medical and surgical patients an 
increased morbidity and mortality 
are associated with these hospital- 
acquired infections.3 4 Many patients 
will require urinary catheterization 
within 24 to 48 hours of operation, 
and surgeons recognize the possi­
bility of catheter-induced bacteri­
uria. However, the incidence and
Accepted for publication June 16, 1988
importance of the problem in this 
particular group has not been stud­
ied adequately. We undertook a 
prospective study of bacteriuria as­
sociated with short-term postopera­
tive catheterization, employing 
closed urinary catheter drainage 
systems under near ideal conditions 
of catheter insertion and ongoing 
catheter care.
Patients and Methods
Randomly selected obstetric and 
urologic patients requiring short­
term urinary drainage after opera­
tion were catheterized in the operat­
ing room, using strict sterile tech­
nique. Excluded from the study 
were patients whose catheter was, 
or was likely to be, removed within 
24 hours, those who had an exist­
ing bacteriuria or could not be 
catheterized with a no. 16 French 
Foley catheter, and those who had 
an open urinary tract (i.e., percuta­
neous nephrostomy) or required 
catheter irrigation. None were ex­
cluded because of age, sex, medical 
condition or antibiotic use. Ran­
domly selected for use were either a 
no. 16 French silicone catheter pre­
connected to a drainage bag (sys­
tem 1) or a latex catheter in a 
similar closed catheter system (sys­
tem 2). A sterile urine sample was 
obtained and meatal culture swabs 
were collected at the time of cathe­
terization. Specimens were collected 
daily from the catheter sample port 
and from the outlet tube of the 
drainage bag by an appointed study 
nurse who also inspected the cathe­
ter system to see that it was proper­
ly connected and ascertained wheth­
er the catheter had been irrigated. 
Bacterial counts of 106 cfu /L  or 
more were considered to indicate 
bacteriuria. A midstream urine spec­
imen for culture was obtained with­
in 12 hours of catheter removal.
Results
Of the 100 patients entered in 
the study, 5 were excluded: 3 be­
cause of initial bacteriuria, 1 be­
cause of catheter irrigation and 1 
because of incomplete culture col-
From the Department o f Urology, Queen’s University, Kingston, Ont.
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lection. Patient variables and results 
for the study populations are shown 
in Table I. There were six episodes 
of catheter-related bacteriuria, three 
in each system, for an overall infec­
tion rate of 6.3%. There was no 
significant difference in the rates of 
bacteriuria between the two systems 
(6.1% versus 6.5%). The overall 
daily infection rate was 2.1% at 24 
hours, 6.8% at 48 hours, 6.5% at 
72 hours and 20.0% at 96 hours 
(Table II).
A postoperative body tempera­
ture greater than 37.5°C developed 
in 29.2% of the group; however, 
only one of the six bacteriuric pa­
tients had a temperature greater 
than 38.5°C during catheterization. 
One of the six received a single 
dose of antibiotic preoperatively; 
the others did not. These five afeb­
rile patients were asymptomatic and 
showed no growth on a midstream 
urine culture after removal of the 
catheter, indicating spontaneous 
clearing of their bacteriuria with 
only catheter removal.
Discussion
We reduced the rate of bacteri­
uria below the reported incidence by 
using closed catheter drainage sys­
tems and sterile technique at time 
of catheter insertion; however, the 
rate of bacteriuria still increased 
after 3 days of catheterization. In 
our low-risk patient population 
there was no significant difference 
in the incidence of bacteriuria be­
tween the two drainage systems. 
Both employed preconnected closed 
systems with antireflux mechanisms 
to prevent upstream, intraluminal 
bacterial contamination.
As noted, only one patient had a 
significant urinary tract infection 
secondary to the postoperative uri­
nary catheterization. The other five 
with bacteriuria had only asymp­
tomatic urinary tract infections 
which did not add to the cost of 
care or length of hospital stay. In 
fact, when the catheters were re­
moved, the bacteriuria resolved 
spontaneously without antibiotic 
treatment. In these circumstances, 
it is very unlikely that the asymp­
tomatic bacteriuric episodes would 
even be noted during routine post­
operative hospitalization. The study 
is too small to comment definitively 
on the effectiveness of antibiotics in 
postoperative catheter-associated 
bacteriuria. In our series it did not 
appear to be a major factor.
This study revealed that even
with closed catheter drainage sys­
tems, a small but definite incidence 
of bacteriuria is unavoidable in 
short-term postoperative catheter­
ization. However, most such cases 
remain asymptomatic and will re­
solve spontaneously upon removal 
of the catheter. It appears therefore 
that the risk of symptomatic uri­
nary tract infection developing post- 
operatively in patients who have 
sterile urine preoperatively and who 
require short-term catheterization 
(24 to 48 hours) is very small (1%) 
provided a closed urinary drainage 
system is employed under strict, 
sterile conditions of catheter inser­
tion and with meticulous ongoing 
catheter care. There is no evident 
advantage to using either a latex or 
silicone catheter system.
We thank the staff of the Queen’s 
University urology department and Dr. 
Glen VanCott of the Kingston General 
Hospital obstetrical department for 
their participation in this study. We 
acknowledge the logistical and editorial 
support of Dimitra Baxter.
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T a b le  II .  Rate o f B ac te riu ria  (1 06 c fu /L )  in 
P o s to p e ra tiv e  P a tien ts  W ith  In d w e llin g  
F o ley C a the te rs
D uration  of No. D a ily  rate  of
c a th e te r iza tio n , w ith b acteriu ria ,
h bacteriu ria %
24 2 /9 5 2.1
48 5 /7 3 6 .8
72 3 /4 6 6 .5
9 6 2 /1 0 20 .0
T a b le  I. P atie n t V a r ia b le s  and  C u ltu re  R e su lts
V a r ia b le
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T o ta l/
m ean
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Synovial Cyst of the Hip: an Unusual 
Cause of an Inguinal Mass
Bruce B. Forster, MD;* Douglas G. Connell, MD, FRCPC;*
Charles H. Scudamore, MD, FACS, FRCS, FRCS(Edin), FRCSCt
A palpable groin mass is a common surgical problem. The authors describe the case 
of a 58-year-old man who had a painless right groin mass. Initial clinical evaluation 
suggested a femoral hernia. Subsequent radiologic evaluation revealed a synovial 
cyst of the hip. Awareness of this anomaly will aid early diagnosis and influence 
treatment.
La decouverte d’une masse palpable dans l’aine est un probleme chirurgical 
frequent. Les auteurs decrivent le cas d’un homme de 58 ans porteur d’une masse 
indolore a l’aine gauche. L’examen clinique initial etait evocateur d’une hernie 
femorale. L’examen radiologique subsequent revela un kyste synovial de la hanche. 
La connaissance de cette anomalie favorisera son diagnostic precoce et en 
influencera le traitement.
Inguinal masses are common clin­ical problems. A knowledge of 
the more unusual causes of such 
presentations is important to avoid 
unnecessary or inappropriate sur­
gery. We describe a case of a syno­
vial cyst of the hip which presented 
as a painless right groin swelling. 
Although this is not the first such 
case reported,1-4 there is no recent 
discussion in the surgical literature 
of the modern radiologic evaluation 
of this entity.
Case Report
A 58-year-old man was referred 
because of a painless right groin
mass, which had enlarged slowly 
over 3 months. For 2 years he had 
had intermittent back and right hip 
pain associated with activity. There 
was no history of arthritis or other 
joint problems or of any other 
medical problem.
On physical examination a 6 X 
4-cm smooth, firm, nontender mass 
was noted below the inguinal liga­
ment. The mass was lateral to the 
femoral artery and displaced it me­
dially. No bowel sounds or bruits 
were heard within the mass and the 
distal pulses of the right leg were 
normal. Standard x-ray films re­
vealed only mild narrowing of the 
right hip joint space superiorly. A 
femoral hernia was suspected, but,
because of the medial displacement 
of the femoral artery, ultrasonogra­
phy was done.
On ultrasonography of the right 
groin (Fig. 1), a 5 X 3-cm cystic 
lesion was demonstrated lateral and 
deep to the femoral artery and just 
anterior to the right femoral head. 
The lesion did not have the appear­
ance of a bowel loop, and Doppler 
evaluation demonstrated no flow. 
With ultrasonic guidance, 80 ml of 
clear yellow fluid was aspirated 
from the mass. Cytologic examina­
tion of the fluid revealed a few 
lymphocytes only and Gram’s stain­
ing and culture gave negative re­
sults. The protein concentration 
was 38 g /L  and glucose level 4.4 
mmol/L. No crystals were seen in 
the fluid.
A synovial cyst was suspected, so 
15 ml of air was injected under 
fluoroscopic guidance into the right
FIG. 1. Transverse sonogram of right 
groin demonstrates cystic lesion (ar­
rows). Femoral artery (curved open 
arrow) and vein (curved closed arrow) 
lie medial to cyst.
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hip joint and computed tomography 
carried out (Fig. 2). A 3.5 X 4.5-cm 
cystic lesion anterior to the right 
hip and lateral to the femoral ves­
sels was demonstrated, with an air- 
fluid level within it, confirming that 
the cystic lesion communicated with 
the right hip joint and was indeed a 
synovial cyst.
Because the mass was asymptom­
atic, treatment was conservative. 
Follow-up 1 year later demonstrated 
no change in the mass, which re­
mained asymptomatic.
Discussion
Synovial cysts are protrusions of 
synovial membrane caused by raised 
intra-articular pressure. Cyst forma­
tion in the hip, which is rare, 
usually occurs through the weak 
anterior zone of the joint capsule, 
between the iliofemoral and pubo-
FIG. 2. Computed tomogram of pelvis 
after injection of air into right hip 
joint demonstrates cystic lesion with 
air-fluid level within it (closed arrow) 
anterior to femoral head. Femoral ar­
tery (curved open arrow) and vein 
(curved closed arrow) are medial and 
ilipsoas muscle (open arrow) is lateral 
to cyst.
femoral ligaments.1 The iliopsoas 
bursa lies just anterior to the hip 
joint and posterior to the iliopsoas 
muscle and often acts to decom­
press rising intra-articular pressure. 
In approximately 15% of normal 
hips and 40% of hips showing ar­
thritic changes, there is a communi­
cation between the hip joint and the 
iliopsoas bursa, allowing the bursa 
to swell when there is excessive 
synovial fluid production.2 This en­
larged bursa or “synovial cyst” may 
then dissect anteriorly between the 
ilipsoas tendon and the pectineus 
muscle to present as a groin mass 
lateral to the femoral artery. Rarely, 
it may extend retroperitoneally to 
present as an intrapelvic cyst, com­
pressing the bladder, ureters, sig­
moid colon or cecum.3
Most patients with groin masses 
and synovial cysts of the hip will 
have a history of traumatic, inflam­
matory (especially rheumatoid) or 
degenerative joint disease suggest­
ing a diagnosis. As in our case, 
however, these lesions may occur 
with minimal symptoms referrable 
to the hip. Physical examination 
should also suggest the diagnosis, 
as it usually reveals a nonpulsatile 
swelling inferior to the inguinal 
ligament and lateral to the femoral 
artery, in contrast to inguinal and 
femoral hernias, which are usually 
medial to the femoral vessels.
Standard x-ray Films of the hip 
may reveal underlying joint disease 
or may be entirely normal. Ul­
trasonography should follow; it will 
reveal the cystic nature of the mass, 
rule out an aneurysm with Doppler 
studies and allow cyst puncture to 
exclude an abscess or hematoma.4
The need for more invasive studies 
such as arteriography or lymphan­
giography is obviated by this ap­
proach. Injection of the cyst with 
contrast medium under ultrasonic 
control, followed by plain-film imag­
ing, may show communication be­
tween the cyst and the hip joint and 
confirm the diagnosis. In some in­
stances, however, retrograde filling 
of the hip joint may not occur.3
In this event, injection of the hip 
joint with air, then computed to­
mography or injection of the hip 
with contrast followed by plain-film 
evaluation, will demonstrate the 
communication.
Therapy for synovial cysts of the 
hip has varied from treatment of 
symptoms with rest, salicylates and 
physiotherapy, to instillation of 
sclerosing agents after cyst aspira­
tion and surgery.3 Many patients 
can be treated conservatively, which 
emphasizes the importance of care­
ful clinical and radiologic evalua­
tion.
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Congenital Abdominal Aortic Aneurysm
D. Latter, MD; M.J. Beland, MD, FRCPC; A. Batten, MD; C.I. Tchervenkov, MD, FRCSC;
A.R.C. Dobell, MD, FACS, FRCSC
The authors report the extremely rare occurrence of a congenital abdominal aortic 
aneurysm, 6 cm in diameter, found in a 1-month-old infant. Prenatal ultrasono­
graphy at 34 weeks’ gestation had shown the aneurysm, which at that time was 
interpreted as a renal cyst. At operation, an 8-mm polytetrafluoroethylene tube graft 
was interposed between the infrarenal aorta and the bifurcation. Cardiopulmonary 
bypass facilitated operative management by permitting return of blood lost and by 
maintaining body temperature.
In a review of the literature, the authors could not find any report of a neonatal 
aneurysm of this magnitude. Regrettably, the cause of this true aneurysm remains 
obscure.
Les auteurs signalent l’observation extremement rare d’un anevrisme congenital de 
l’aorte abdominale, de 6 cm de diametre, chez un bebe de 1 mois. L’echographie prenatale 
a la 34e semaine de la gestation avait montre l’anevrisme, lequel avait ete confondu pour 
un kyste renal. A la chirurgie une tubulure de polytetrafluoroethylene de 8 mm fut 
intercalee entre l’aorte sous-renale et la bifurcation. La circulation extracorporelle a 
facilite l’intervention en permettant le retour de la deperdition sanguine et le maintien de 
la temperature corporelle.
A la revue de la litterature, les auteurs n’ont pu retrouve de rapport d’un anevrisme de 
cette taille chez un nouveau-ne. Malheureusement, la cause de cet anevrisme vrai 
demeure obscure.
A bdominal aortic aneurysms are extremely rare in infants and 
children, and only one congenital 
abdominal aortic aneurysm has 
been described.1 We recently treated 
an infant with a large abdominal 
aneurysm, demonstrated on prena­
tal ultrasonography. The unusual 
nature of the malformation, the 
surgical management of the infant 
and pathological features of the 
specimen are discussed in this re­
port.
Case Report
A female infant, weighing 3200 
g, and delivered at term by cesar­
ean section, was transferred to 
The Montreal Children’s Hospital at 
22 days of age. The mother’s preg­
nancy had been uncomplicated. 
Amniocentesis had been done with 
no problems at 14 weeks’ gesta­
tion. Subsequent ultrasonography 
showed a cystic lesion interpreted 
as a left renal cyst (Fig. 1). Follow­
From the Division o f Cardiovascular and Thoracic Surgery, The Montreal Children’s Hospital, 
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ing delivery, the infant appeared 
well and fed normally. On physical 
examination a large, easily palpable, 
pulsatile mass, approximately 6 cm 
in diameter, was noted on the left 
side of the abdomen. Femoral 
pulses were normal. Ultrasonogra­
phy confirmed the clinical diagnosis 
of a large abdominal aortic aneu­
rysm and left hydronephrosis, 
thought to be secondary to com­
pression of the left ureter (Fig. 2).
The aorta was explored through 
a midline abdominal incision. The 
third part of the duodenum was 
reflected off the neck of the aneu­
rysm, the origin of which was below 
the renal arteries. The aortic bifur­
cation was normal. The inferior 
mesenteric artery came off the ante­
rior aspect of the aneurysm and was 
ligated at its origin. The midline 
incision was extended cephalad and
FIG. 1. Prenatal ultrasonography at 34  
weeks’ gestation shows aneurysm  
which was considered to be renal cyst.
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the sternum divided, permitting ex­
posure and cannulation of the as­
cending aorta and right atrium for 
cardiopulmonary bypass, at which 
time the patient was heparinized. 
Cross clamps were applied below 
the renal arteries and to the iliac 
arteries. The aneurysm was opened 
and the contained blood aspirated, 
using the coronary suction device. 
During the process of assessment 
and repair, blood was aspirated 
from the aneurysm at a rate of 
approximately 10 ml/min and re­
turned directly to the baby through 
the aortic cannula.
From its origin, the aneurysm 
extended both proximally and dis- 
tally anterior to the aorta. A strip of 
the anterior wall of the aneurysm 
was removed for histologic study. 
The aorta above the aneurysm mea­
sured about 7 mm in diameter and 
an 8-mm polytetrafluoroethylene 
graft was interposed to bridge the 
aneurysm gap, using 5-0 Prolene. 
Cardiopulmonary bypass was then 
applied to warm the baby from 31° 
to 37°C. Protamine sulfate was 
administered and the cannulas were 
removed from the aorta and right 
atrium. The redundant anterior an­
eurysm wall was closed in front of 
the polytetrafluoroethylene graft.
Postoperatively the infant did 
well and at clinical examination 10 
months later excellent femoral 
pulses were present. Evidence of 
left hydronephrosis remained, but 
renal scans showed that the kidney 
was functioning normally.
Pathological Examination
The aneurysm was saccular. The 
fact that the inferior mesenteric 
artery came off the anterior wall 
indicates that it was a true rather 
than a false aneurysm. On histolog­
ic examination of the excised por­
tion of the aneurysm, all compo­
nents of the normal aortic wall were
seen (Figs. 3 and 4). The intima was 
greatly thickened and consisted of 
myxoid tissue underlying endotheli­
um. The media was decreased in 
thickness to about one-third to one- 
half that of an age-matched control
FIG. 2. (Top) Preoperative ultrasonography of aneurysm indicates origin of distal 
aorta from aneurysm. Measurement markers are 10 mm apart. (Bottom) Ultrasonog­
raphy of lower thorax and upper abdomen shows aorta entering aneurysm. A = 
anterior, Cr =  cranial, Ca =  caudal, P =  posterior, An =  aneurysm, dA = distal 
aorta, L = liver, H = heart, pA = proximal aorta.
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specimen from the same region of 
the aorta. Elastic lamellae were 
mostly well organized, regular and
' »•- . » * » V  ^
i *
< /  - "■
*  4
*  -
FIG. 3. Photomicrograph of anterior 
wall of aneurysm. Intima (top) shows 
marked thickening due to accumula­
tion of myxoid material with new blood 
vessel formation (arrow). Media shows 
thinning with mild fibrosis between 
elastic lamellae. Entire media is shown 
(Van Gieson’s elastic stain, original 
magnification X 388).
nonfragmented, but they were gen­
erally thinner than those of the 
control, with slight collagen deposi­
tion in between. In one focal area (1 
mm in size), the media was com­
pletely deficient and the intima di­
rectly underlay the adventitia. No 
inflammatory infiltrate was present.
The pathological findings were 
not considered diagnostic of any 
specific defect. The focal complete 
medial deficiency might represent a 
type of incomplete dissection.
Discussion
Most of the abdominal aneurysms 
reported in young children had an 
identifiable etiology. Some were my­
cotic,23 others were related to trau­
ma.45 There were disorders of con­
nective tissue,16-7 such as Ehlers- 
Danlos syndrome or Marfan’s syn­
drome or tuberous sclerosis8 and 
cases of Takayasu’s disease or cys- 
tinosis.9 We are unable to put for­
ward a specific cause for this un­
usual aneurysm, which was clearly
present before birth. Trauma during 
the amniocentesis is one possibility, 
but we have discounted this on the 
basis of an uncomplicated proce­
dure and the fact that the aneurysm 
had neither the gross or microscop­
ic features of a false aneurysm.
A search of the literature dis­
closed three other cases of idiopath­
ic abdominal aortic aneurysms in 
young children: one in a
16-month-old infant who died after 
rupture of the aneurysm;10 a second 
in a 7-year-old girl who survived 
rupture and underwent emergency 
repair.6 The media in this case was 
noted to contain areas of degenera­
tion with widely separated elastic 
fibres, thought to be compatible 
with Marfan’s syndrome. The pa­
tient had no signs of the syndrome, 
however, so the aneurysm was con­
sidered idiopathic. The third case 
was that of a neonate considered to 
have a Wilms’ tumour of the left 
kidney; operation led to exsangui­
nating hemorrhage.11 Pathological 
examination of the specimen 
showed a saccular aneurysm of the 
infrarenal aorta containing all layers 
of the aortic wall. The intima was 
thickened and the gross and micro­
scopic features were similar to 
those seen in our case.
Cardiopulmonary bypass may not 
have been necessary in our patient, 
but it relieved us of concern regard­
ing blood loss during the aneurysm 
repair. We did not wish simply to 
discard the significant volume of 
blood within the aneurysm nor that 
emanating from the lumbar arteries, 
as is normally done during aneu­
rysm resection in adults. In our 
opinion, the cardiopulmonary by­
pass greatly facilitated the opera­
tion and helped in returning the 
infant’s body temperature to normal 
at its conclusion. In fact, the ve­
nous drainage line was opened only 
after the aneurysm had been com­
pletely repaired; the bypass until 
that time was simply used to aspi-
FIG. 4. Photomicrograph of aneurysm wall; lumen is at top. Media at right is 
completely deficient (large arrow); to left, media has same thickness as elsewhere. 
In this area, note focal collections of mucopolysaccharide, appearing as clear spaces 
(curved arrow) (Masson’s trichrome stain, original magnification X 183).
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rate intra-aortic blood and return it 
to the ascending aorta. Partial car­
diopulmonary bypass has been ad­
vocated previously for certain high- 
risk aortic aneurysm repairs in 
adults.12 In this report of our 
unique experience in repairing a 
large abdominal aortic aneurysm in 
a young infant, the cardiopulmo­
nary bypass provided security for 
the surgical procedure.
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ORIGINAL ARTICLES
Primary Anterior Mediastinal Tumours: 
“ an Investigational Algorithm”
Guy Fradet, MD, MSc, FRCSC;* Kenneth G. Evans, MD, FRCSC;* Bill Nelems, MD, FRCSC;* 
Roberta R. Miller, MD, FRCPC;t Nestor L. Muller, MD, FRCPC$
A review of 33 months’ experience with primary anterior mediastinal masses in 31 
patients disclosed that in 9 (29%) the tumour was benign. Nineteen (86%) of the 22 
malignant tumours and only 2 of the 9 benign tumours were symptomatic. Diagnosis 
was established by histopathologic examination of a biopsy specimen or resected 
tissue and serum radioimmunoassay for a-fetoprotein or human chorionic 
gonadotropin, /3-subunit. The authors present an investigational algorithm, using 
modern procedures, to facilitate the diagnosis of this relatively uncommon and 
challenging condition.
L’etude de 31 cas de tumeurs primitives du mediastin anterieur observes au cours 
d’une periode de 33 mois revele que 9 fois (29%) les tumeurs etaient benignes. 
Dix-neuf (86%) des 22 tumeurs malignes et 2 des tumeurs benignes etaient 
symptomatiques. Le diagnostic fut pose a l’examen histopathologique des echantil- 
lons de biopsie ou des tissus de resection, et par radio-immunodosage dans le serum 
des a-foetoproteines ou des sous-unites /3 de la gonadotrophine chorionique 
humaine. Les auteurs proposent un algorithme d’examens s’appuyant sur des 
techniques modernes, pour faciliter le diagnostic de cette affection deroutante et 
relativement rare.
A number o f cysts and tumours occur as primary lesions of the 
mediastinum. By surgical conven­
tion, metastatic lesions, tumours 
secondarily invading the mediasti­
num, trachea, esophagus, heart and 
great vessels are not classified as 
primary mediastinal masses.1 The 
anterior compartment, defined as
the area bounded by the sternum 
anteriorly, the heart posteriorly, the 
thoracic inlet superiorly and the 
diaphragm interiorly,2 contains the 
thymus, thyroid and parathyroid 
glands, adipose, areolar and lym­
phatic tissues. This area is the most 
common site for mediastinal neo­
plasms.1"3 The traditional approach
to primary anterior mediastinal 
masses is excision o f  the lesion.14 5 
However, with the newest chem o­
therapy regimens and improved ra­
diotherapy techniques, the most ef­
ficacious treatment for a number o f 
these tumours is nonsurgical.2-4-6 
Better preoperative diagnosis is af­
forded by computed tom ography 
and serum radioimmunoassays for 
secretory products o f germ cell tu­
m ours.13'6"8 Cervical and paraster­
nal mediastinoscopy, thoracoscopy 
and percutaneous fine-needle biopsy 
may all provide adequate tissue for 
diagnosis and are now satisfactory 
alternatives to surgical excision.
With these new developments, a 
more systematic diagnostic ap­
proach to these tumours may spare 
patients from inappropriate surgical 
procedures. We reviewed our last 
33 months’ experience with ante­
rior mediastinal masses to realize 
an appropriate algorithm for diag­
nosing them.
Patients and Methods
Thirty-one consecutive patients 
with primary anterior mediastinal 
masses were admitted to Vancouver 
General Hospital between March 
1985 and December 1987. Tum our 
location was determined by chest 
roentgenography and computed to­
mography. The diagnosis was es­
tablished by histopathologic exami-
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nation of a biopsy specimen or 
resected tissue and serum radioim­
munoassay for a-fetoprotein (AFP)
or human chorionic gonadotropin, 
/3-subunit (bHCG). The medical re­
cords of the patients were reviewed
for demographic data, clinical pre­
sentation and details of their diag­
nostic evaluation.
Findings
There were 16 men and 15 wom­
en, ranging in age from 15 to 79 
years (mean 49 years). The age 
distribution among the sexes was 
similar. The relative frequency of 
various tumours and associated in­
cidence of symptomatic presenta­
tion are shown in Table 1. Histologi­
cally, 22 (71%) lesions were malig­
nant and 9 (29%) benign. Nineteen 
(86%) of the patients who had histo­
logically malignant lesions and 2
Table 1. Anterior Mediastinal Masses. Tumour Type and Associated Symptoms
Tumour type No. (%) Symptoms
Thymic 11 (35)
Benign (encapsulated) 5 0
Malignant 6 5
Thyroid 3 (10)
Benign 2 1
Malignant 1 1
Lymphatic 12 (39)
Malignant 12 10
Germ cell 4 (13)
Benign 1 0
Malignant 3 3
Mediastinitis 1 (3)
Benign 1 1
Totals 31 (100) 21
Benign 9 (29) 2
Malignant 22 (71) 19
Table II. Diagnostic Evaluation of Patients by Tumour Type
Sex
Age,
yr Diagnosis Symptoms CT AFP bHCG
Thymus
M 39 Encapsulated thymoma N L _ _
F 45 Encapsulated thymoma N L 0 0M 66 Encapsulated thymoma N 0 0 0M 75 Encapsulated thymoma N 0 0 0M 53 Encapsulated thymoma N 0 0 0F 75 Invasive thymoma N 0 0 0F 15 Thymic tumour of childhood S, T, SVC l-A 0 0M 36 Malignant carcinoid of thymus S, T, SVC I 0 0F 78 Squamous thymic carcinoma T I 0 0M 61 Squamous thymic carcinoma T-S I 0 0F 65 Squamous thymic carcinoma T. SVC I 0 n
Thyroid
M 79 Multinodular goitre N L 0 0F 56 Multinodular goitre T, SVC L 0 0F 77 Follicular thyroid carcinoma T L 0 n
Lymphatic
M 20 Hodgkin's lymphoma S l-A 0 0F 20 Hodgkin’s lymphoma S A 0 0F 27 Hodgkin's lymphoma S 0 0 0
F 45 Hodgkin’s, fibrocystic breast N l-A 0 0M 51 Hodgkin’s lymphoma S A 0 0
F 35 Non-Hodgkin’s lymphoma S L 0 0
F 56 Non-Hodgkin’s lymphoma s A 0 0
M 68 Non-Hodgkin’s lymphoma N A 0 0
M 60 Non-Hodgkin’s lymphoma S l-A 0 0
F 34 Non-Hodgkin’s lymphoma S.T I 0 0
F 55 Non-Hodgkin’s lymphoma S,T A 0 0
M 58 Non-Hodgkin’s lymphoma S 0 0 0
Germ cell
M 19 Embryonal type carcinoma s I + 0
M 30 Embryonal type carcinoma s I + 0
M 35 Embryonal type carcinoma T 1 +
M 36 Benign cystic teratoma N 1
Mediastinitis
F 58 Idiopathic sclerosing mediastinitis T 1 0 0
Diagnosis
Median sternotomy 
Median sternotomy 
Median sternotomy 
Median sternotomy 
Median sternotomy 
Median sternotomy 
Right thoracotomy 
Median sternotomy 
Right thoracotomy 
Left anterior mediastinotomy 
Fine-needle biopsy at CT
Neck +  median sternotomy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Manubriotomy, thymectomy
Mediastinoscopy
Mediastinoscopy
Mediastinoscopy
Left anterior mediastinotomy
Right parasternal mediastinotomy
Mediastinoscopy
Right anterior mediastinotomy 
Median sternotomy post chemo 
Fine-needle biopsy at CT, median 
sternotomy post chemo 
Median sternotomy
Manubriotomy
"  u „y.aH"y, „ i  r  -  mem, unuu =  Human cnoriomc gonaoorropin, p-suoumt, I =  tnoracic, S =  systemic, N =  none SVC
superior vena caval obstruction, 0 =  not done, L =  encapsulated thyroid, thymus, I =  invasive, A =  lymphadenopathy, +  =  positive, -  =  negative.
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who had benign lesions were symp­
tomatic.
The clinical presentation and di­
agnostic evaluation of our patients 
is shown in Table II. Of 11 patients 
with thymic epithelial tumours, 6 
were asymptomatic; 5 had totally 
encapsulated thymomas and 1 had 
an encapsulated thymoma with 
focal microscopic capsular invasion. 
The five symptomatic patients had 
cytologically malignant thymic epi­
thelial tumours, including three 
squamous carcinomas, one malig­
nant carcinoid and one thymic epi­
thelial tumour of childhood.9 Symp­
toms included neck discomfort, su­
perior vena caval syndrome, dys­
pnea, night sweats and weight loss. 
No patient had myasthenia gravis 
or other thymoma-associated para­
neoplastic syndromes.
In the thyroid group, two pa­
tients had benign multinodular 
goitres, one of which gave rise to 
symptoms of tracheal compression. 
The third patient, with follicular 
carcinoma in a mediastinal thyroid 
gland, presented with goitre. None 
of these patients had clinical hyper­
thyroidism.
In the lymphoma group, 10 of 
the 12 patients complained of symp­
toms at the time of presentation; 
they included night sweats, fatigue, 
weight loss and fever. None had a 
superior vena caval syndrome. In 
two patients the diagnosis was 
made during investigation of symp­
toms due to an unrelated disease.
The symptoms of three patients 
with malignant germ cell tumours 
included dyspnea and nonspecific 
chest pain at the time of diagnosis. 
Our only patient with a benign 
cystic teratoma was asymptomatic 
when his tumour was discovered on 
a routine chest film.
Finally, one patient who present­
ed with a superior vena caval syn­
drome of 3 months’ duration was 
found to have idiopathic sclerosing 
mediastinitis.
ANTERIOR MEDIASTINAL TUMOURS
All patients had a chest x-ray film 
taken and 28 had computed tomog­
raphy of the chest. The diagnosis of 
anterior mediastinal mass was first 
made by chest x-ray in all but one 
patient in whom both the chest 
x-ray film and computed tomogram 
showed a pulmonary density in the 
right middle lobe. Following a non­
diagnostic fine-needle biopsy, right 
thoracotomy was done and the pa­
tient was found to have a thymic 
squamous cell carcinoma invading 
the right-middle lobe. Computed to­
mography was very useful in local­
izing the mediastinal tumour in 27 
of 28 cases. Five of the six patients 
with thymoma underwent computed 
tomography preoperatively and in 
four the diagnosis was suggested. 
In 10 of 12 patients with lympho­
ma, computed tomography showed 
mediastinal lymphadenopathy in 8 
whose lymphoma was suspected at 
clinical examination. The scan accu­
rately localized the lesion in all 
patients with thyroid tumours. Five 
patients, young men between the 
ages of 19 and 39 years with a 
symptomatic anterior mediastinal 
mass on chest x-ray film and signs 
of invasion on computed tomogra­
phy, had tumour marker assays 
done.
Discussion
Comparison of our series with 
others of primary anterior mediasti­
nal masses310' 12 showed a similar 
distribution of lesions in terms of 
tumour type and ratio of benign to 
malignant lesions. In the anterior 
mediastinum, approximately one- 
third of the lesions are benign and 
two-thirds are malignant. As previ­
ously noted,11 the association of 
symptoms with malignant disease 
was also seen in our study.
Chest roentgenography was sen­
sitive in detecting an anterior medi­
astinal mass, and computed tomog­
raphy, though unlikely to be more 
informative, was helpful in localiz­
ing the mass to the thyroid or 
thymus gland. It also revealed the 
extent and character of the mass, 
be it homogeneous, necrotic, asso­
ciated with obliteration of fat 
planes, suggesting invasiveness, or 
with lymphadenopathy in the mid­
dle mediastinum or hilum, suggest­
ing lymphoma.
Davis and colleagues3 noted the 
value of computed tomography in 
assessing lesions in all mediastinal 
compartments. Keen and Libshitz,13 
in their evaluation of computed to­
mography in patients with thymic 
lesions, found that it contributed 
information over and above the 
standard chest x-ray film in more 
than 50% of cases. Additional find­
ings noted in their series included 
evidence of encapsulation of the 
lesion, mediastinal soft-tissue inva­
sion, metastases and recurrence 
after therapy. Although not men­
tioned in previous series, computed 
tomography correctly identified me­
diastinal thyroid tissue in all three 
cases in our group, with no false­
positive interpretations. In none of 
these cases were the goitres hyper­
functioning. It has been suggested14 
that hyperthyroidism in a patient 
with an anterior mediastinal mass 
can be due to thymic lymphoid 
hyperplasia, which may be treated 
effectively without surgery. Lym­
phoid lesions can easily be distin­
guished from thyroid lesions by 
computed tomography.
Serum radioimmunoassay for 
AFP and bHCG is an important new 
noninvasive test in some patients 
with anterior mediastinal masses. 
More than 90% of nonseminoma- 
tous malignant germ cell tumours 
secrete either AFP or bHCG,3 and 
most of them are in men under 50 
years of age.15 Therefore, we agree 
with the recommendation for rou­
tine measurement of these two sub­
stances in young men with anterior
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mediastinal masses.3 In our series, 
five patients underwent this test, 
three giving a positive result; there 
were no false-positive or false-nega­
tive results.
With increasingly accurate preop­
erative examinations, the various 
methods of establishing tissue diag­
nosis and the nonsurgical treatment 
protocols available, a management 
plan for patients with anterior medi­
astinal masses is desirable. The al­
gorithm we found useful is illustrat­
ed in Fig. 1. Tumour encapsulation 
or infiltration into the mediastinum 
and the possibility that the tumour 
is thymic, thyroid or vascular, can 
all be assessed by computed tomog­
raphy using an intravenous bolus of 
contrast material. Thus, we used 
the findings of this examination as 
a major branching in our manage­
ment schema. If the mass is found 
to be of thyroid tissue or thymic 
encapsulated, it is excised if clinical­
ly indicated. If the lesion infiltrates 
the anterior mediastinum and the 
patient is male between the ages of 
10 and 50 years, AFP and bHCG 
assays are done. In the event of a 
positive result, chemotherapy is fol­
FIG. 1. Algorithm for diagnosis and 
treatment of anterior mediastinal mass­
es. AFP =  a-fetoprotein, bHCG =  
human chorionic gonadotropin, /3-sub­
unit.
lowed by surgical removal of the 
necrotic tissue.6 With a negative 
result, tissue diagnosis is required 
either by fine-needle biopsy, cervical 
or parasternal mediastinoscopy, an­
terior mediastinotomy, thoracotomy 
or sternotomy, depending on the 
site and size of the lesion.
Conclusions
Having demonstrated the need 
for a more selective diagnostic ap­
proach to the patient who has an 
anterior mediastinal mass, we have 
presented an investigative algo­
rithm. The diagnosis of malignant 
nonseminomatous germ cell tumour 
can be established by tumour mark­
ers (AFP, bHCG), which will be 
elevated in more than 90% of cases. 
Needle biopsy, mediastinoscopy and 
anterior mediastinotomy will pro­
vide adequate tissue for the diagno­
sis of lymphoproliferative disorders. 
Other lesions may need open biopsy 
or excisional surgery. This diagnos­
tic approach should, theoretically, 
eliminate unwarranted thoracoto­
mies and sternotomies.
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BOOK REVIEWS
continued from page 120
or topic is omitted. References are de­
tailed and have been updated. The chap­
ters are arranged by body systems and 
cover congenital, inflammatory, degen­
erative, dysplastic, neoplastic and im­
munologic lesions as well as lesions of 
uncertain pathogenesis. Clinicopatho- 
logical correlation is discussed, but this 
is not an outstanding feature of the 
book. The chapters on the alimentary 
tract, lymphohematopoietic system and 
cardiovascular system are excellent.
The charts and tables of differential 
diagnosis are extremely useful and far 
surpass those found in some textbooks 
on pathology of a single organ. For a 
pathologist, the relative lack of gross 
photographs is not a defect, but may it 
be for the clinician. There are over 
1400 photomicrographs. They are re­
produced as non-glossy prints which is 
disconcerting initially.
For the clinician, this is an excellent 
reference book without numerous elec­
tron photomicrographs or detailed im- 
munocytochemistry to distract. For the 
pathologist, it is a current, detailed, 
everyday working book with a lucid 
style.
This book is recommended as a refer­
ence book for clinicians and as a basic 
text for pathologists and residents in 
pathology.
D.P. Hill, MD, FRCPC
Clinical Professor o f Pathology,
Faculty o f Medicine,
University o f  Ottawa.
Director o f Medical Education,
Ottawa General Hospital,
501 Smyth Rd.,
Ottawa, Ont.
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TRAUMA, SEPSIS AND SHOCK. 
THE PHYSIOLOGICAL BASIS OF 
THERAPY. Edited by George H.A. 
Clowes, Jr. 587 pp. Illust. Marcel Dek- 
ker, Inc., New York, 1988. $125.00 
(US). ISBN 0-8247-7502-3.
This comprehensive text on the fre­
quently related subjects of trauma, sep­
sis and shock, is organized into six 
parts: basic background, physiological, 
metabolic and immunologic responses, 
healing, monitoring and support. There 
are 35 contributors, most of them im­
mediately recognizable for their interest 
and expertise in the subjects they cover.
The authors take full advantage of 
diagrams, flow charts and summary 
tables to present their material. For 
example, one table presents the 18 
preventive factors known to reduce sur­
gical infections, documents the basic 
reason for the efficacy of each and 
provides one pertinent reference for 
each. A concise summary statement 
also accompanies most chapters.
Although this work is mainly con­
cerned with basic mechanisms and 
pathologic responses, there is a host of 
material on practical stepwise manage­
ment of difficult clinical problems. 
Much dogma is challenged. For exam­
ple, a statement with which 1 agree is 
“the widespread use of fresh frozen 
plasma for restoration of oncotic pres­
sure, for augmentation of the immune 
system in injured patients or for the 
rapid correction of hypoproteinemia is 
unwarranted.”
Caloric and specific substrate require­
ments in normal and in acutely ill 
patients are discussed and it is noted 
that increasing the daily amino acid 
content of intravenous solutions over
2.5 m g/kg is wasteful. Glucose calories 
are preferred over fat calories in the 
acutely ill and a rate per minute of 5 
m g/kg is well tolerated. This translates 
into a 2.5% amino acid solution provid­
ing 4184 kJ/L  with administration of
3.5 L /d  to a patient weighing 70 kg. 
The amount of protein lost with injury 
and sepsis cannot be eliminated by 
administering protein and calories but 
can be greatly reduced. The importance 
of calories is emphasized in this process 
which decreases gluconeogenesis by the 
liver.
Excellent suggestions, based on ele­
gant previous investigation, to prevent 
multiple-system organ failure include 
the immediate operative fixation of frac­
tures which markedly reduces ventilator 
time, high protein enteral nutrition,
vigorous cardiopulmonary resuscitation 
and early resection of all necrotic tissue.
The precise identification of patients 
likely to have a septic complication and 
die as a result has been the subject of 
countless projects but still eludes our 
grasp. However, these investigations 
have revealed many abnormalities of 
cellular, humoral and general immuno­
logic responses in injured patients. 
Even the most skeptical now agree that 
defects in host resistance are important 
preliminaries to sepsis and death, even 
though the precise mechanisms remain 
to be defined and the predictors are not 
infallible. Specific immune therapy to 
treat a given defect in lymphocyte func­
tion, polymorph delivery or antibody 
production rate is not yet available. In 
contrast, the role of antibiotics, given 
either prophylactically or therapeutical­
ly, is now clearly defined and is suc­
cinctly presented.
The final section on monitoring and 
support is particularly well done. It 
contains excellent, clearly described 
practical information on the detailed 
management of critically ill patients. 
Many problems of the critically injured 
can be avoided by good initial care, and 
this is repeatedly emphasized, but ex­
pert care of devastating problems and 
serious complications can also result in 
a successful outcome.
This text emphasizes physiological 
principles, background developments 
and practical expert appreciation of this 
knowledge in the treatment of patients 
with shock and sepsis which frequently 
follow trauma.
This publication can be enthusiasti­
cally recommended to all physicians 
dealing with the victims of trauma, 
particularly to those with a special 
interest in shock and sepsis.
Lloyd D. MacLean, MD, FRCSC
Coeditor,
Canadian Journal o f  Surgery
Surgeon-in-Chief,
Royal Victoria Hospital,
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Montreal, PQ 
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GENERAL SURGEON: SK -  An opportunity 
exists for a general surgeon to join in busy 
practice of general surgery, university centre, 
western Canada. Please send CV to: Box 
726, Canadian Journal of Surgery, PO Box 
8650, Ottawa, ON K1G 0G8. -S89-01
GENERAL PRACTITIONER/ANESTHE-
TIST: AB -  Required by a well established 
15-doctor group. Laboratory and x-ray facili­
ties in clinic. Accredited 120-bed active treat­
ment hospital in community of 12 000 and 
servicing the regional needs of 30 000 peo­
ple, Camrose is a beautiful place to live; close, 
but not too close to Edmonton, with universi­
ty accredited, active recreational, sports and 
cultural programs. Contact: Mr. T. C. Ofrim, 
administrator. Smith Clinic, 4825-51 St., 
Camrose, AB T4V 1R9. Tel: (403) 672 
2424. -S89-08
GENERAL SURGEON: BC -  Required by 
Saltspring Island, one of BC's Gulf Islands, 
population 7000. Nine practising doctors in­
cluding internist; 19-bed acute care unit, 
31-bed extended care. Suitable for semi- 
retirement. Good potential, low overhead. 
OR, ER and delivery suite recently modern­
ized. Apply in confidence, enclosing curricu­
lum vitae, to: Dr. A. C. Waldie, chief of 
staff. Lady Minto Gulf Islands Hospital, 
Ganges, BC VOS 1EO. Person-to-person 
telephone enquiries: (604) 537-9464 (res­
idence), (604) 537-5545 (hospital).
-S89-09
GENERAL SURGEON AND ORTHOPEDIC 
SURGEON: BC — For thriving BC sunshine 
coast community of 20 000 on the doorstep 
of Desolation Sound. Fully accredited 
140-bed hospital under construction. Medical 
staff includes 17 GPs, 4 GP anesthetists, 
internist, pediatrician and 2 surgeons. Excel­
lent year round recreation and cultural attrac­
tions include boating, fishing, golfing, modern 
indoor recreation theatre complex and com­
munity college. Frequent daily air and ferry 
connections to Vancouver. Contact: Dr. B.K. 
Cutler, Department of Surgery, Powell 
River General Hospital, 5871 Arbutus 
Ave., Powell River, BC V8A 4S3. Tel: 
(604)483-3211. -S89-10
SPINAL SURGERY FELLOWSHIP: ON -
Available July 1, 1989 and July 1, 1990, 
Department of Surgery, Division Orthopedic 
Surgery, University of Western Ontario, Lon­
don. For information contact: Stewart I. Bai­
ley, MD, FRCSC, 345 Westminster Ave., 
London, ON N6C 4V3. Tel: (519)
439-0701. -S89-11
Canadians all over are 
waiting for the gift of a 
life-saving transplant.
The Kidney 
Foundation of Canada 
urges you to sign an 
organ donor card.
GENERAL 
SURGEON
Applications are invited from recently 
qualified General Surgeons with 
Canadian fellowship qualifications 
and who are eligible for licensure in 
B.C.
The Fraser-Burrard Hospital Society 
(Royal Columbian Hospital, 500-bed 
major referral and teaching centre 
and Eagle Ridge Hospital, 150-bed 
community hospital) serves a com­
munity of approximately 140 000 
people and a catchment area of 
200 000. The hospitals are located in 
New Westminster and Coquitlam, 
just 20 minutes by rapid transit or 
freeway to downtown Vancouver 
and close to multi-recreational areas.
Direct inquiries with curriculum vitae 
to: Dr. R.C. MacPherson, Vice Presi­
dent, Medicine, The Fraser-Burrard 
Hospital Society, 260 Sherbrooke 
Street, New Westminster, BC V3L 
3M2. S-89-12
The Fraser-Burrard 
Hospital (Society
Royal Columbian _  Eagle Ridge
Hospital Hospital
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